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A B S T R A C T
This Ph.d. project describes the development of a workflow for Monte
Carlo Treatment Planning for clinical radiotherapy plans. The work-
flow may be utilized to perform an independent dose verification of
treatment plans. Modern radiotherapy treatment delivery is often con-
ducted by dynamically modulating the intensity of the field during the
irradiation. The workflow described has the potential to fully model
the dynamic delivery, including gantry rotation during irradiation, of
modern radiotherapy.
Three corner stones of Monte Carlo Treatment Planning are identi-
fied: Building, commissioning and validation of a Monte Carlo model
of a medical linear accelerator (i), converting a CT scan of a patient
to a Monte Carlo compliant phantom (ii) and translating the treat-
ment plan parameters (including beam energy, angles of incidence,
collimator settings etc) to a Monte Carlo input file (iii).
A protocol for commissioning of a Monte Carlo model of a medical
linear accelerator, ensuring agreement with measurements within 1%
for a range of situations, is presented. The resulting Monte Carlo
model was validated against measurements for a wider range of
situations, including small field output factors, and agreement with
measurements within 1–2% was found. Although the protocol was
applied to a specific accelerator type it can be applied to any medical
linear accelerator with similair design.
A new algorithm for converting CT scan of a patient to a Monte
Carlo compliant phantom is presented. It is more sophisticated than
previous algorithms since it uses delineations of structures in order to
include and/or exclude certain media in various anatomical regions.
This method has the potential to reduce anatomically irrelevant media
assignment.
In house MATLAB scripts translating the treatment plan parameters
to Monte Carlo input files were written. The scripts are tested and val-
idated for modern treatment delivery including multi leaf collimator
movement and gantry rotation during irradiation.
Moreover, a workflow binding the elements together and thus en-
abling Monte Carlo Treatment Planning is presented.
Comparison between dose distribution for clinical treatment plans
generated by a commercial Treatment Planning System and by the im-
plemented Monte Carlo Treatment Planning workflow were conducted.
Good agreement was generally found, but for regions involving large
density gradients differences of 6% were observed.
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D A N S K S A M M E N FAT N I N G
Dette Ph.d.-projekt beskriver udviklingen af en arbejdsproces for
Monte Carlo beregning af kliniske strålebehandlingsplaner. Arbejd-
sprocessen kan anvendes til at udføre en uafhængig dosis kontrol
af behandlingsplaner. Moderne strålebehandling leveres ofte ved at
dynamisk modulere intensiteten af feltet under bestrålingen. Den
beskrevne arbejdsproces har potentiale til fuldt at modellere den dy-
namiske levering, inklusive rotation af stålehovedet under bestråling.
Tre hjørnestenene i Monte Carlo beregning er identificeret: Kon-
struktion, kommissionering og validering af en Monte Carlo model af
en medicinsk lineær accelerator (i), konvertering af en CT–scanning af
en patient til et Monte Carlo kompatibel phantom (ii) og oversætte af
behandlingsplanens parametre (herunder stråleenergi, indfaldsvinkler,
kollimator indstillinger osv.) til en Monte Carlo inputfil (iii).
En protokol for kommissionering af en Monte Carlo model af
en medicinsk lineær accelerator, der sikrer overensstemmelse med
målinger indenfor 1% for en række situationer, er præsenteret. Den
resulterende Monte Carlo model blev valideret mod målinger for en
bredere række af situationer, herunder output faktorer for små felter,
og overensstemmelse med målinger inden for 1 til 2% blev fundet.
Selv om protokollen blev anvendt til en specifik accelerator type, kan
den anvendes på enhver medicinsk lineær accelerator med lignende
design.
En ny algoritme for at konvertere en CT–scanning af en patient
til et Monte Carlo kompatibel fantom blev præsenteret. Den er mere
sofistikeret end tidligere algoritmer, da den bruger afgrænsning af
strukturer med henblik på at inkludere og/eller udelukke visse mate-
rialer i forskellige anatomiske regioner. Denne metode har potentialet
til at reducere anatomisk irrelevant materiale tildeling.
MATLAB scripts til oversætte af behandlingsplan parametre til
Monte Carlo inputfiler blev kreeret. De scripts blev testet og valid-
eret for moderne strålebehandlings levering, herunder multi blad
kollimator bevægelse og gantry rotation under bestråling.
Desuden er en arbejdsproces der binder elementerne sammen og
dermed gøre det muligt at udføre Monte Carlo beregninger præsen-
teret.
Sammenligning mellem dosisfordeling for klinisk behandling planer
genereret af et kommercielt planlægningssystem og af det præsen-
terede Monte Carlo beregnings proces er udført. God overensstem-
melse blev generelt fundet, men for regioner, der involverer store
densitetsgradienter blev forskelle omkring 6% observeret.
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D I S S E RTATAT I O N O B J E C T I V E S A N D O U T L I N E
Radiotherapy is regulated by the mutually contradicting objectives of
delivering a high and uniform dose to the target volumes while sparing
any surrounding healthy tissue. Thus it is integral that the absorbed
dose can be accurately predicted. A decrease in dose to the target
may lead to a severe decrease in Tumor Control Probability (TCP).
Meanwhile, an excessive dose to the healthy tissue might lead to
drastically increased Normal Tissue Complication Probability (NTCP).
Due to the high dependence on dose of the TCP and NTCP curves
and the small therapeutic window, even small deviations in dose may
have serious consequences (see Figure 1).
International Commission on Radiation Units and Measurements
(ICRU) recommends a dosimetrical accuracy, with respect to the
planned dose, within 5% for the entire treatment chain [International
Commission on Radiation Units and Measurements, 1976], which
includes uncertainty of dose calculation, set upp errors, intra fraction
movement etc. In order to acheive this limit it is estimated that the
dose accuracy must be within 3% [Fraass et al., 2003].
Currently, commercially available treatment planning systems for
high energy photon external beam, radiotherapy apply analytical
approximations in the calculation of the delivered dose to the patient.
Such approximations might lead to errors in the calculated dose. The
are largest in regions of the body with considerable changes in mass
density; e.g. in the chest where there is a large density difference
between lung and other tissues and in the head and neck region
where air cavities are present.
Monte Carlo (MC) methods have the potential to accurately calculate
dose in heteregoneous geometries as it relies on precisely determined
interaction cross sections and do not inherently employ any approxi-
mations. The major factors limiting the obtainable accuracy using an
MC dose calculation engine are:
• how accurately the linear accelerator (linac) is modelled,
• statistical uncertainty due to the stochastic process of MC simu-
lation,
• how accurately the dose scoring geometry can be modelled,
• uncertainties in the cross section database, and
• uncertainties in the modeling of the particle transport.
Implementation of a MC treatment planning work flow is not a plug
and play task, but requires efforts in numerous areas. A virtual model
1
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Figure 1: A schematic illustration of the dose dependence of TCP (green) and
NTCP (red). As the goal of radiotherapy is to achieve a high TCP
while a limited NTCP the absorbed dose should be in the region
with the maximum TCP for acceptable NTCP. This region is called
the therapeutic window (blue).
of a linear accelerater must be built and verified against measured
doses for a range of situations. The geometry in which dose is to be
calculated, this may be a homogenous phantom or a highly heterego-
neous patient geometry, must be accurately represented in terms of
interaction cross sections. Furthermore, means of realizing treatment
planning parameters, such as gantry angle, jaws and Multi Leaf Colli-
mator (MLC) positions etc. in the simulation must be designed and
validated.
Although the particle transport in Monte Carlo codes is highly
accurate, it is important to remember that the MC–linac output is com-
missioned using free parameters fitted to dosimetrical measurements.
MC simulations report statistical uncertainty only. Adding uncertainty
due to fitted parameters will be a step towards the full image of the
uncertainty associated with MC simulation of medical linacs.
A properly commissioned MC system may be used to perform full
MC dose calculation, to a high level of accuracy, in patient geometry
as well as to study highly specific dosimetrical properties that are
impractical or even impossible to measure physically.
Recently developed treatment delivery techniques (e.g. Intensity
Modulated RadioTherapy (IMRT) and Volumetric Modulated Arc
Therapy (VMAT)) consist of beam segments under which cavity theory,
and thereby currently available dosimetry protocols, does not hold
true. No valid protocol for dose measurements of such segments has
been established and the uncertainty on dose in such segments, and
thereby in treatments applying them, is unknown and might be large.
dissertatation objectives and outline 3
MC dose calculation can be utilized for situations where experimen-
tal measurements are impractical. For any given situation it is possible
to assign an ideal detector in MC. Correction factors for experimental
measurements can also be derived using MC.
The overall objectives of this Ph.D. project were to address the
following topics using accurate Monte Carlo calculation procedures of
radiation transport.
1. Develop and implement a work flow enabling Monte Carlo
Treatment Planning for conventional as well as advanced ra-
diotherapy. Benchmark results obtained with the conventional
treatment planning system against high–accuracy Monte Carlo
calculations for all types of treatment plans.
2. Benchmark commercial dose calculation engines against Monte
Carlo for sites containing heterogeneous geometries, which are
most susceptible to errors introduced by the approximation
based dose–calculation algorithms used by the treatment plan-
ning systems of today (e.g. lung and head&neck).
3. Investigate the usability of alanine/EPR dosimetry in advanced
radiotherapy beams and give recommendation based on issues
related to energy dependence, dose gradients and perturbation.
4. Determine the influence of fitted parameters on the resulting
fluence produced by the Monte Carlo–model of the linear accel-
erator.
The scope of this thesis is limited to consider high energy photon
radiation only. Moreover, measurements as well as Monte Carlo sim-
ulations are conducted using Varian 2300 iX linacs or Monte Carlo
models thereof. The thesis is structures as follows:
Chapter 1 deals with the theoretical aspects of dosimetry in radio-
therapy and specifically addresses issues regarding dosimetry
under situations where reference conditions are not applicable.
Chapter 2 serves as a short introduction to Monte Carlo techniques
in radiotherapy. The main features of the different MC codes
used throughout this dissertation are also discussed.
Chapter 3 accounts for the commissioning and verification of the
virtual Monte Carlo model of the linac in question. The free
parameters, mean energy and radial distribution of the imping-
ing electrons are determined through fitting simulated profiles
and output factors to the corresponding measurements. Further-
more, the considerations made on the modeled electron fluence
incident on the linac target are discussed and motivated.
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Chapter 4 regards the conversion of patient Computer assisted To-
mography (CT) data to density and tissue composition, which
are the information needed in order to perform Monte Carlo
simulation using the codes encompassed in this thesis. A new
algorithm for the conversion of CT data to a MC compliant phan-
tom is presented in section 4.4. It uses delineations of structures
in order to include and/or exclude certain media in various
anatomical regions. This method has the potential to reduce
anatomically irrelevant media assignment.
Chapter 5 highlights the most important issues to consider when
translating the parameters of a DICOM treatment plan file to a
EGS4/EGSnrc compliant input file and covers the steps necessary
to calibrate the virtual MC model to report absolute dose as op-
pose to dose per particle incident on the linac target. Simulated
field size dependent monitor chamber BackScatter correction
Factors (BSFs) are compared to measurement and it is confirmed
that the use of directional bremsstrahlung splitting does not
compromise simulation of backscatter correction factors.
Chapter 6 summarizes the Monte Carlo Treatment Planning (MCTP)
work flow developed in this study. In essence, it serves as a
cookbook on how to go from a treatment plan in a Treatment
Planning System (TPS) to full Monte Carlo dose calculation,
converting the resulting dose distribution to absolute dose (Gy)
and rewriting the structure of the EGS4/EGSnrc outputted dose
file to a DICOM RP file.
Chapter 7 holds comparisons between dose distributions obtained
through analytical calculations, by means of a treatment plan-
ning system, and through Monte Carlo simulations. Moreover,
the influence of the fitted MC model parameters on the dose dis-
tribution of advanced radiotherapy treatment plans is discussed.
Chapter 8 investigates the need of additional correction factors
for alanine/EPR dosimetry under non reference conditions by
means of MC simulations.
Chapter 9 studies the potential use of an alanine/EPR based dosime-
try system for determining small field ROFs by means of com-
paring measurements to Monte Carlo simulations.
Appendix A is a paper published in Physics in Medicine and Biol-
ogy. The choice between low and high energy photon energy
for Intensity Modulated RadioTherapy treatment of non–small
lung cell cancer is investigated using Pareto front analysis. The
included dose calculation algorithms are the Pencil Beam Con-
volution algorithm, the Analytical Anisotropical Algorithm and
Monte Carlo.
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Appendix B is a paper published in Physics in Medicine and Biology.
A new algorithm, using delineation of structures in order to
include and/or exclude certain media in various anatomical re-
gions, for the conversion of CT data to a MC compliant phantom
is presented and tested for a number of clinical cases.
Appendix C is a paper published in Physics in Medicine and Biology.
A dosimetry system based on fiber–coupled organic scintillators
is presented. It has the potential to conduct point measurements
of absorbed dose in radiotherapy beams involving high spatial
and temporal dose gradients. The system is tested against Monte
Carlo simulations for Percentage Depth Dose curve and Relative
Output Factor for square fields down to 0.6×0.6 cm2 size.
Appendix D is a paper submitted for publication in Radiation Mea-
surements. The need for additional correction factors for alanine
dosimetry in small field photon beams is investigated using MC.
Appendix E is an unpublished study in which the Monte Carlo
simulation of palliative IMRT lung treatment is compared to dose
calculated by Pencil Beam Convolution algorithm and Analytical
Anisotropical Algorithm for low (e.g. 6Mega Voltage (MV)) and
high (e.g. 15MV) photon beams.

1
I N T R O D U C T I O N
The field of radiotherapy has evolved greatly over the years. Some of
the milestones are the construction of the medical linac, the CT imag-
ing and the introduction of IMRT. An integral part of the evolution
of external beam radiotherapy has been the rapid development and
increased availability of computers.
The objective of radiotherapy is to kill cancerous tissue, while mini-
mizing the short and long term effects of surrounding healthy tissue.
Ionizing radiation induce unrepairable DNA damage to tissue by caus-
ing single and double–strand breaks which leads to cell death if the
damage is beyond repair. Thus, the goal of radiotherapy is to deliver
high doses of ionizing radiation to cancerous tissue, while low doses
to surrounding healthy tissue. These objectives are naturally mutually
contradicting, which leads to radiotherapy being a trade off between
the two objectives.
The absorbed dose is defined as the absorbed energy deposited
by the ionizing radiation in a medium per mass unit, i.e J/kg. The
International System of Units (SI) derived unit for absorbed dose is
gray (Gy) after the British physicist Louis Harold Gray (1905–1965).
Radiotherapy can be classified as internal or external depending
on weather the source of radiation is situated inside or outside of
the patient during treatment, respectively. External radiotherapy can
furthermore be divided according to the primary delivery particle type
(e.g. photon, electron, positron etc.). This dissertatation encompass
only external beam radiotherapy using high energy X–rays and for
simplicity this is what will be referred to whenever radiotherapy is
discussed, unless otherwise specifically stated.
1.1 the linac
In medical linacs (Figure 2) electrons, generated from a filament (the
electron gun) are accelerated to a given potential, using an RF–field.
Once accelerated, the electrons are directed onto the target using
a bending magnet, which also functions as an energy filter. For
high energy X–rays the electron beam is incident on a high–Z tar-
get in which the electrons undergo interaction resulting in a divergent
bremsstrahlung photon beam. The photons emitted from the target
are referred to as the primary radiation.
A number of additional components, each with a specific purpose,
are encompassed in the treatment head and each of them generate
scattered, or secondary, radiation. The largest source of secondary
7
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Figure 2: One of the Varian Clinac 2300 iX linacs located at the Copenhagen
University Hospital, Herlev.
radiation is the field flattening filter [Jaffray et al., 1993], which is
introduced in order to ensure uniform radiation intensity distribution.
Two independent transmission ionization chambers are mounted
below the flattening filter as a dose monitoring system.
The shape of the photon beam emitted form the treatment head can
be defined using a beam limiting aperture. A fixed primary collimator
is located close to the bremsstrahlung target, while movable secondary
collimating jaws are located further down the beam direction. These
jaws are made of a material with high atomic number, usually tungsten,
which blocks transmission of radiation through them. In addition
to the secondary jaws a set of opposing MLC banks (Figure 3) are
mounted on modern linacs. An MLC bank consists of a number of
parallel collimating leafs, with a typical width of 2.5 to 5 mm each.
The leafs may be positioned independently of each other and can thus
be utilized to produce irregular field shapes that can be conformed to
a desired target. The design of the MLCs leads to inter– and intra–leaf
leakage and are therefore commonly used in conjunction with the
collimating jaws.
1.1.1 Calibration
It is the upper transmission ionization chambers (the monitor cham-
bers), located in the linac treatment head, that are responsible for
terminating the beam when the requested dose has been delivered.
The monitor chamber is located above the beam collimating devices
and is therefore relatively1 insensitive to changes in field size and is
1 Depending on the design of the linac a small field size dependent back scatter
contribution to the monitor chamber dose may be observed.
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Figure 3: The MLC used in the Varian Clinac 2300 iX linacs located at the
Copenhagen University Hospital, Herlev. The two opposing banks
are located above each other. The individual leaf can be positioned
independently of each other.
blind to the actual patient or phantom geometry. Therefore an addi-
tional unit of dose has been established, namely Monitor Unit (MU). In
order to relate the signal from the monitor chamber to a physical dose
in the treatment geometry it is necessary to calibrate the linac. The
calibration is typically conducted so that the delivery of 100 MU for a
10×10 cm2 field, delivered with a Source to Surface Distance (SSD) of
100 cm corresponds to 1 Gy at the maximum dose along the central
axis, dmax, in a homogeneous water phantom [Almond et al., 1999;
Andreo et al., 2000].
1.2 treatment delivery
The treatment mode can be categorized depending which features that
are being employed during the beam delivery. Each treatment delivery
mode has its benefits and drawbacks and ultimately the choice of
delivery mode is determined by the characteristics of the region that
is to be treated. The treatment delivery modes encompassed by this
dissertatation are outlined in chronological order in the following text.
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1.2.1 3D Conformal Radiotherapy
Before the introduction of computers in radiotherapy, the delivered
dose was calculated by hand using simple methods. With the intro-
duction of computers, the dose could be calculated on a 3D rendered
volume of the patient, typically a CT scan.
Prior to the introduction of MLCs, treatment fields were defined
using the secondary collimator alone. This limited the shape of the
treatment field to square geometries seriously compromising the con-
formity of the treatment field. Field specific molded lead blocks were
at times used to achieve increased conformity. The drawback of lead
blocks is that they need to be manually positioned before delivering
the treatment field and removed after. This drawback was eliminated
with the introduction of the MLCs as they can be positioned automati-
cally.
1.2.2 Intensity Modulated Radiotherapy
IMRT is a treatment modality in which MLC leaves are used to mod-
ulate the intensity of the radiation. This can be achieved either by
dynamically moving the MLC during the beam delivery (dynamic
IMRT) or by dividing the treatment field into a number of static
segments each with a different MLC collimation and delivering the
radiation when the MLC are positioned in accordance with one of
the segments (step and shoot IMRT). The advantage of IMRT over 3D
Conformal RadioTherapy (3DCRT) is the possibility of higher dose
conformity to the target, while still sparing proximal healthy tissue.
The inherent drawback of IMRT over 3DCRT is an increased com-
plexity. Stricter demands are required on the precision of the MLC as
they are used to shape the dose region throughout the field rather than
along the edges of the field. A non–flat lateral dose profiles requires a
Quality Assurance (QA) system in which the dose is measured using
a high spatial resolution.
1.2.3 Volumetric Modulated Arc therapy
VMAT is a recent sophistication of IMRT. The implementation of
VMAT on Varian linacs is called RapidArc (developed by Varian Med-
ical Systems Inc., USA). As for IMRT the target conformity is achieved
by modulating the intensity of the radiation. The most apparent dif-
ference between VMAT and IMRT is that the entire linac gantry is
rotated during delivery in addition to the dynamically moving MLC
jaws. Moreover the rotational speed of the gantry and the dose rate
may be varied continuously during the beam delivery.
The target conformity and dose sparing of healthy tissue of VMAT
is comparable to that of IMRT, but since the treatment can be delivered
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faster it generally requires less MUs [Otto, 2008]. Compared to IMRT
a VMAT delivery is more complex and poses higher demands on
precision of the gantry angle as well as the dose rate. The QA of
VMAT is more demanding as it requires a non–angular dependent
detector or a reliable method to correct for the dependence.
An apparent drawback of increased complexity of treatment delivery
is that the resulting dose distribution is less intuitive.
1.3 treatment planning
The treatment planning process is conducted using a dedicated soft-
ware – a Treatment Planning System. Patients scheduled for radio-
therapy are commonly diagnosed using a three dimensional imaging
modality (e.g. CT, Magnetic Resonance Imaging (MRI) or Positron
Emission Tomography (PET)–CT). Once diagnosed the Clinical Target
Volume (CTV), or volumes if multiple, is delineated on the image
data set. Margins are added to the CTV in order to account for uncer-
tainties of the delineated volume and the setup procedure as well as
for movement of the CTV during treatment. The CTV with margins
applied is called the Planning Target Volume (PTV). The prescribed
dose to the target volume, ordinated by a radiation oncologist, will de-
pend on the type of diagnosis. Population based dose response curves
for tumor cells as well as for healthy tissue have been derived and
allow for translation of an expected radiological effect to a measurable
physical dose. Ideally, a high and uniform dose would be delivered
to the target, while not irradiating the surrounding healthy tissue at
all. The PTV and important Organ At Risk (OAR), each with its own
dose constraints, are delineated on the image data set. The objective of
treatment planning procedure is to ensure delivery of the ordinated
dose to the PTV, while not exceeding the constraints of the OARs. Due
to the characteristics of the interaction of high energy photons with
matter those objectives are often mutually contradicting. Therefore
radiation therapy is often a balance between target coverage and OAR
sparing. The prescribed target dose is often delivered using multiple
angles of incidence as an act to limit the dose to OARs. Moreover, the
prescribed dose is often delivered in multiple fractions. This procedure
makes use of the feature that healthy cells exhibit a higher repair rate
than malignant cells.
The treatment planning approach will inevitably depend on the
treatment delivery mode. For static delivery modes (i.e. 3DCRT) a
technique called forward planning is employed, while a technique
called inverse planning is utilized for dynamic delivery modes (i.e.
IMRT and VMAT).
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1.3.1 Forward Planning
For 3DCRT an forward planning approach is utilized. The procedure
starts by defining a number of beams each with its individual set of
parameters, such as x–ray energy, gantry, collimator and couch angle,
MU as well as collimator and MLC settings. The planning procedure
is a trial and error process in which beams are added, removed or have
their parameters altered. The forward planning process is determined
to be completed once a satisfactory treatment plan has been achieved.
1.3.2 Inverse Planning
For treatment modalities where the delivered fluence is intensity mod-
ulated an inverse planning approach is utilized. Initially the procedure
resembles the forward planning process as a number of beams (or arcs)
each with a set x–ray energy, gantry (start and end angle for VMAT),
collimator and couch angle as well as collimator settings are defined.
For inverse treatment planning the modulated fluence is determined
using an optimization process. At the start of the optimization process
Dose Volume Objectives (DVOs) each with a weight factor, related to
the importance of fulfilling the objective, are assigned to important
structures (e.g. CTV, PTV, OAR etc.) in accordance with the dose pre-
scription. An iterative optimization process is conducted in order to
achieve a dose distribution in accordance with the specified objectives.
The optimization is terminated when a satisfactory treatment plan
has been achieved. The optimized fluence is converted to deliverable
fluence by taking the MLC movement (and gantry rotation in the case
of VMAT) into account.
1.3.3 Dose Calculation
In order to predict the dose distribution in the patient delivered in a
given treatment plan, analytical dose calculation algorithms have been
developed. The dose calculation process in a TPS needs to be accurate,
but it is also required to be fast as not to be a bottle neck in the
patient flow of a radiotherapy clinic. This has lead to the development
of a number of approximation based commercially available dose
calculation algorithms.
1.3.3.1 Commercial Dose Calculation Algorithms
Throughout this study the Varian Eclipse (Varian Medical Systems Inc.,
USA) TPS was used for treatment planning. Two different dose calcu-
lation algorithms were however used; the Pencil Beam Convolution
algorithm (PBC) and the Analytical Anisotropical Algorithm (AAA).
The two algorithms share many commonalities, but are distinct in
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certain aspects. The following text aims at describing the general
procedure of a dose calculation algorithm but will also describe the
differences between the two algorithms and outline their respective
approximations.
The dose distribution can be divided into four main components
[Ahnesjö and Aspardakis, 1999]; dose due to
a) primary particles,
b) secondary (scattered) particles originating from the treatment head
(head scatter),
c) secondary (scattered) particles originating from the patient or phan-
tom geometry (phantom scatter), and
d) dose due to contaminating electrons.
The primary and phantom scatter components contribute the most
to the dose and originate from photons that have not interacted before
reaching the patient. Dose due to head scatter and contaminating
electrons stem from photons that have undergone interaction in the
treatment head prior to being incident on the patient or – i.e. secondary
particles. The interaction processes might lead to electrons with energy
high enough to reach the patient (d) or to photons scattered in the
treatment head reaching the patient (b). Head scattered photons (b)
might reach large depths in the dose scoring geometry, whilst the
charged particles only have range of a few centimeters.
Commercial dose calculation algorithms are based on dose kernels.
Considering a dose scoring region, divided into voxels, the dose
distribution from a single point kernel will yield a dose distribution
governed by the photon interactions in a given voxel. The total dose
distribution of the dose scoring region is the summation of the photon
interactions from all point kernels, thus photon interactions occurring
in all voxels are accounted for. This process is usually referred to as
kernel superposition.
Most current algorithms use kernels that are calculated in a homoge-
neous medium (water). The dose computed by commercial algorithm
are based on two main parameters: the Total Energy Released in MAt-
ter (TERMA) by primary photons and a pattern for the dose deposition
about the interaction point of a primary photon (the kernel) [Papaniko-
laou et al., 2004]. The point kernels are typically integrated over the
z–axis, thus resulting in pencil kernels. In order to accurately compute
the dose distribution a number of factors needs to be considered:
• The dose scoring volume is not infinite, which means that special
surface effects need to be accounted for.
• The patient (or phantom) geometry may differ in atomic compo-
sition and density from water, which the kernels were calculated
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for, requiring a scaling of the kernels. Moreover, the geometry
may be heterogeneous requiring a complex density correction.
• The kernels are computed under the assumption of charged
particle equilibrium, which may not be fulfilled near tissue inter-
faces or at field edges.
• The divergence of the beam is not accounted for in the kernels,
which will have implications in the penumbra regions.
• The beam hardening effect is not accounted for in the compu-
tation of the kernels, and must be corrected for in the dose
calculation.
• The treatment fields are not identical to the fields for which the
TPS was commissioned. This introduces an uncertainty in the
characterization of the beam.
These issues are handled differently by the dose calculation algo-
rithms encompassed in this study. The approaches of each algorithm
is outlined in the following paragraphs.
the pencil beam convolution algorithm
The PBC consists of two steps; i: the beam reconstruction model
and ii: the patient model.
In the beam reconstruction model the dose is calculated for homo-
geneous water and is based on convolution of pencil beam kernels
that have been estimated from a measured data set used to describe
the accelerator. Beam modifiers are accounted for by modulating the
intensity of the fluence. The beam exiting the treatment head is de-
scribed by a field intensity function. The value of the field intensity
function has the value 1 if the pencil beam did not transverse any
beam modifier, 0 if either of the collimating jaws where encountered
and a value between 0 and 1 if an MLC was traversed. The attenuation
of the MLC is based on measured data.
In the patient model, the depth–dose is calculated through convo-
lution of the field intensity function with a 2D pencil beam scatter
kernel. The convolution, evaluated using fast Fourier transformation,
is performed at five standard depths only and followed by an interpo-
lation along the fanlines of the beam for the remaining voxels in the
dose grid. Moreover, the convolution is conducted under the assump-
tion that the geometry consists of homogeneous water and that the
kernel is spatially invariant. Thus, neglecting the effect of the off–axis
softening of the beam energy due to the shape of the flattening filter
[Ahnesjö and Aspardakis, 1999].
The heterogeneity of the patient or phantom geometry is handled
by a modified Batho inhomogeneity correction method [Wong and
1.3 treatment planning 15
Purdy, 1990]. A correction factor is computed for each voxel, taking
the electron density of the medium from the CT–scan and tabulated
Tissue Maximum Ratio (TMR) data for the beam energy into consid-
eration. Only density variations along the fan lines of the beam are
considered, this results in density correction not being applied for
positions located laterally from the calculation point. The dose ma-
trix computed in a homogenous water geometry is multiplied by the
correction factor–matrix. Furthermore, the modified Batho is invalid
for scattered radiation and assumes that all interactions are Compton
interactions. This is particularly an issue for higher energy, where
Compton interactions become less predominant, as the relative scatter
contribution will be overestimated.
the analytical anisotropic algorithm
The AAA is a pencil beam superposition algorithm, while still using
convolution in some situations. The algorithm consists of two steps
i: the source model, where the delivered beam is described using
a multiple–source model and ii: the patient model where the dose
deposition in the patient (or the phantom) is computed.
The source model divides the radiation into three different sources
[van Esch et al., 2006]:
primary source relates to the primary photons. The primary source
is assumed to be a point located at the focal point of the linac
target.
extra–focal source models the photons scattered in the flatten-
ing filter, the primary collimator and the collimating jaws.
electron contamination source considers the electrons origi-
nating from the photon interactions occurring in the linac head.
The energy spectrum resulting from each of the sources is computed
using Monte Carlo.
The primary photon source is modeled with three fundamental
physical parameters: The unattenuated initial photon energy spectra,
which is precalculated with MC methods. The mean radial energy, to
take into account the beam hardening effect from the flattening filter,
how the mean energy of the photon beam decreases with increase
distance from the beams central axis. The radial intensity profile takes
into account the variation of the photon fluence below the flattening
filter across the treatment field.
The extra–focal photon source is modeled as a virtual source with a
finite width located at the bottom plane of the flattening filter. This
second source is closer to the isocenter and by that produces a broader
beam than the primary photon source. It is calculated from the primary
fluence. This results in empirically based mean energy and relative
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intensity of the extra–focal photon spectrum. The off–axis variation in
the spectrum is not modeled.
The electron contamination source models charged particles orig-
inating from interactions in the flattening filter, monitor ionization
chambers, collimators and air. If accessories, such as MLCs, are em-
ployed a large fraction of the contaminating electrons will be observed
and the accessory itself will be treated as a source of contaminating
electrons. This is modeled with a depth dependent curve that de-
scribes laterally integrated electron contamination dose at different
depth. Parameters used to characterize the MLC are measurements of
the leaf transmission and the effective dosimetric opening between me-
chanically closed leaf pairs (the dosimetric leaf gap), where the latter
parameter takes the effects of the rounded leaf tip into consideration.
In the patient model a diverging coordinate system is defined in
order to account for the divergence of the beam. Each voxel is at-
tributed an electron density, which is determined using information of
the CT data set. The beam is split into narrow beams (beamlets) with
geometrical cross–sections corresponding to the resolution of the dose
calculation grid. The resulting dose distribution in the geometry is
calculated by superpositioning the dose from primary and secondary
photons as well as contaminating electrons for each beamlet.
The pencil beam kernels are computed using MC in a homogeneous
water geometry and composed by monoenergetic kernels weighted
according to the derived energy spectrum of the treatment beam. The
energy deposition from the primary and the extra–focal sources is
separated into a depth direction (along the fanline) and a lateral (per-
pendicular to the fanline) component. In the heterogeneity correction,
the depth and lateral components are scaled independently using the
inverse relative electron density. This implies that the dose geometry
is considered to be made of water with a varying density distribution.
The fluence of the contaminating electrons is modeled as a convolu-
tion of the primary fluence and a Gaussian distribution. The dose due
to the contaminating electrons is calculated as the convolution of this
fluence with a second Gaussian distribution, which is multiplied by a
depth dependent function.
The final energy distribution is the accumulated energy distribu-
tion of all sources. The energy distribution is converted to a dose
distribution by division by the relative electron density distribution.
1.3.3.2 Monte Carlo dose calculation
In addition to the analytical dose calculation algorithms, used in
current clinical routine, Monte Carlo methods can be applied. MC is
based on repeated random sampling using probability distributions.
Due to the stochastic nature of interaction of radiation with matter,
which can be well described by probability distributions, it is very well
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suited for MC simulations. MC applications in radiotherapy in general
and for dose calculation in specific is further discussed in Chapter 2.
1.3.4 The DICOM standard
Digital Imaging and Communications in Medicine (DICOM) is an
international standard for medical digital images and the informa-
tion related to them. The different components in the radiotherapy
treatment chain (e.g. CT, TPS and the linac) all communicate through
DICOM files. Moreover, all the information required at any given step
of the treatment process can be obtained in the DICOM files.
A DICOM file always contains a header, where all information
(imaging parameters, time stamp, patient ID and name etc.) is stored
in a standardized structure. If applicable the DICOM file will also
contain a 2D or 3D matrix of the element the DICOM file is describing.
For this dissertatation there are four classes of DICOM files that are
of interest.
ct During a CT scanning a DICOM file is created for each slice.
The 2D matrix containing the pixel values are encompassed in
the DICOM file along with information related to the scanning
procedure, such as scanning modality, the name of the scanner,
scanning potential, slice location, slice width etc.
structure The information about the delineated structures are
stored in a separate DICOM file, which is linked to the CT
data set it was delineated on. Each structure is attributed with
a name, type of structure and an array of points describing the
delineation in the CT data set coordinates.
plan The information related to the treatment plan is stored in a
separate DICOM file which is linked to the CT data set used
during the treatment planning process. The fractionation scheme
of the treatment plan along with characteristics of each beam
is contained in the DICOM plan file. Moreover, for dynamical
delivery modes, each beam is divided into a number of static
control points each with settings for the dynamical components
and a cumulative MU index, which effectively sets a time scale
for the treatment delivery. The control points are utilized as
a check point scheme during the treatment delivery. For an
IMRT plan the linac control software checks that the actual MLC
settings correspond to that of the ith control point when the
cumulative MU index of the ith control point has been delivered.
dose The 3D dose matrix is stored in a separate DICOM file that also
contains information on the coordinates of the dose grid, which
typically is more sparse than the CT grid. The file is linked to
the DICOM file of the treatment plan it is calculated for.
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Figure 4: A schematic sketch, illustrating the Pareto concept. For two mu-
tually contradicting objectives, A and B, an endless number of
solutions exist. The solutions where one of the objectives can not
be improved without detoriating the other are Pareto optimal. All
Pareto optimal solutions lie on the Pareto front (represented by the
solid line) and are dominating the non-Pareto optimal solutions.
1.3.5 Pareto Front Comparison
Even though a treatment plan has been approved for treatment there
is no guarantee that it is the optimal plan since the number of possi-
ble combinations of parameters is virtually endless. A solution to a
problem with mutually contradicting objectives is said to be Pareto
optimal when it is not possible to improve one objective without dete-
riorating at least one of the other. A Pareto front is constituted by the
Pareto optimal solutions (Figure 4). The Pareto concept applies well to
the inverse planning process, which involves inherently contradictory
objectives, high and uniform target dose on one hand, and sparing of
surrounding tissue and nearby OAR on the other.
Thieke et al. [2007] demonstrated the usefulness of creating a
database of Pareto optimal solutions for interactive treatment plan
selection on a case to case basis. Craft and Bortfeld [2008] concluded
that N+ 1 treatment plans (where N is the number of objectives) are
sufficient to sample the Pareto front. By interpolation of the N+ 1
plans it is possible to construct a number of treatment plans that are
close to being Pareto optimal. The treatment plan can then be selected
by browsing the Pareto front.
The Pareto front concept can be useful when comparing classes of
plans in addition to single plan–to–plan comparisons. Consider the sit-
uation where two treatment strategies with different energies or gantry
angles are discussed. If a single plan is constructed for each strategy
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Figure 5: A schematic sketch illustrating the Pareto fronts of two competing
strategies (red and blue). As seen the Pareto front representing the
red strategy is consistently better in terms of both objectives and is
thus superior to the blue strategy.
the comparison will be rather inconclusive. The respective plans may
not be optimal or representative for the strategy. By sampling the
Pareto front for each strategy the comparison can be conducted using
the entire Pareto front. If the Pareto front representing either strategy
is consistently more optimal than the other (see Figure 5), clearly that
strategy is favorable.
In clinical situations multiple target structures and numerous OARs
are usually considered. Thus Pareto surfaces, rather than Pareto fronts
needs to be considered.
1.4 dosimetry
The general goal in dosimetry is to determine the absorbed point–dose
in a medium, Dmed, in the absence of the detector. The absorbed dose
in a medium, Dmed, is related to the photon energy fluence in the
medium, hνΦmed, by
Dmed
CPE
= hνΦmed
(
µen
ρ
)
med
(1.1)
where hν is the photon energy and (µen/ρ) is the mass–energy absorp-
tion coefficient of the medium in question. It should be stressed that
equation 1.1 is valid only under Charged Particle Equilibrium (CPE)
conditions.
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Correspondingly, Dmed may be related to the charged particle flu-
ence in the medium by
Dmed
δ–eq
= Φe
−
med
(
Scol
ρ
)
med
(1.2)
where (Scol/ρ) is the unrestricted electron mass collision stopping
power of the medium in question. Equation 1.2 is valid only under δ–
ray equilibrium (equilibrium in terms of secondary charged particles).
1.4.1 Cavity Theory
Excellent texts on the fundamentals of cavity theory have been pub-
lished on multiple occasions. Section 1.4.1 covers the basics needed
in later sections of this dissertatation. A much more extensive review,
written by Nahum, of the field can be found in chapter 3 of [Rogers
and Cygler, 2009].
The goal of any dosimetric exercise is to determine the absorbed
point–dose in a medium, Dmed, in the absence of the detector. The
set up can be thought of as a homogeneous medium to which we
introduce a detector of a different medium. For historical reason we
shall call the detector a cavity, although the theory presented holds true
also for non–cavity–like media. Cavity theory gives us an expression
that relates the dose to the detector to that of the undisturbed system.
f(Q) =
(
Dmed
Ddet
)
Q
(1.3)
for the radiation quality Q.
In two special cases it is possible to derive exact expressions for f(Q):
(i) for large photon detectors in a photon field where there is CPE and
assuming that the perturbation inferred by the detector is negligible
and (ii) for Bragg–Gray cavities.
1.4.1.1 Large photon detectors
In order for a detector to be able to be treated as a large photon
detector the photon attenuation within the detector must be negligible
and the dimension of the sensitive material of the detector must be
large in comparison to the ranges of the secondary electrons, so that
CPE is established within the detector. With these conditions fulfilled
the dose at a point can be calculated through
Dmed
CPE
= Ψmed
(
µen
ρ
)
med
(1.4)
where Ψmed is the energy fluence at the point of interest. Equation
1.4 applies analogously to a the situation where a detector is placed
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at the point of interest. Providing that the introduction of a detector
infers negligible changes on Ψmed, f(Q) is given by
f(Q) =
Dmed
Ddet
=
(
µen
ρ
)med
det
(1.5)
where the bar over Ddet indicates that we are considering the
average signal to a finite size detector with its effective point of mea-
surement at the point of interest. As we in RT are concerned with a
bremsstrahlung spectrum as oppose to monoenergetic beams, equation
1.5 is written as
(
µen
ρ
)med
det
=
∫Emax
0 Ehν
dΦmed
dE
(
µen(E)
ρ
)
med
dE∫Emax
0 Ehν
dΦmed
dE
(
µen(E)
ρ
)
det
dE
(1.6)
where (dΦmed/dE) is the energy differential photon fluence.
1.4.1.2 Bragg–Gray Cavity Detectors
A detector may be considered as a Bragg–Gray cavity if the following
two prerequisites are fulfilled:
• The cavity must not disturb the charged particle fluence (includ-
ing its distribution in energy) existing in the medium in absence
of the cavity.
• The absorbed dose in the cavity is deposited entirely by the
charged particle crossing it.
The first prerequisite can be fulfilled in two ways: (i) when the interac-
tion properties of the detector and the medium are identical for the
radiation quality, Q, in question or (ii) if the cavity is small compared
to the electron ranges. In the case of MV photon beams, as used in
radiotherapy, this is only fulfilled for gas filled detectors, i.e. ionization
chambers.
The ratio of dose to the undisturbed medium and dose to the
detector may be written as
Dmed
Dgas
=
Φe
−
med (Scol/ρ)med
Φe
−
gas (Scol/ρ)gas
(1.7)
Given that the detector is a Bragg–Gray cavity, the electron fluencies
are identical and the dose ration, f(Q) then becomes
Dmed
Dgas
=
(
Scol
ρ
)med
gas
(1.8)
which is known as the mass (collision) Stopping Power Ratio (SPR).
Just as for photons, the general case is a fluence spectrum as oppose
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to monoenergetic electrons. Therefore the SPR must be evaluated as
an integral over the electron fluence spectrum, this corresponds to
rewriting equation 1.8 as
(
Scol
ρ
)med
gas
δ−−eq
=
∫Emax
0
(
Φe
−
E
)
med
(Scol(E)/ρ)med dE∫Emax
0
(
Φe
−
E
)
med
(Scol(E)/ρ)gas dE
(1.9)
The electron fluence considered in equation 1.9 must be that of
primary electrons only, as all other generations of charged particles,
δ–rays, are accounted for in the collision stopping power.
Equation 1.9 is only valid under δ–ray equilibrium. In short, one can
assume that δ–ray equilibrium only can exist if the mean excitation
energies of the detector material and the medium are identical or very
close.
A modification of the Bragg–Gray theory was published by Spencer
and Attix [1955], in which identical electron fluencies only is required
in the range [∆,Emax] but not below. The formalism consider all
generations of charged particles entering the cavity and is considers
weather the incoming particle has enough energy to cross the cavity or
not. Only incoming electrons with energy larger than a cutoff energy
∆, derived from the size of the cavity and the charged particle range,
are considered and energy losses less than ∆ are assumed to remain in
the medium they are generated. With this equation 1.9 may be written
as
(
L∆
ρ
)med
gas
=
∫Emax
∆
(
ΦtotE
)
med
[L∆(E)/ρ]med dE∫Emax
∆
(
ΦtotE
)
med
[L∆(E)/ρ]gas dE
(1.10)
where [L∆/ρ] is the restricted SPR. It should be noted that the
lower limit of the integrals is ∆ as oppose to 0 in equation 1.9. The
interpretation of this is that energy depositions between 0 and ∆ are
left unaccounted for. This is rectified by including a “track end” term:
ΦtotE (∆) [Scol(∆)/ρ]∆. The absorbed point–dose in a medium, f(Q),
can then be written as
(
L∆
ρ
)med
gas
=
∫Emax
∆
(
ΦtotE
)
med
[L∆(E)/ρ]med dE+Φ
tot
E (∆) [Scol(∆)/ρ]med∆∫Emax
∆
(
ΦtotE
)
med
[L∆(E)/ρ]gas dE+Φ
tot
E (∆) [Scol(∆)/ρ]gas∆
(1.11)
1.4.1.3 General Cavity Theory
For cases where the detector size can be treated as neither as large
nor small compared to the range of electrons no exact expression for
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f(Q) can be derived. If neither small nor large, the detector size may
be thought of as intermediate. Hence, a weighted average between the
two exact expressions may be used as an approximation. The “General
cavity theory” was suggested by Burlin [1966], therefore detectors
that fall into this category can be referred to as Burlin Cavities. The
approximate expression for f(Q) may then be written as [Attix, 1986]
Ddet
Dmed
= d
(
L∆
ρ
)det
med
+ (1− d)
(
µen
ρ
)det
med
(1.12)
where d is a weighting factor whose value depends on the size of the
detector compared to the range of electrons as well as the radiation
quality.
In the case of megavoltage photon beams all solid–state detectors are
classified as Burlin detectors. As oppose to using analytical expressions
to solve f(Q) for Burlin detectors Monte Carlo techniques can readily
be applied [Rogers, 2006].
1.4.2 Detectors
There are numerous types of detectors, each with specific benefits and
intended situations of usage. A number of requirements needs to be
considered when choosing a detector type.
stability The measurement result from a detector should be highly
reproducible, preferably over a high dose range as well as over a
long period of time.
dose linearity The response of the detector should ideally be
linear over a the dose range of interest.
dose rate independence As the dose rate of a linac can be var-
ied, the detector should be insensitive to changes in dose rate.
energy response As dose generally is measured as dose–to–water,
the ideal detector should be totally water equivalent. A water
equivalent detector would not suffer from variations in stopping
power ratios or mass energy absorption coefficient ratios with
energy variation. Moreover the signal should be proportional
to the absorbed dose regardless of energy. Many solid–state
detectors are susceptible to ionization density effects, dose–rate
effects etc.
spatial resolution The detector should have a spatial resolution
high enough to resolve gradients in the dose distribution. How-
ever, reduction of detector volume inevitably leads to a reduction
of signal–to–noise ratio and in increased uncertainty.
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orientation The response of the detector should ideally not be
affected by the influence angle of the radiation. This is of particu-
lar importance when considering VMAT, where the linac gantry
rotates about the detector during measurements.
perturbation Unless the detector consists of water it will perturb
the photon fluence. This is particularly important for small fields
where the detector volume becomes relatively large compared
to the field size. Apart from the detector itself, cables will also
perturb the photon fluence.
The types of detectors utilized in this study will here be briefly
described.
1.4.2.1 Air Filled Ion Chambers
The air filled ionization chamber, commonly simply referred to as an
ionization chamber, has been the back bone of radiotherapy dosimetry
since its introduction. An Ionization Chamber (IC) typically consists
of an air-filled cavity and a central electrode, and is connected to an
electrometer via a coaxial cable. The air in the sensitive volume of
the detector is ionized by the incident radiation. The central electrode
collects the generated ions, which produces a measurable current.
The ionization current, which is measured using an electrometer, is
proportional to the dose absorbed in the chamber volume.
The sensitive volume of an ionization chamber is typically too large
to resolve high dose gradients. Moreover, the signal–to–noise ratio is
low in comparison with other detector types. Since the active material
in the detector is air, the detector is highly energy dependent, but
precise correction factors are available.
The estimated relative uncertainty on measured dose to water at
reference conditions, using an ionization chamber, is approximately
1.5% [Andreo et al., 2000].
1.4.2.2 Diodes
Diodes are an alternative to ionization chambers in many situations.
The diodes are doped semiconductors, in which ionization leads to
electron–hole pairs which induces a measurable current in the p–n
junction of the sensitive volume. Diodes are more sensitive than ioniza-
tion chambers and typically have higher spatial resolution. However,
the sensitivity of diodes depend on temperature, dose rate and irradi-
ation angle, and therefore corresponding correction factors must be
applied. Moreover, diodes are highly energy dependent and typically
only calibrated to a single nominal beam energy and under CPE con-
ditions. This may infer complications as the energy spectrum varies
slightly with off–axis distance and substantially when CPE no longer
is fulfilled.
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1.4.2.3 Alanine/EPR
Alanine is an amino acid that produces free radicals when exposed
to irradiation. The amount of free radicals is proportional to the
absorbed dose and can be measured using Electron Paramagnetic
Resonance (EPR) [Bradshaw et al., 1962; Regulla and Deffner, 1982].
Using a binder material, alanine can be pressed into dosimeter of any
size and shape. Typically cylindrical pellets of (ø5×3 mm) are used.
The alanine dosimeters are close to water equivalent and thus only
slightly energy dependent. The non–destructive read out procedure
and low fading are desirable characteristics of alanine dosimeters
[Anton, 2005, 2006]. Moreover alanine dosimetry does not require any
wires or cables and thus the only perturbation of the particle fluence
is that of the detector.
The sensitivity of alanine is low and in order to achieve reason-
able measurement precision the pellets must be irradiated to doses in
the region of 10 Gy. The read out procedure of alanine by EPR spec-
troscopy is complex and requires dedicated equipment [Helt-Hansen
et al., 2009]. Furthermore, alanine is hydrophobic which yields practi-
cal limitations in measurements in liquid water. Therefore alanine is
more suitable for measurements in solid phantoms.
EPR dosimetry is not limited to using alanine. Lithium Formate
monohydrate (LiF) is a particularly promising substance. Compared
to alanine it exhibits higher sensitivity than alanine [Lund et al., 2003;
Vestad et al., 2004] and equally limited energy dependence for clinical
MV photon beams [Waldeland and Malinen, 2011]. LiF is however
neither as well documented as alanine nor as easily available.
1.4.2.4 Radiochromic film
A Radiochromic film is a thin (≈300 µm) layer of plastic material
with a radiosensitive dye material (the active layer is ≈30 µm thick).
When exposed to radiation the radiosensitive layer undergoes a poly-
merization process that changes the optical density. The change in
optical density is proportional to the absorbed dose for doses in the
cGy to Gy range. The radiation–induced change in optical density is
self–developing and is established a couple of hours post irradiation.
The film is typically read out using a commercial flatbed scanner.
Ferreira et al. [2009] found that the optimal scanning resolution for
a Gafchromic EBT film (International Specialty Products, NJ, USA)
was 75 dpi, which corresponds to a resolution of ≈0.35 mm. Thus,
radiochromic film is a suitable detector alternative in situations where
apparent dose gradients exist. Moreover, the plastic material of ra-
diochromic film is considered near–tissue equivalent and is therefore
only moderately energy dependent.
The accuracy of radiochromic film has been reported to lie within
2–3% [Devic et al., 2005; Mack et al., 2003; McLaughlin et al., 1994].
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Hartmann et al. [2010] reported that due to manufactoring inhomo-
geneities the uncertainty may increase to 8.7% for Gafchromic EBT2
film.
2
M O N T E C A R L O M E T H O D S I N R A D I O T H E R A P Y
A Monte Carlo method consists of representing the solution of a problem as
a parameter of a hypothetical population, and using a random sequence of
numbers to construct a sample of the population, from which statistical
estimates of the parameter can be obtained.
— J O H N H . H A LT O N Halton [1970]
The above quote is one of many definitions of Monte Carlo meth-
ods. The interpretation of the definition is that MC is an analytical
technique in which a large number of simulations are run using ran-
dom quantities for uncertain variables and looking at the distribution
of results to infer which values are most likely. With this it is easy
to see that MC applies well to particle transport, where interaction
cross sections can be parameterized. Thus, MC is a useful method
for dose calculation in radiotherapy. In fact, it is the most accurate
method available [Andreo, 1991; Chetty et al., 2007; Reynaert et al.,
2007; Rogers et al., 1995].
Numerous MC codes for particle transport in matter have been
developed and a variety are used for Monte Carlo simulations of
radiotherapy. The MC codes discussed in this work can be divided
into two classes: general purpose codes and MC dose engines for
MCTP.
2.1 general purpose monte carlo codes
The general purpose Monte Carlo codes commonly used in radiother-
apy include EGSnrc, EGS4, GEANT4, PENELOPE and MCNP. The
particle transport is conducted in similar fashion for all of the codes.
Consider a particle obtained from a source, the characteristics of the
primary particle and how it is generated is not of concern at this point,
with a certain energy and direction. A random number is drawn in
order to determine a distance to the next particle interaction, which
will depend on the type of particle, its energy and the medium in
which the particle is located. The particle is transported along its direc-
tion for a distance determined by the random number drawn. A new
random number is drawn in order to determine the type of interaction
the particle should undergo using a cross section database. The type
of interaction will again depend on the type of particle, its energy
and the medium in which the interaction takes place. Depending on
the type of interaction, the particle may change its direction and/or
energy, moreover new particles may be generated as a consequence of
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the interaction. This is again determined by drawing random numbers
and using a cross section data base. This process is repeated until the
primary particle either reaches a predetermined cut–off energy (see
Section 2.3) or leaves the boundaries of the system. The process is then
conducted for all secondary particles, which in turn may give rise to
additional particles, created along its path. A new primary particle
is subsequently drawn from the source and the same procedure is
repeated.
The mean free path of MV photons in a tissue–like medium is on
the order of decimeters, thus relatively few photon interactions occur
within a typical simulation geometry. Therefore it is reasonable to
treat each photon and interaction individually.
For charged particles, however, as a slowing–down process of a sin-
gle electron can encompass hundreds of thousands of interactions. To
treat each interaction individually would be extremely time consum-
ing and is not a reasonable approach. A condensed history technique
[Berger, 1993] is utilized, in which a large number of interactions are
condensed and considered in a single electron step. This is a feasible
approximation since the majority of the charged particle interactions
result in small energy losses and minor directional changes. The en-
ergy losses, directional and positional changes of the electron are
sampled from multiple scatter distributions.
The energy deposition events are kept track of over the course of
the simulation and converted to absorbed dose by dividing the accu-
mulated deposited energy in all defined regions with their respective
masses.
The general purpose MC codes of choice for this study were EGS4
(electron gamma shower) [Nelson et al., 1985] and EGSnrc [Kawrakow
and Rogers, 2012] (developed by the Canadian national research coun-
cil, hence the nrc). As indicated by the names they simulate particle
transport of electrons (and positrons) and photons, but disregards
other particles such as neutrons and protons. EGSnrc may be con-
sidered as a continued development of EGS4 and as such the two
systems share many properties. The major new features of EGSnrc in
terms of particle transport properties include a new electron transport
algorithm, EXACT, in which electrons are transported in single elastic
scattering mode when they are within a user–defined distance from
a region boundary [Kawrakow, 2000a]. The EGSnrc system has been
benchmarked against EGS4 for a range of situations relevant to radio-
therapy. Although the results are generally in agreement, the small
differences found are attributed to the improvements made to EGSnrc
in general and the multiple scattering theory [Walters et al., 2012].
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2.2 specific purpose monte carlo codes
In addition to the general purpose MC codes, user codes dedicated
to addressing specific situations have been developed. This section
discusses the specific purpose MC codes used throughout this study.
Commonly for all of the specific purpose MC codes are that they
have been developed as add–ons to a general purpose MC codes. In
short this means that the particle transport is handled by the general
purpose MC code, and that the specific purpose MC codes is used an
“interface” in which the geometry and parameters necessary for the
particle transport are defined.
2.2.1 BEAMnrc
BEAMnrc is an add–on to EGSnrc, which handles the actual parti-
cle transport. BEAMnrc was developed as a user code intended to
simulate a medical linear accelerator. A number of Component Mod-
ules (CMs), each intended to model a specific component in a medical
linear accelerator (i.e. flattening filter, monitor chamber etc.), are avail-
able. A model of the linear accelerator is constructed by stacking CMs
along the beam direction. The input file consists of a text file in which
the geometrical properties of each CM is defined along with a number
of parameters defining the primary particle source, the scoring plane,
particle transport parameters and variance reduction parameters (see
Section 2.3).
A number of different source routines are available, each with its
own characteristics and required input parameters. Throughout this
study two different source routines are used in BEAMnrc. The charac-
teristics and input parameters of these source routines are described
below.
source 19 models an elliptical beam with Gaussian distributions,
with user–defined Full Width Half Maximum (FWHM), in X
and Y. The type of particles1 incident on the first CM and their
energy needs to be defined in the input file. The particles may be
monoenergetic or defined by an energy spectrum. Furthermore,
the direction of the incident particles is defined by a set of
parameters and an optional angular spread about the Z–axis (the
beam direction) may be defined.
source 21 utilizes a phase space file as a source. The required source
parameters include a path to the phase space file in question, the
charge of the particles to be considered and which CM, in the
simulation geometry, the particles are incident on.
1 electrons, photons or positrons
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At each user–defined scoring plane, which can be located at the
bottom of any CM, a phase space file may be generated as a result
of the simulation. Coarsely described, a phase space file is a list of
the particles crossing the scoring plane and their characteristics2. The
characteristics recorded in the phase space file are particle charge,
position (X and Y) in the scoring plane, direction and the particle
weight. The transport history of the particle is also recorded, which
allows the code to calculate the dose contribution from user defined
region.
A file (.egslst) listing a summary of the simulation parameters,
warning messages if any, dose and fluence results of the simulation.
Furthermore the dose and deposited energy in all user defined dose
scoring zones are listed.
2.2.2 DOSXYZnrc
The MC user code DOSXYZnrc simulates dose in a Cartesian voxalized
geometry (e.g. a phantom or a patient). The input file consists of a text
file in which the particle source, the geometry and variance reduction
parameters are defined. The geometry may be defined implicitly in the
input file or explicitly by pointing to a predefined phantom file. Each
voxel is assigned a density and medium. The actual particle transport
is handled by EGSnrc.
A number of different source routines are available, each with its
own characteristics and required input parameters. The characteristics
and input parameters of the source routines used in this study are
described below.
source 2 utilizes a full phase space file as a particle source. The
required parameters include a path to the phase space file, which
types of particle that are to be considered, the location of the iso
center, the distance between the iso center and the scoring plane
and angles defining the direction of incidence on the geometry.
source 9 refers to a BEAMnrc simulation which is runs concurrently
with the DOSXYZnrc simulation. An analogy to source 2 can
be made as the particles are sampled from the scoring plane of
the BEAMnrc simulation. With this the need for intermediate
phase space files is eliminated. The required input parameters
of source 9 are consistent with those of source 2, but with a path
to a BEAMnrc simulation rather than a phase space file.
source 20 uses a phase space source as input but allows for con-
tinuously variation of the incident angles. This is realized by
2 The IAEA phase-space database for external beam radiotherapy (url: http://www-
nds.iaea.org/phsp/phsp.htmlx) features downloadable phase space files for various
linacs.
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listing a number of settings, each with its own parameters of the
location of the iso center, the distance between the iso center and
the scoring plane and angles defining the direction of incidence
on the geometry. Each setting is attributed with an acummulated
index, ranging from 0 to 1. For each incident particle a random
number, between 0 and 1, is drawn and used to decide the source
parameters. Moreover, an external MC code simulating the MLC
may be encompassed in the DOSXYZnrc simulation.
source 21 is related to source 20 analogously to the relation between
source 9 and source 2. This means that the treatment head may
be simulated concurrently using BEAMnrc with the incidence
parameters changing during the simulation as for source 20.
The main output of a DOSXYZnrc simulation is a 3ddose file, which
lists the dose and the relative statistical uncertainty for each voxel
defined in the simulation geometry. For the sources discussed, the dose
is given in Gy per incident particle3. For the full BEAMnrc simulation
source (i.e. sources 9 and 21), doses are normalized by the number
of primary histories incident in the BEAMnrc simulation. Since the
BEAMnrc simulation is being run concurrently with DOSXYZnrc, the
exact number of primary histories is known. For phase space sources
(i.e. source 2 and 20) the quantity is estimated [Rogers et al., 2009].
The statistical uncertainty is estimated using a history by history
method [Walters et al., 2002] in which the uncertainty of the dose is
estimated by grouping all energy depositions originating from the
same primary particle rather than using the variance of individual
events. The method takes the latent variance of a phase space file into
account, which means that the uncertainty introduced by statistical
variations in the phase space file itself is accounted for.
2.2.3 DOSRZnrc
DOSRZnrc is another EGSnrc–based user code developed to score
dose in an user–defined geometry. It differs from DOSXYZnrc in
that the geometry is cylindrical, where each element is defined by
a thickness, an inner and an outer radius. As in DOSXYZnrc each
element is assigned a density and a medium. A number of different
source routines are available each with its own characteristics and
required input parameters. The characteristics and input parameters
of the source routines used in this study are described below.
source 0 describes a parallel beam incident on the top of the de-
scribed geometry. The required parameters are the particle type
and energy (this may be an energy distribution or mono en-
3 This refers to the primary particles in the BEAMnrc simulation
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Table 1: The energy deposition categories of SPRRZnrc
Category Description
α Energy deposition events from electrons for a step with the energy entirely
above ∆ (a cutoff energy below which energy losses are assumed to remain
in the medium they are generated).
β Events formed by electrons and photons which are created with their energy
initially below the cut off energies of the simulation.
δ The energy deposition events in which a particle (electrons and photons)
starts with its energy greater than cut off energy of the simulation and ends
with an energy below.
γ The energy deposition events in which an electron starts a step with its energy
greater than ∆ and ends with an energy below ∆.
ergetic) as well as the radius and the direction of the parallel
beam.
source 22 utilizes a full phase space file as a particle source and is
analogous to source 2 of DOSXYZnrc.
The resulting dose and uncertainty estimation are computed using
the same procedures as for DOSXYZnrc. For source 0, however, the
dose is normalized to the incident particle fluence as no phase space
is used.
2.2.4 SPRRZnrc
The EGSnrc–based user code SPRRZnrc was developed in order to
simulate Spencer–Attix restricted mass collision stopping–power ratios.
The simulation is conducted for a cylindrical geometry, which is
defined just as for DOSRZnrc. The SPR are computed by scoring the
dose deposited in the medium and the cavity, see Section 1.4.1 and
Equation 1.11, but for a simulation in which the cavity is filled with
the transport medium rather than the detector medium. The energy
deposition in the detector medium is then computed by multiplying
the energy deposited in the transport medium, at the location of the
cavity, with stopping power ratios. Whether restricted or unrestricted
stopping power ratios and at what energy they are considered depends
on the type of energy deposition events. SPRRZnrc divides the energy
deposition events into four categories; α, β, δ and γ each described in
Table 1.
For the α events, restricted stopping powers at the mid point energy
of the particle step are used. The β particles are not considered in the
SPR computation as they would deposit their energy locally regardless
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of medium and thus cancel in the computation of ratios. For the δ
events, which are not β events, the unrestricted stopping powers
at ∆, the cutoff energy below which energy losses are assumed to
remain in the medium they are generated (see Section 1.4.1) are used.
The γ event are divided into two components. The component with
energy above ∆ are treated as an α event, while the part of the energy
deposited below ∆ is treated as it were an δ event. The stopping power
ratios are then computed as the ratio of accumulated dose to the cavity
voxel occupied by the transport medium and the estimated dose to
the detector medium.
2.2.5 particle Dmlc
The particle Dmlc is a stand alone MC user code intended for fast,
while still accurate, simulation of MLCs [Keall et al., 2001; Siebers
et al., 2002]. Incident particles are read from a phase space file, this is
typically a simulation of the part of the linac head located above the
MLC, transported through the MLC and written to a phase space file
below the MLC.
The particle transportation through the MLC is simplified. The MLC
is divided into a number of regions along the beam direction. The
weight of the particles are modified by considering the amount of
material the particle transverses when being transported through a
region. Electrons encountering any MLC material are assumed to be
absorbed, while for photons attenuation and Compton scattering (first
generation only) is considered.
Although the particle transportation is simplified and includes
approximations, the geometry of the MLC is accurately modeled,
which results in the method accounting for the intraleaf thickness
variations, interleaf leakage, MLC leaf end effects and tongue and
groove.
The method has been benchmarked against measurements for MLC
apertures with high modulation [Siebers et al., 2002].
2.2.6 MCSIM
MCSIM is a MC user code developed for radiotherapy treatment veri-
fication studies and dose calculation. MCSIM is in many ways similar
to DOSXYZnrc in that it calculates dose to a Cartesian voxalized geom-
etry in which each element is assigned a density and a medium. The
particle transport of MCSIM is handled by EGS4, which is one of the
distinct differences between MCSIM and DOSXYZnrc. Another dis-
tinct difference is that beam modifiers, such as collimators and MLC,
are included in the patient simulation. Full particle transport is per-
formed for the collimating jaws, whereas the MLCs are simulated by
modifying the particle weights using an intensity distribution derived
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from an MLC sequence file [Pawlicki and Ma, 2001]. The intensity
maps are generated by accumulating the MUs for all unblocked areas
and a transmission fraction of the MUs for blocked areas. The fraction
is determined by taking a set of parameters for MLC inter– and intra–
leaf transmission, which are defined in the input file, into account. The
transmission factor for areas wich are blocked by the jaw collimators
is set to zero. In this approach, beam hardening due to attenuation
of low energy photons in the MLC, and scatter from the MLC leafs
are ignored. Moreover, the MLC geometry is simplified and each leaf
is approximated by a rectangular slab, which effectively means that
MLC leaf end effects and tongue and groove are not considered.
2.3 variance reduction techniques
Simulation of particle transport in matter requires a large number of
computations and is therefore time consuming. In order to reduce the
time, while not compromising statistical accuracy, numerous variance
reduction techniques have been implemented. The following text is
limited to discussing only the variance reduction techniques explicitly
employed throughout this study. Some of the variance reduction
techniques may not be applicable to all MC user codes.
Cutoff energy
The energy below which particles transport is terminated is called
the cutoff energy. Any particles falling below that energy deposits
all of its remaining energy locally. Different cutoff energies may be
attributed to photons and electrons and to different regions of the
simulation geometry. The cutoff energy for electrons highly influences
the simulation time, since electrons undergo many interactions with
small energy losses. The general rule of thumb is to choose the Electron
CUT-off energy (ECUT) corresponding to less than a third of the
range4 of the smallest dimension in the scoring geometry. The Photon
CUT-off energy (PCUT) does not influence the simulation time to the
same degree, therefore a low value, typically 10 keV, may be chosen
for photons.
Range Rejection
An efficient variance reduction technique for charged particles is
range rejection. An energy, ECUTRR, which charged particles needs
to exceed in order to be able to leave the current region is defined.
Different values for ECUTRR may be chosen for each region. The range
4 The continuous slowing down approximation range is typically used since it is easily
calculated while still a very close approximation to the average path length traveled
by a charged particle.
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corresponding to ECUTRR is determined using restricted stopping
power ratios and, thus, correspond to the the longest possible range.
Range rejection is available for BEAMnrc only.
Bremsstrahlung Splitting
Bremsstrahlung splitting may be conducted for photons in BEAMnrc.
Two different types of splittings are used; Uniform Bremsstrahlung
Splitting (UBS) and Directional Bremsstrahlung Splitting (DBS).
UBS
When an electron undergoes a bremsstrahlung event, instead of pro-
ducing only one photon, NBRSPL (the splitting number) photons are
generated each with a weight of 1NBRSPL times the weight of the electron.
The characteristics of the each photon, energy and direction, are sam-
pled individually. The energy of the electron, however, is determined
by one of the bremsstrahlung interactions. This means that the energy
is not conserved for a given bremsstrahlung event, but for a large
number of histories the energy is conserved on average. This approach
is implemented in order to preserve the effect of energy straggling.
DBS
Just as for UBS, bremsstrahlung events generate NBRSPL photons
each with a weight of 1NBRSPL times the weight of the electron. For
DBS, photons aimed inside a user defined splitting field (which is
defined at radius at a given plane, typically the iso center plane) are
continued while photons aimed outside the splitting field undergo
Russian Roulette with a “survival threshold” of 1NBRSPL . The weight
of the surviving photons are multiplied by NBRSPL. The photons
surviving the Russian Roulette are called fat photons. Should a fat
photon undergo a Compton event generating a charged particle, it is
considered a fat charged particle.
While employing DBS only a limited number of charged particle
reach the scoring plane. This is due to all Compton interactions un-
dergoing Russian Roulette, with a survival ratio of 1NBRSPL and playing
Russian Roulette on “non–fat” photons before they are allowed to
undergo pair production, Compton events or photoelectric effect. Thus
charged particles reaching the scoring plane will be fat charged parti-
cles, unless they are are generated just above the splitting field.
In order to improve on the charged particle statistics, a splitting
plane for charged particles may be defined inside a given CM. When
crossing the defined plane, all fat charged particles are split NBR-
SPL times (and their weights are multiplied by 1NBRSPL ). A “Russian
Roulette plane” is placed above the charged particle splitting plane.
Below this Russian Roulette plane the DBS characteristics are relaxed:
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Electrons generated through “non–fat” photons undergoing Compton
interaction are no longer subjected to Russian Roulette. “Non–fat”
photons undergo pair production, photoelectric and Compton events
without Russian Roulette. Moreover, fat photons pair production and
photoelectric effect interactions result in the generation of 2×NBRSPL
and NBRSPL non–fat charged particles, respectively.
Photon and electron splitting
Photon splitting may be employed in DOSXYZnrc and in MCSIM.
Each photon incident on the scoring geometry is split n_split times
and given a wight of 1n_split times the weight of the original photon.
The mean free path to the next iteration is determined individually
for each split photon. At the following interaction site each secondary
photon undergo Russian Roulette, with a survival ratio of 1n_split
and the survivors having their wight multiplied by n_split. Charged
particles generated through interactions are allowed to survive, but
have their wight reduced by a factor of n_split. Should the charged
particles undergo bremsstrahlung or annihilation events the generated
photons undergo Russian Roulette (with a survival ratio of 1n_split ).
The surviving photons have their wight increased by n_split. Thus,
the photons have a weight equal to the incident photon and are
subjected to photon splitting again.
A phase space file of a linac consists of relatively few electrons
compared to photons. When employing photon splitting, the contami-
nating electrons will be few but have a high weight factor, compared
to the split photons. This might lead to the dose in the build up region
being too highly influenced by the electrons. In order to compensate
for this the particle splitting may be conducted for the charged parti-
cles as well. It is recommended to employ the same splitting factor for
electrons, e_split as for photons [Rogers et al., 2009].
Howfarless
When simulating homogeneous geometries in DOSXYZnrc, a variance
reduction technique called howfarless may be employed. If so, only the
outer boundary of the geometry is considered when calculating the
distance along the particle trajectory to the next region boundary and
the perpendicular distance to the nearest region boundary respectively.
Charged particle trajectories are approximated by two straight line
steps joined at a hinge point. It is imperative to disengage howfarless
for simulation of heterogeneous geometries.
3
C O M M I S S I O N I N G O F T H E M O N T E C A R L O L I N A C
M O D E L
In order to ensure that a Monte Carlo linac model accurately predicts
dose in any given circumstance it must be calibrated and validated for
a range of critical situations. The process of calibration and validating
is what here is referred to as commissioning. This purpose of this
chapter is to describe the commissioning of a Varian 2300iX linear
accelerator at Copenhagen University Hospital, Herlev but the process
could in principle be applied to any linac. The underlaying issue with
commissioning of an MC model of a linac is that the exact geometry
generally is not known and impracticle to measure directly. Moreover,
the characteristics of the electrons impinging on the linac target are
also unknown.
The first issue encountered is how to define what to verify. Chetty
et al. [2007] states that a MC dose calculation engine will benefit from
a verification procedure similar to a conventional TPS. Chetty et al.
[2007] therefore recommend that the commissioning procedure should
follow the guidelines, with regards to the dose calculation, presented
in the American Association of Physicists in Medicine (AAPM) TG–53
report [Fraass et al., 1998]. A verification scheme covering the range of
clinical usage is advised. Specifically, comparison with measurements
should be conducted for open (square, rectangular and asymmetri-
cal) as well as blocked fields (wedge and MLC). Comparisons should
be conducted along the Central AXis (CAX) as well as in the trans-
verse plane. Moreover, relative as well as absolute agreement with
measurements should be investigated.
For an MC model, the initial step is however to build the geometry.
A linac vendor will typically provide details on the main component
of the linac treatment head. There is no practical way to experimen-
tally determine the validity of these details and therefore they are
considered as ground truth. An initial estimate of the parameters of
the particle impinging on the linac target may or may not be pro-
vided by the vendor. The commissioning procedure is then reduced to
finding a set of parameters of the impinging particles that results in
dose distributions agreeing with measured dose distributions, within
a given accuracy. This raises the question of what parameters that
should be tweaked, how they influence the resulting dose distribution
and most importantly, how to determine their values.
There are many studies devoted to the commissioning/verification
MC linac models and many different strategies are suggested in the
literature [Bush et al., 2009; Chibani et al., 2011; De Smedt et al., 2005;
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Deng et al., 2000; Ding, 2002, 2003; Fix et al., 2001; Hartmann Siantar
et al., 2001; Künzler et al., 2009; Lewis et al., 1999; Libby et al., 1999;
Lovelock et al., 1995; Ma and Jiang, 1999; Ma et al., 1999; Mesbahi et al.,
2005; Mohan et al., 1985; Rogers et al., 1995; Schach von Wittenau et al.,
1999; Sempau et al., 2001; Sheikh-Baghei and Rogers, 2002; Sheikh-
Bagheri et al., 2000; Siebers et al., 1999; Verhaegen and Seuntjens, 2003].
The common denominator of all studies is that a measurable quantity
is compared to the simulated one. The initial guess on, for example,
mean impinging electron energy and focal spot size is tweaked until
agreement, within an acceptance criteria, is found. The agreement
is typically quantified using a statistical measure (e.g. γ–analysis or
χ2–test). Typically the fit is made by tuning the mean energy and the
spatial distribution of the electrons impinging on the target. Some
studies also include the angular spread of the electrons (e.g. [Bush
et al., 2009; Chibani et al., 2011]) and the target density [Keall et al.,
2003].
A review of existing relevant literature is initially presented below
and followed by a sensitivity analysis of the characteristics of the
electrons impinging on the linac target. A protocol for calibration of
an MC model representing a Varian 2300iX linear accelerator, but in
principle applicable to any linac type, is presented, using the BEAMnrc
[Rogers et al., 2009] MC code. Finally, the validity of the calibrated
model is verified over a wide range of situations.
3.1 review of literature
Keall et al. [2003] describe the commissioning process of a Varian 21EX
accelerator (Varian Oncology Systems, Palo Alto, CA, USA) in which
a number of assumptions on the initial electron fluence are made. The
following section revisits and revises the assumptions made by Keall
et al. [2003].
The distribution of the electrons impinging on the bremsstrahlung
target, Ψ, can be described by a five dimensional function
Ψ(E, x,y, θ,φ), (3.1)
where E is the kinetic energy, x and y are the lateral positions and θ
and φ are the polar and azimuthal angles, respectively.
As will be outlined in the following sections consensus is not found
in the literature as to what simulations type are best suited to de-
termine the values of the mean energy, spread in energy, spatial
distribution and mean angular divergence of the electrons impinging
on the linac target. This might be due to differences between linac
types and models.
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3.1.1 The spread of the electrons about the mean energy
Tanabe and Hamm [1985] found an energy spread of 3% FWHM for
a Varian Clinac 1800 for both 6 and 18 MV modes. The sensitivity to
the energy distribution of the impinging electrons were studied by
Sheikh-Baghei and Rogers [2002] for a Siemes KD linac, which has
a nominal energy spread FWHM of 14%. They found no statistical
significant impact on off–axis factors when varying the FWHM of
the energy distribution between 0 and 20%. This is explained by
multiple scattering effects and Bremssstrahlung angular distribution
for electrons with energy above mean are compensated by those below
and thus resulting in photon distribtution similar to the corresponding
monoenergetic spectrum. The Percentage Depth Dose curve (PDD)
on the other hand showed small dependence on energy distribution,
especially for large depths. This is explained by the nonlinear variation
of attenuation and scattering with energy. For the 18 MV mode, a
suggested distribution was Lorentzian, with a sharper fall of past
the peak, rather than a Gaussian. This was modelled by joining two
Gaussian distributions with FWHM of 14% and 3% for the low and
high end, respectively. Simulated off–axis factors1), at 15 cm, showed
a 2% deviation for the assymetrical distribution compared to the
symmertrical 14% FWHM.
3.1.2 Divergence of the impinging electrons
Karzmark et al. [1993] state that the acceptance value for the initial
electron energy should be 1–5 mradians (corresponding to 0.06–0.3
degrees). This angle is very close to 0 and it may be tempting to
assume non diverging beam based on this alone. Sheikh-Baghei and
Rogers [2002] investigated the impact on off–axis factors due to beam
divergence for a Siemens KD linac and found no difference on off–axis
factors for a divergence of 0.5◦. Moreover PDD were insensitive to
a divergence as large as 5◦. Studies by [Chibani et al., 2011; Ding,
2002; McEwen et al., 2011; Tonkopi et al., 2005] indicate that angular
divergence increase the amount of scattered radiation and thereby the
contaminating (scattered) radiation impinging on the phantom surface.
This primarily affects the dose in the build–up region [Ding, 2002].
The need to include angular distribution seems to be more important
for high energy modes [Chibani et al., 2011; Tonkopi et al., 2005].
Chibani et al. [2011] found agreement between simulated PDDs and
lateral profiles for the 15 MV mode of a Varian 21EX using an angular
divergence of 0.6◦, while a 1.15◦ divergence was reported for the 25
MV mode of an Elekta Precise linac by Tonkopi et al. [2005]. Both of
these findings far exceeds the acceptance values stated by Karzmark
1 The off–axis factor is defined as the ratio of the dose at a point located at a distance
from the central axis to that on the central axis.
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et al. [1993]. The need to use such a large angular divergence may be
due to discrepancies between the specifications by the vendor and the
real linac. Errors in the vendor specified data have been pointed out
(e.g. Chibani [2004]) and later on been confirmed by the vendor. It is
not unlikely that other inaccuracies that will affect the exit fluence in
general and the fluence due to scattered radiation in particular exists.
Moreover, high energy modes would be more susceptible to such
inaccuracies since the scattered radiation generated will have higher
energies and thus longer ranges. A pragmatic approach is employed in
Tonkopi et al. [2005], where the angular divergence was included only
when a match could not be found by varying the incident electron
energy and spot size alone. Moreover, Sheikh-Baghei and Rogers [2002]
ignored the divergence of the electron beam based on the fact that no
reliable estimate is supplied by the vendors.
3.1.3 The spatial distribution of impinging electron source
Jaffray et al. [1993] measured the size and shape of the focal spot of
various linacs. In short it was conducted by restricting the source, as
viewed from the detector, to small strips by a collimating slit. The
signal produced in the detector will then correspond to the integrated
x–ray emission spectrum over the slit. Measurement were conducted
for various locations and angles. The size and shape of the focal
spot was then reconstructed using CT reconstruction techniques. A
Gaussian distribution was found for all linacs studied. Karzmark et al.
[1993] also report that the electron beam impinging on the target has
Gaussian shape. Jaffray et al. [1993] found that the FWHM of the
bremsstrahlung focal spot of a Varian 2100C was between 1.2 and
1.4 mm for the 6 MV mode and between 0.9 and 1.6 mm for the 18
MV mode. The Varian 2300iX linac design is similar to that of Varian
2100C and therefore the results can be expected to be similar. At the
very least the focal spot can be expected to be Gaussian as this was
found for all linacs studied. A recent study by Bush et al. [2009] found
that a Gaussian spot size with an extra focal halo present resulted
in better agreement between measured and MC simulated 18 MV
40×40 cm2 lateral profiles for a Varian 21EX. However, no supporting
measurements of the focal spot shape were presented. Moreover, the
current version of EGS/BEAM does not allow the use of such a source.
3.1.4 The symmetry of the spacial distribution
The final assumption made by Keall et al. [2003], and the only one
to be revised in this study, was that the focal spot size was rotational
symmetric about the z–axis. Jaffray et al. [1993] showed the spot size
was elliptical rather than circular on almost all occasions. Moreover
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Scott et al. [2009] found that an elliptical electron spot size2 yielded
better agreement on penumbra widths for small fields. The degree of
ellipticity is rather small and the symmetry of the spacial distribution
can to first order approximated circular.
Outcome of the assumptions
The parameters to be considered for tweaking are thus the mean
energy, spread in energy, spatial distribution and mean angular diver-
gence of the electrons impinging on the linac target.
3.1.5 Sensitivity to characteristics
of the impinging electrons
Verhaegen and Seuntjens [2003] published a concept for commission-
ing of external photon beams for radiotherapy where simulated PDDs
and lateral dose profiles are to be compared with measurements. The
general idea of the protocol is that PDDs can be commissioned by
tweaking the mean impinging electron energy, that lateral profiles
can be commissioned by tweaking the focal spot size FWHM. The un-
derlying hypothesis is that this can be done independently, such that
simulated PDDs are unaffected by changes in focal spot size FWHM
and that lateral profiles are unaffected by changes in mean impinging
electron energy. An iterative commissioning process as described in
figure 6 was suggested.
Several studies have pointed out that PDDs are rather insensitive
to changes in mean energies [Keall et al., 2003; Libby et al., 1999;
Lovelock et al., 1995; Pena et al., 2004]. Pena et al. [2004] demonstrated
that for a change of mean energy of 0.5 MeV to result in two well
separated depth dose curves, for a Siemens PRIMUS linacs, the relative,
statistical, uncertainty of the simulations needed to be 0.3–0.4%.
Sheikh-Baghei and Rogers [2002] showed that in–air off-axis fac-
tors are sensitive both to mean energy and focal spot size. In–air
off–axis factors require measurements that are generally not part of
the standard data set generated during commissioning of a linac. Fur-
thermore, they are costly, in terms of CPU time, to simulate as they
ideally require separate simulations for each data point. Keall et al.
[2003] and Pena et al. [2004] suggested the use of wide–field lateral–
profiles instead as they also show sensitivity to both to mean energy
and focal spot size and typically are contained in a standard linac
commissioning data set. Comparison should be done at as a shallow
depth as possible as phantom scatter becomes increasingly more im-
portant with depth and reducing the sensitivity to the electron beam
2 It is important to distinguish between the focal spot of the electrons impinging on
the target and that of the bremsstrahlung photons emitted from the target – the one
typically discussed in MC is the focal spot of the electrons impinging on the target.
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parameters [Sheikh-Baghei and Rogers, 2002]. However, comparison
should be conducted for depths below dmax, since dosimetry in the
build up region is associated with large uncertainties.
3.2 sensitivity analysis
In this work MC simulations were conducted in order to study the
influence of the mean energy, spread in energy and spatial distribution
of the electrons impinging on the linac target for a Varian 2300 iX,
which is the linac model to be commissioned in this study (a detailed
description of the model is presented in Section 3.3).
Figure 7 show MC simulated PDDs of a 10×10 cm2 field for the
Varian 2300iX linac modelled in this study3. The mean energy was
varied from 5.60 MeV to 6.20 MeV in steps of 0.10 MeV and the spot
size FWHM was 0.075 cm. The number of histories were chosen so
that the relative uncertainty was at most 0.5% between dmax and 30
cm depth along the CAX. The depth dose curves were normalized at
10 cm using a forth degree polynomial fit between 5 and 15 cm [Pena
3 DOSXYZnrc was used for phantom simulation with a voxel size of 0.5×0.5×0.2 cm3.
Simulation properties were ECUT = 521 keV, PCUT = 10 keV, nsplit = 25, esplit =
25 and howfarless turned on. The treatment head was simulated using source 9 in
DOSXYZnrc. Simulation properties were ECUT = 700 keV, PCUT = 10 keV, direction
bremsstrahlung splitting was used (FS = 10, SSD = 100), NBRSPL was set to 1000,
with the splitting plane for electrons (ZPLANE_DBS) defined as the bottom of the
flattening filter and russian roulette conducted for electron at a plane 0.20 cm above
the bottom of the flattening filter.
Figure 6: Schematic sketch of the iterative commissioning process.
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Figure 7: 10×10 cm2 PDD along CAX for MC simulation of a range of mean
energies (left) and local deviation from the reference energy (right).
Also shown is the ±1% deviation level (dashed black). The nom-
inal photon beam nominal energy, 6.00 MeV, was chosen as the
reference.
et al., 2004]. The electron energy corresponding to the nominal energy
of the photon beam, i.e. 6.00 MeV, was chosed as the reference energy.
Local deviation from the reference energy was generally within 1%
beyond dmax for the mean energy range [5.80,6.20] MeV. Considering
the statistical uncerntainty of the simulated data it was not possible to
distinct between PDDs differing by less than 0.30 MeV. This is slightly
better than reported by [Pena et al., 2004], but still showing that PDDs
are insensitive to small changes in mean energy.
In order to study the influence of spot size on wide–field lateral–
profiles MC simulations4 were conducted for 20×20 and 40×40 cm2
fields with a mean energy of 6.0 MeV and for (circular) spot sizes with
FWHM 0.10, 0.20 and 0.30 cm (figure 8–9). The central value (spot
FWHM = 0.20 cm) was taken as the reference and local relative devia-
tion were calculated through: (Xi −Xrefi )/X
ref
i × 100. Uncertainties of
the ratio were computed using error propagation. The result showed
that the larger fields were more susceptible to changes in spot size
and that a variation of 0.10 cm FWHM results in profiles differing by
10% near the field edges. Similair results were found when making
the same comparison at 10 cm depth (not shown).
4 DOSXYZnrc was used for phantom simulation with a voxel size of 0.25×0.25×0.5
cm3. Simulation properties were ECUT = 761 keV, PCUT = 10 keV, nsplit = 25, esplit
= 25 and howfarless turned on. The treatment head was simulated using source 9 in
DOSXYZnrc. Simulation properties were ECUT = 700 keV, PCUT = 10 keV, direction
bremsstrahlung splitting was used (FS = 20 and 40 cm for the 20×20 and 40×40 cm2
fields respectively at SSD = 100), NBRSPL was set to 1000, with the splitting plane for
electrons (ZPLANE_DBS) defined as the bottom of the flattening filter and russian
roulette conducted for electron at a plane 0.20 cm above the bottom of the flattening
filter.
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Figure 8: 20×20 cm2 field, at 5 cm depth, for a varying spot size (top) and
local deviation from reference (spot FWHM = 0.20 cm) simulation
(bottom) for crossline (left) and inline (right) lateral profiles.
In order to study the influence of mean energy on wide–field lateral–
profiles MC simulations5 were conducted for 40×40 cm2 fields with a
spot size FWHM of 0.175 cm and mean energies 5.70, 5.85 and 6.00
MeV (figure 10). The central value (mean energy = 5.85 MeV) was taken
as the reference and local relative deviation were calculated through:
(Xi−X
ref
i )/X
ref
i ×100. Uncertainties of the ratio were computed using
error propagation. The profiles were normalized to the same value as
the reference at CAX before computing local deviation. The results
show that a 0.15 MeV change in mean energy produced differences
on the order of 4% near the field edges for the decreased energy,
whereas no difference was observed for the increase of energy. The
comparison was conducted for simulations with statistical uncertainty
of 0.8% and it is likely that improving on this would lead to more
distinct separation between the profiles as an, insignificant, trend was
observed on the relative deviation in case of the increase in energy.
5 DOSXYZnrc was used for phantom simulation with a voxel size of 0.25×0.25×0.5
cm3. Simulation properties were ECUT = 761 keV, PCUT = 10 keV, nsplit = 25, esplit
= 25 and howfarless turned on. The treatment head was simulated using source 9 in
DOSXYZnrc. Simulation properties were ECUT = 761 keV, PCUT = 10 keV, direction
bremsstrahlung splitting was used (FS = 40 cm at SSD = 100), NBRSPL was set to
1000, with the splitting plane for electrons (ZPLANE_DBS) defined as the bottom of
the flattening filter and russian roulette conducted for electron at a plane 0.20 cm
above the bottom of the flattening filter.
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Figure 9: 40×40 cm2 field, at 5 cm depth, for a varying spot size (top) and
local deviation from reference (spot FWHM = 0.20 cm) simulation
(bottom) for crossline (left) and inline (right) lateral profiles.
With this, it should be clear that 40×40 cm2 profiles are more sensitive
to changes in mean energy than PDDs. Similair results were found
when making the same comparison at 10 cm depth (not shown).
The effect of the angular divergence of the beam on 10×10 cm2 field
PDDs as well as 40× 40 cm2 field lateral profiles were investigated.
Simulations6 were conducted, at SSD = 90 cm, for a fixed mean energy
(15.5 MeV) and spot size FWHM (0.15 cm – cylindrical) while the
angular divergence was 0.0◦, 0.5◦ and 1.0◦. The 10 × 10 cm2 field
PDDs were normalized at 10 cm using a forth degree polynomial fit
between 5 and 15 cm, whereas no normalization was conducted for
the 40× 40 cm2 field lateral profiles. The PDDs and residuals (taking
θ = 0.0◦ as reference) are shown, without uncertainties, in figure 11.
From the residuals it can be concluded that the difference is limited
to the build up region. The increase in build up–dose with increased
6 DOSXYZnrc was used for phantom simulation with a voxel size of 2.0×2.0×0.25
cm3 for the 10× 10 cm2 field PDDs and 0.25×0.25×0.5 cm3 for the 40× 40 cm2 field
lateral profiles. Simulation properties were ECUT = 761 keV, PCUT = 10 keV, nsplit =
25, esplit = 25 and howfarless turned on. The treatment head was simulated using
source 9 in DOSXYZnrc. Simulation properties were ECUT = 700 keV, PCUT = 10 keV,
direction bremsstrahlung splitting was used with FS = 10 and 40 cm (for the 10× 10
cm2 fields and 40× 40 cm2 fields, respectively) at SSD = 100, NBRSPL was set to
1000, with the splitting plane for electrons (ZPLANE_DBS) defined as the bottom of
the flattening filter and russian roulette conducted for electron at a plane 0.20 cm
above the bottom of the flattening filter.
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Figure 10: 40×40 cm2 field, at 5 cm depth, for a varying mean energy (left)
and local deviation from reference (mean energy = 5.85 MeV) sim-
ulation (right) for crossline profiles. The profiles were normalized
to the same value as the reference at CAX before computing local
deviation.
angular divergence is likely to be due to the increased amount of
contaminant electrons (as described in section 3.1.2). The results are in
contradiction with Chibani et al. [2011], who reported a 1.5% difference
at 30 cm depth for a 10× 10 cm2 field PDD of a Varian 2300C/D linac.
The sensitivity of the 10× 10 cm2 field PDDs shows agreement with
the results of Sheikh-Baghei and Rogers [2002]. Inline and crossline
profiles, at 3 cm depth and SSD = 90 cm, are shown for the 40× 40 cm2
fields in figure 12. For the residuals (lower panel in figure 12) the local
devation from the simualtion with θ = 0.0◦ was computed through:
(Xi−X
ref
i )/X
ref
i × 100. Uncertanties of the ratio were computed using
error propagation. A local difference of ≈3% and 10% is observed for
θ = 0.5◦ and θ = 1.0◦, respectively along the CAX. The difference is
however confined to the central part (approximately in the [-5;5] cm
range) of the profiles, making it possible to distinguish between the
impact of varying the spot size, which predominantly is present on
the distal parts of the lateral profiles (see e.g. figure 9).
In order to investigate the impact of the spread in energy of the
electrons impinging on the linac target, 10×10 cm2 cm field CAX–PDD
and off–axis factors, for a 40×40 cm2 cm field, were simulated for
three different spectra with mean energy 6.0 MeV: i) a monoenergetic
spectrum, ii) a Gaussian distribution about 6.0 MeV with 3% FWHM
and iii) a Gaussian distribution with 1.5% FWHM on the lower end
and a sharp cut off at 6.0 MeV (figure 13). The latter was to account for
the fact that the energy distribution presented by Tanabe and Hamm
[1985], for a Varian Clinac 1800, showed a sharper fall of on the high
end.
No difference between the three different energy spectra was noted
on the PDD beyond the build–up region Figure 14. Furthermore no
substantial differences, as compared to influence of mean energy
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Figure 11: Left: Simulated 10× 10 cm2 field PDDs with mean energy 15.5
MeV, (cylindrical) spot size FWHM 0.15 cm and an angular di-
vergence of 0.0◦ (black), 0.5◦ (red) and 1.0◦ (blue). The PDDs
were normalized at 10 cm depth using a forth degree polynomial
fit in the [5;15] cm region. Local statistical uncertainty was 0.2–
0.3%. Right: Local relative deviation from the reference simulation
(θ = 0.0◦ selected as reference) for angular divergence of 0.5◦ (red)
and 1.0◦ (blue). A line corresponding to perfect agreeement is also
shown in the figure (dashed black).
and/or spot size changes, were noted on the off–axis factors. A Gaus-
sian spread with a 3% FWHM was assumed for this study.
The use of a 40×40 cm2 field for commissioning does however pose
a possible problem. The maximum field size that the Varian Millen-
nium 120 leaf MLC can define is 40×40 cm2 and thus the MLC may
influence the dose distribution. However, the properties of the MLC
are not given in full detail by the vendor and merits a separate com-
missioning where density, distance from the source and dimensions
of the individual leafs are determined. A cyclic dependence between
the MLC properties and those of the impinging electron source (mean
energy and spatial distribution) may not be neglected without further
investigation. Simulations7 of 6MV 40×40 cm2 fields were conducted
with MLC parameters as derived by Heath and Seuntjens [2003] (here-
after referred to as with MLC) and with MLC parameters where the
leafs were further contracted and with over exaggerated leaf widths
so that the MLC defined a 45×45 cm2 field (hereafter referred to
as without MLC). As shown previously, the wide–field profiles are
highly sensitive to changes in spot size, therefore the simulations
were conducted for a number of different spot sizes (0.100, 0.250 and
7 DOSXYZnrc was used for phantom simulation with a voxel size of 0.25×0.25×0.5
cm3. Simulation properties were ECUT = 761 keV, PCUT = 10 keV, nsplit = 25, esplit
= 25 and howfarless turned on. The treatment head was simulated using source 9 in
DOSXYZnrc. Simulation properties were ECUT = 761 keV, PCUT = 10 keV, direction
bremsstrahlung splitting was used (FS = 40 cm at SSD = 100), NBRSPL was set to
1000, with the splitting plane for electrons (ZPLANE_DBS) defined as the bottom of
the flattening filter and russian roulette conducted for electron at a plane 0.20 cm
above the bottom of the flattening filter.
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Figure 12: Upper panel: Simulated 40× 40 cm2 field profiles, at 3 cm depth,
with mean energy 15.5 MeV, (cylindrical) spot size FWHM 0.15
cm and an angular divergence of 0.0◦ (black), 0.5◦ (red) and
1.0◦ (green). No normalization of the data was conducted. Lower
panel: Local relative deviation from the reference simulation (θ =
0.0◦ selected as reference) for angular divergence of 0.5◦ (red) and
1.0◦ (green).
0.325 cm) while the mean energy was kept constant at 6.0 MeV. Local
relative deviation, between simulations with and without MLC, were
calculated through: (Xi −Xrefi )/X
ref
i × 100. Uncertainties of the ratio
were computed using error propagation. The profiles were normalized
to the same value as the reference at CAX before computing local
deviation. No difference were observed between simulations with and
without the MLC (figure 15), hence the general commissioning can
safely be conducted without a properly commissioned MLC, which in
turn can be conducted once satisfactory agreement has been obtained
for open fields.
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Figure 13: The three energy spectra used: a monoenergetic spectrum (blue),
a Gaussian distribution with 3% FWHM (black) and a Gaussian
distribution with 1.5% FWHM on the lower end with a sharp cut
off at 6.0 MeV (red).
Figure 14: Left: Local relative difference in dose along CAX for 40×40 cm2
fields simulated the Gaussian distribution with 1.5% FWHM on
the lower end with a sharp cut off at 6.0 MeV (red) and the mo-
noenergetic spectrum (blue) compared to the 3% FWHM Gaussian
distribution (black). The local combined statistical uncertainty is
on the order of 1%. Right: Lateral profiles for 40×40 cm2 fields
simulated with the monoenergetic spectrum (blue), a Gaussian
distribution with 3% FWHM (black) and a Gaussian distribution
with 1.5% FWHM on the lower end with a sharp cut off at 6.0
MeV (red).
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Figure 15: Local dose difference for MC simulations of a 6MV 40×40 cm2
field with and without (reference) the MLC included. Lateral
profiles are scored parallel (left) and orthogonal (right) to the
MLC direction of movement for three different (Gaussian shaped)
spot sizes with FWHM 0.100 (red), 0.250 (green) and 0.325 cm
(blue) respectively and at 5 cm depth in a homogenous water
phantom.
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3.3 suggested protocol for calibration
The following section describes the calibration of an MC model of a
Varian 2300iX linear accelerator at Copenhagen University Hospital,
Herlev. The commissioning is conducted for two high energy photon
modes: 6MV and 15MV.
The first step in the calibration process is to build the representation
of the physical linac — the MC model. In this study, the model was
based on drawings supplied by the vendor [Varian Medical Systems,
1999; Varian Oncology Systems, 2008]. A model was built using EGSnrc
and BEAMnrc. The different CM of BEAMnrc can readily be used as
building blocks, where the specific geometrical and physical properties
of each module can be specified independently of each other. Table 2
lists the included components and the CM used to model them and a
schematic illustration of the 6MV treatment head geometry is shown
in Figure 16.
Measurements used for the calibration were all conducted during
the commissioning of the physical linac. The advantage of this is
obviously that no, time consuming, dedicated measurements were
required. The measurements conducted are listed in Sjöström et al.
[2009]. All measurements were conducted in a Blue Phantom (IBA
Dosimetry AB, Uppsala, Sweden) 48×48×48 cm3 water tank (± 0.1
mm position accuracy) and the data acquisition was controlled by
the OmniPro Accept v.6.5A (IBA Dosimetry AB, Uppsala, Sweden)
software. Depth dose curves were measured using a Wellhöfer/IBA
CC13 (IBA Dosimetry AB, Uppsala, Sweden) Ionization Chamber
(0.13 cm3 active volume) while lateral profiles were measured using
a Scanditronix/IBA PFD3G (IBA Dosimetry AB, Uppsala, Sweden)
Si–photon diode. The shielded diodes produce reliable readings under
Table 2: List of linac components and the corresponding CM used to model
them
Linac component EGSnrc CM
Target and backing SLABS
Primary collimator CONS3R
Vacuum window CONESTAK
Flattening filter FLATFILT
Monitor chamber CHAMBER
Light mirror MIRROR
Secondary movable collimators JAWS/SYNCJAWS?
MLC DYNVMLC
Exit window SLABS
?Used exclusively in VMAT simulations utilizing DOSXYZnrc source 20/21.
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Figure 16: Schematic illustration of the 6MV MC model geometry. The upper
collimating jaws are shown rotated 90◦. The figure was produced
using BEAMnrc.
requirement of lateral CPE condition only. This requirement is not
fulfilled near the edges of the lateral profiles. In order to account for
that, comparisons are made up to off-axis distances of X− 3 cm and
X− 5 cm for 6MV and 15MV, respectively. Within this range lateral
CPE will exist. All measurements are assumed to have negligible
uncertainties in the comparisons.
The protocol suggested in this study is based on matching simulated
dose distributions to measurements of PDDs, lateral profiles as well
as Relative Output Factors (ROFs). Agreement between simulated and
measured PDDs and lateral profiles is enough if single field relative
comparisons with experimental data is of interest alone. In order to
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Figure 17: Simulated 6MV beam quality index as a function of impinging
electron mean energy for initial electron beam radial FWHM 0.075
cm (left) and 0.20 cm (right). The blue line corresponds to mea-
sured TPR2010, while black circles represent simulated values. The
error bars corresponds to the combined statistical uncertainties of
the simulations.
utilize MC to calculate dose distributions generated by multiple fields
of different shapes and sizes, which is commonly used in radiother-
apy, it is also vital that agreement is found between simulated and
measured ROFs.
As an initial step a range of possible mean impinging electron
energies were selected by comparison between measured and sim-
ulated TPR2010, calculated from 10× 10cm2 field with SSD = 100 cm,
as described in Andreo et al. [2000], using the empirical expression
established by Followill et al. [1998]: TPR2010 = 1.2661PDD
20
10 − 0.0595.
MC simulations8 were conducted for both the small and large initial
focal spot size guess (figure 17). The range of energies resulting in sim-
ulated Beam Quality Index (BQI) (for either spot size) in agreement,
within the statistical uncertainty, with measurments were selected. The
selected energies were [5.6;6.0] and [14.75;16.25] MeV for 6MV and
15MV, respectively.
8 DOSXYZnrc was used for phantom simulation with a voxel size of 0.5×0.5×0.2 cm3.
The number of histories were chosen so that the statistical uncertainty along the CAX
was 0.2–0.3% at 5–15 cm depth. Simulation properties were ECUT = 521 keV, PCUT
= 10 keV, nsplit = 25, esplit = 25 and howfarless turned on. The treatment head was
simulated using source 9 in DOSXYZnrc. Simulation properties were ECUT = 700
keV, PCUT = 10 keV, direction bremsstrahlung splitting was used (FS = 10, SSD =
100), NBRSPL was set to 1000, with the splitting plane for electrons (ZPLANE_DBS)
defined as the bottom of the flattening filter and russian roulette conducted for
electron at a plane 0.20 cm above the bottom of the flattening filter.
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Figure 18: Slope of ratio between simulated and measured PDDs compared
to the acceptance criteria 0.005Dmax/(40/2) as a function of im-
pinging electron mean energy for 6MV (left) and 15MV (right).
Energies within [-1,1] was selected of further calibration. The
selection criteria, ±1.0, is also shown in the figure (solid blue line).
10×10 cm2 CAX PDDs
PDDs were simulated9 for 10×10 cm2 fields with varying impinging
electron mean energy while keeping the focal spot sizes constant at
0.075 cm. The depth dose curves were normalized at 10 cm using a
forth degree polynomial fit between 5 and 15 cm [Pena et al., 2004].
As oppose to other commissioning protocols, (e.g. Verhaegen and Se-
untjens [2003]) where the mean energy best fitting the measurements
is selected for further calibration, a range of energies are selected.
The acceptance criteria were based on the criteria specified by Keall
et al. [2003] where the slope of a linear fit to the ratio between the
measured and simulated curve is computed. A ratio of <0.5% was
sought over (0,40) cm depth. In order to fulfill this criteria, the slope of
the ratio needs to be less than 0.005Dmax/(40/2). The selected range
of consideration was [5,25] cm, since it is well beyond the build–up
region for both energies and thus not influenced by contaminating
electrons while not extending to the bottom of the phantom where ma-
terial producing back scatter radiation was omitted in the simulations.
Energies where ratio of the slope of the linear fit, to the ratio between
measured and simulated PDDs, and the acceptance criteria was <|1|
were selected for further calibration (Figure 18). The selected energies
were [5.7,6.0] and [14.5,16.75] MeV for 6MV and 15MV, respectively.
9 DOSXYZnrc was used for phantom simulation with a voxel size of 0.5×0.5×0.2 cm3.
The number of histories were chosen so that the statistical uncertainty along the CAX
was 0.2–0.3% at 5–15 cm depth. Simulation properties were ECUT = 521 keV, PCUT
= 10 keV, nsplit = 25, esplit = 25 and howfarless turned on. The treatment head was
simulated using source 9 in DOSXYZnrc. Simulation properties were ECUT = 700
keV, PCUT = 10 keV, direction bremsstrahlung splitting was used (FS = 10, SSD =
100), NBRSPL was set to 1000, with the splitting plane for electrons (ZPLANE_DBS)
defined as the bottom of the flattening filter and russian roulette conducted for
electron at a plane 0.20 cm above the bottom of the flattening filter.
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Figure 19: χ2/NDF for 40×40 cm2 lateral profiles as a function of radial focal
spot size FWHM for impinging electron mean energies 6.0 MeV.
40×40 cm2 lateral profiles
For each of the selected energies lateral 40×40 cm2 fields were sim-
ulated10 for a range of focal spot sizes, while keeping the impinging
electron mean energy constant. The shallowest measured depth, be-
yond dmax, was used for comparison. The selected depths were 10 cm
and 3 cm for 6MV and 15MV, respectively. The descission to compare
at the shallowest depth of measurement was motivated by the fact that
phantom scattering becomes increasingly important with depth. Thus,
the sensitivity to the calibration parameters (e.g. spot size FWHM
and angular divergence) will decrease with depth due to increased
phantom scatter. The lateral profiles were normalized at CAX using a
second degree polynomial fit to the inner most 4 cm of the profiles.
χ2/NDF were calculated, using equation Equation 3.2, and plotted
as a function of radial focal spot size (Figure 19 shows χ2/NDF as a
function of spot size for a mean energy of 6.0 MeV).
χ2/NDF =
N∑
i=1
(si −mi)
2
σ2i
/(N− 1), (3.2)
where si is the simulated dose at position i, mi is the measured dose
at position i and σi is the simulated uncertainty at position i. A visual
inspection of the profiles were also conducted. Such a visual inspection
is shown in Figure 20 for a impinging electron mean energy of 6.0
MeV and for a (circular) spot size FWHM ranging from 0.15 cm to 0.25
10 DOSXYZnrc was used for phantom simulation with a voxel size of 0.25×0.25×0.5
cm3. The number of histories were chosen so that the statistical uncertainty along the
CAX was 0.5–0.7% at 3–15 cm depth. Simulation properties were ECUT = 761 keV,
PCUT = 10 keV, nsplit = 25, esplit = 25 and howfarless turned on. The treatment head
was simulated using source 9 in DOSXYZnrc. Simulation properties were ECUT =
700 keV, PCUT = 10 keV, direction bremsstrahlung splitting was used (FS = 40, SSD =
100), NBRSPL was set to 1000, with the splitting plane for electrons (ZPLANE_DBS)
defined as the bottom of the flattening filter and russian roulette conducted for
electron at a plane 0.20 cm above the bottom of the flattening filter.
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Figure 20: 6MV 40×40 cm2 lateral profiles, along X–direction at 10 cm depth,
for a number of radial focal spot size FWHM for an impinging
electron mean energy of 6.0 MeV. The actual spot size FWHM is
indicated in the title of each figure. The figures shows measured
(blue) and simulated (red) profiles as well as relative difference
(green) between them (taking the measurement as reference).
cm. It can clearly be seen that the horns of the profiles are decreased
with increasing spot size FWHM.
If passing the visual inspection, the spot size FWHM yielding the
minimum χ2/NDF, for X– and Y–profiles individually, was selected
for each energy. All energies selected for the 6MV mode passed the
visual inspection and for each energy a set of spot size FWHMs was
identified as best matching the measurements. The parameters selected
for each energy is given in Table 3. For the 15MV mode, however, the
visual inspection resulted in rejection of all parameter sets. This is
illustrated by Figure 21, where the simulated profile undershoots, in
comparison with the measurement for all spot size FWHMs, indicating
that angular divergence needs to be considered.
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Figure 21: 15MV 40×40 cm2 lateral profiles, along X–direction at 3 cm depth,
for a number of radial focal spot size FWHM for an impinging
electron mean energy of 15.5 MeV. The actual spot size FWHM is
indicated in the title of each figure. The figures shows measured
(blue) and simulated (red) profiles as well as relative difference
(green) between them (taking the measurement as reference).
For each of the selected 15MV energies lateral 40×40 cm2 fields
were simulated11 for a range of focal spot size FWHMs and mean
angular divergencies, while keeping the impinging electron mean
energy constant. With spot size FWHM and mean angular divergence
as free parameters all energies selected for the 15MV mode passed the
visual inspection as well and for each energy a compination of spot
size FWHMs and angluar divergence was identified as best matching
the measurements. The parameters selected for each energy is given
in Table 3. 15MV 40×40 cm2 lateral profiles, along X–direction at 3 cm
depth, for a number of radial focal spot size FWHM for an impinging
electron mean energy of 15.5 MeV and a mean angular divergence of
0.4◦ is shown in Figure 22. It can clearly be seen that the simulations
coincided substantially better with the measurements when including
11 DOSXYZnrc was used for phantom simulation with a voxel size of 0.25×0.25×0.5
cm3. The number of histories were chosen so that the statistical uncertainty along the
CAX was 0.5–0.7% at 3–15 cm depth. Simulation properties were ECUT = 761 keV,
PCUT = 10 keV, nsplit = 25, esplit = 25 and howfarless turned on. The treatment head
was simulated using source 9 in DOSXYZnrc. Simulation properties were ECUT =
700 keV, PCUT = 10 keV, direction bremsstrahlung splitting was used (FS = 40, SSD =
100), NBRSPL was set to 1000, with the splitting plane for electrons (ZPLANE_DBS)
defined as the bottom of the flattening filter and russian roulette conducted for
electron at a plane 0.20 cm above the bottom of the flattening filter.
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Figure 22: 15MV 40×40 cm2 lateral profiles, along X–direction at 3 cm depth,
for a number of radial focal spot size FWHM for an impinging
electron mean energy of 15.5 MeV and a mean angular divergence
of 0.4◦. The actual spot size FWHM is indicated in the title of each
figure. The figures shows measured (blue) and simulated (red)
profiles as well as relative difference (green) between them (taking
the measurement as reference).
angular divergence as a free parameter (cf. Figure 21 where the angluar
divergece was set to 0◦).
The χ2/NDF test is intended for uncorrelated events, which may
not be assumed when considering a lateral dose profile. Moreover, if a
simulated lateral profile differs only from the corresponding measure-
ment by statistical fluctuation the computed χ2/NDF should precisely
equal 1 and in any other situation the χ2/NDF is expected to be >1.
However, as the uncertainty in the measurements are neglected the
total combined uncertainty is therefore underestimated, which might
lead to a χ2/NDF of <1. The set of parameters minimizing χ2/NDF,
regardless of its value, were selected as the optimal parameter set for
each energy. A useful feature of the χ2/NDF test is that it is possible
to relate the computed values to uncertainties of the varied parame-
ters. An increment of 1 on the χ2/NDF, for a single varied parameter,
corresponds to one standard deviation on that parameter [Berendsen,
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Figure 23: χ2/NDF plots for a fixed mean energy (6.0 and 15.5 MeV) and
mean angular divergence (0.0 and 0.4◦) as a function of varying
(circular) spot size FWHM for 6 (left) and 15MV (right) mode.
Evaluation was conducted for a 40×40 cm2 profile at 10 and 3 cm
depth, respectively for the 6 and 15MV mode and for crossline
(X) and inline (Y) profiles separately. A single (global) minima is
identifiable for each data set.
2011; Hughes and Hase, 2010]. Put more clearly, the value minimizing
the χ2/NDF corresponds to the optimal value while one standard
deviation of that parameter is the value resulting in min(χ2/NDF)+1.
This was used as an criteria such as only parameter sets resulting in
min(χ2/NDF)+1 (of the global min(χ2/NDF) for 6MV and 15MV,
respectively) were accepted for further calibration. χ2/NDF for a fixed
mean energy (6.0 and 15.5 MeV) and mean angular divergence (0.0 and
0.4◦) as a function of varying (circular) spot size FWHM are shown in
Figure 23. A single, global, minima is identifiable for each data set and
about that minima the χ2/NDF is monotonically increasing (except
for the smallest spot size FWHM for the 6MV mode).
Relative Output Factors
Special attention must also be given to the agreement between mea-
sured and simulated ROF. IC measured ROFs (normalized to 10×10
cm2) was measured using a Wellhöfer/IBA CC13 ion chamber, with
a sensitive volume of 0.6 cm3, in an otherwise homogenous water
phantom, for a range of field sizes at a depth of 10 cm and with SSD
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Table 3: Parameter sets resulting in local minima of χ2/NDF, while still
fulfilling the acceptance criteria for further calibration.
Mean Spot size Spot size Mean angular
Name energy FWHM: X FWHM: Y divergence
(MeV) (cm) (cm) (◦)
6MV
6a 5.70 0.250 0.250 –
6b 5.80 0.250 0.225 –
6c 5.90 0.175 0.175 –
6d 6.00 0.175 0.175 –
15MV
15a 15.00 0.150 0.150 0.20
15b 15.25 0.125 0.150 0.30
15c 15.50 0.125 0.125 0.40
90 cm. MC simulations12 were conducted in a homogenous water
phantom were the dose to a voxel of 0.6 cm3 at 10 cm depth, with
SSD 90 cm, was scored for a range of field sizes (3×3, 5×5, 10×10,
15×15 and 20×20 cm2). The ROFs were calculated as the ratio between
the dose at a given field size and that of 10×10 cm2. The simulated
ROFs were multiplied by the corresponding measured back scatter
correction factor in order to compensate for backscatter to the monitor
chamber (see Section 5.1). The relative deviation between simulated
and measured ROF (Figure 24) were computed through:
(ROFMC −ROFmeasured) /ROFmeasured × 100. (3.3)
The parameter set resulting in the smallest summed absolute value
of the relative difference was selected for further calibration. The
parameter sets were 6d and 15b (The full parameter sets are given in
Table 3) for 6MV and 15MV, respectively.
40×40 cm2 lateral profiles revisited
Figure 9 illustrate that lateral profiles are sensitive to changes in spot
size FWHM. Small changes in spot size FWHM on one of the axes
12 DOSXYZnrc was used for phantom simulation with a voxel size of
0.8434×0.8434×0.8434 cm3. The number of histories were chosen so that the sta-
tistical uncertainty at 10 cm depth along the CAX was 0.5%. Simulation properties
were ECUT = 521 keV, PCUT = 10 keV, nsplit = 25, esplit = 25 and howfarless turned
on. The treatment head was simulated using source 9 in DOSXYZnrc. Simulation
properties were ECUT = 700 keV, PCUT = 10 keV, direction bremsstrahlung splitting
was used (FS was set equal to the length of the square field and SSD = 100), NBRSPL
was set to 1000, with the splitting plane for electrons (ZPLANE_DBS) defined as the
bottom of the flattening filter and russian roulette conducted for electron at a plane
0.20 cm above the bottom of the flattening filter.
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Figure 24: Relative deviation between simulated and measured ROF for 6MV
(left) and 15MV (right). The full parameter sets are given in Table 3
affects the profile lined up with that axes, while the orthogonal profile
is rather unaffected (Figure 25). Thus the X–and Y–spot size FWHM
can be tuned individually. The selected parameter sets were fine tuned
by varying the parameters individually, while keeping the others
fixed. As small changes of mean energy is not detected on 40×40 cm2
lateral profiles it was not further tuned. The remaining parameters
were thus: spot size FWHM in X– and Y–direction as well as mean
angular divergence (for 15MV mode only). The spot size FWHM in
X–and Y–direction was varied independently of each other and thus
allowing for an elliptical source. Simulations13 were conducted for a
resolution of 0.05 cm and 0.05◦ on spot size FWHM and mean angluar
divergence, respectively. χ2/NDF tests were conducted as previously
and the parameter minimizing the χ2/NDF was selected and used
in the tuning process of the latter parameters. The order of the fine
tuning process were: spot size FWHM in X–direction, spot size FWHM
in Y–direction and mean angular divergence (for 15MV mode only).
An acceptance criteria similar to that for 10×10 cm2 PDDs were
posed such that the slope of a linear fit to the ratio between the
measured and simulated curve was computed. A ratio <1.0% was
sought over [0;20] cm lateral distance form the CAX. In order to fulfill
this criteria, the slope of the ratio needs to be less than 0.01Dmax cm−1.
The selected range of consideration was [0;20-3 cm] and [0;20-5 cm]
for 6MV and 15MV, respectively. Within this range, lateral CPE will
exist, and the diode reading is reliable.
13 DOSXYZnrc was used for phantom simulation with a voxel size of 0.25×0.25×0.5
cm3. The number of histories were chosen so that the statistical uncertainty along the
CAX was 0.5–0.7% at 3–15 cm depth. Simulation properties were ECUT = 761 keV,
PCUT = 10 keV, nsplit = 25, esplit = 25 and howfarless turned on. The treatment head
was simulated using source 9 in DOSXYZnrc. Simulation properties were ECUT =
700 keV, PCUT = 10 keV, direction bremsstrahlung splitting was used (FS = 40, SSD =
100), NBRSPL was set to 1000, with the splitting plane for electrons (ZPLANE_DBS)
defined as the bottom of the flattening filter and russian roulette conducted for
electron at a plane 0.20 cm above the bottom of the flattening filter.
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Figure 25: Local relative difference between 40×40 cm2 lateral profiles with
spot size FWHM set to 0.15 and 0.20 cm respectively (mean energy
= 6.00 MeV, spot Size FWHM 0.175 in X–direction). Comparison
was made at 10 cm depth. Included in the figure is a line represent-
ing identical profiles (dashed black) and a four degree polynomial
fit to the results (blue). It can be seen that the inline profiles are
affected in the entire range [-15; 15] cm and predominantly so
with increasing distance from the CAX, while the crossline profile
is affected only at the very edges of the range and to a smaller
degree.
Table 4: Parameter sets producing best agreement with measurements, by
means of χ2/NDF test, after the final fine tuning of spot size FWHM
(for X– and Y–direction separately) and mean angular divergence.
Nominal Mean Spot size Spot size Mean angular
Energy energy FWHM: X FWHM: Y divergence
(MV) (MeV) (cm) (cm) (◦)
6 6.00 0.155 0.170 –
15 15.25 0.130 0.140 0.35
Agreement with measurement using the slope of difference/accep-
tance criteria were -0.2/0.6 for the 6MV model in X– and Y– direction,
respectively and 0.4/0.1 for the 15MV model in X– and Y– direction,
respectively and thus well within the criteria of <1.0% difference over
[0;20] cm (a slope of difference/acceptance criteria <|1| correspondce
to having met the criteria).
The parameter sets resulting in the best agreement with measure-
ments are given in Table 4.
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10×10 cm2 CAX PDDs revisited
Following the fine tuning of the parameter set, the 10×10 cm2 CAX
PDDs were resimulated14 in order to verify that the agreement with
measurement had not been invalidated. Measured and simulated
PDDs along CAX are shown in Figure 26. Most data points agree
within ±0.5%. The scatter of the difference is larger with increas-
ing depth due to the increased uncertainty of the individual voxels
with depth. Agreeemnet with measurement using the slope of differ-
ence/acceptance criteria (as descirbed in section 3.3) were -0.4 and 0.5
for 6MV and 15MV, repsecitively and thus well within the crietria of
<0.5% difference over (0,40) (a slope of difference/acceptance criteria
<|1| correspondce to having met the criteria).
Relative Output Factors revisited
ROFs were resimulated15 using the final pramtere set and compared
to IC measurements. Simulated ROFs were multiplied by measured
BSF to account for field size dependant monitor chamber backscatter.
Measured and simulated ROFs as well as deviation between the two
are shown in Figure 27. Measured and simualted ROFs agreed within
the statistical uncertainty from the simulations. A trend is observed
for the 6MV, where simulated ROFs for field sizes < 10×10 cm2 are
higher compared to measured and ROFs for field sizes > 10×10 cm2
are lower. This is not seen for 15MV and might be due to the inclusion
of mean angular divergence.
14 DOSXYZnrc was used for phantom simulation with a voxel size of 0.5×0.5×0.2 cm3.
The number of histories were chosen so that the statistical uncertainty along the CAX
was 0.2–0.5% at 5–30 cm depth. Simulation properties were ECUT = 521 keV, PCUT
= 10 keV, nsplit = 25, esplit = 25 and howfarless turned on. The treatment head was
simulated using source 9 in DOSXYZnrc. Simulation properties were ECUT = 700
keV, PCUT = 10 keV, direction bremsstrahlung splitting was used (FS = 10, SSD =
100), NBRSPL was set to 1000, with the splitting plane for electrons (ZPLANE_DBS)
defined as the bottom of the flattening filter and russian roulette conducted for
electron at a plane 0.20 cm above the bottom of the flattening filter.
15 DOSXYZnrc was used for phantom simulation with a voxel size of
0.8434×0.8434×0.8434 cm3. The number of histories were chosen so that the sta-
tistical uncertainty at 10 cm depth along the CAX was 0.5%. Simulation properties
were ECUT = 521 keV, PCUT = 10 keV, nsplit = 25, esplit = 25 and howfarless turned
on. The treatment head was simulated using source 9 in DOSXYZnrc. Simulation
properties were ECUT = 700 keV, PCUT = 10 keV, direction bremsstrahlung splitting
was used (FS was set equal to the length of the square field and SSD = 100), NBRSPL
was set to 1000, with the splitting plane for electrons (ZPLANE_DBS) defined as the
bottom of the flattening filter and russian roulette conducted for electron at a plane
0.20 cm above the bottom of the flattening filter.
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Figure 26: Simulated and measured 10×10 cm2 PDDs for 6MV (top) and
15MV (bottom) for the final parameter set of the MC model (see
Table 4). The left panel shows the PDDs while the right panel
shows local relative difference (black) and a second order polyno-
mial fit (in the range [1.5;27.5] cm and [3;27.5] for 6MV and 15MV,
respectively) to the difference (blue).
3.4 the multi leaf collimator
So far only open fields (fields collimated by the jaw collimators) have
been considered. An important component for advanced radiotherapy,
such as IMRT and VMAT, are the MLCs which are used as an addi-
tional collimation device. The Varian Millennium 120 leaf MLC has
been hard coded in MCSIM (2.2.6), whereas it may be modelled in
detail using the DYNVMLC [Heath and Seuntjens, 2003] CM in BEAM-
nrc. Moreover, DOSXYZnrc sources 20 and 21 [Lobo and Popescu,
2010] have the option to include an external MLC simulation (e.g. the
particle dMLC transport described by Keall et al. [2001]; Siebers et al.
[2002]).
Studies investigating the influence of MLC parameters on the MC
dose distributions have been conducted by several groups (e.g. Belec
et al. [2005]; Borges et al. [2012]; Fix et al. [2011]; González et al.
[2011]; Heath and Seuntjens [2003]; Jang et al. [2006]; Kairn et al.
[2010]; Keall et al. [2001]; Leal et al. [2004]; Li et al. [2010]; Pönisch
et al. [2006]; Reynaert et al. [2005]; Siebers et al. [2002]; Tyagi et al.
[2007]). In order to commission the MLC measurements of a 10×30
cm2 field with fully closed MLC (at 10 cm from CAX) were conducted
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Figure 27: Simulated and measured ROFs for 6MV (top) and 15MV (bottom)
for the final parameter set of the MC model (see Table 4). The left
panel shows the ROFs while the right panel shows local relative
difference (red). Included in the residual plots are also a line
corresponding to perfect agreement (dashed black).
using GafChromic EBT film (International Specialty Products, NJ,
USA) placed at 5 cm depth in a Gammex 457 solid water phantom
(Gammex–RMI, Nottingham, UK) with an SSD of 95 cm and irradiated
for 4000 MU. The film was read with a flatbed Epson (Seiko Epson
Corporation, Nagano, Japan) 4990 scanner the day after irradiation (as
to prevent any effect of post–exposure density growth). The scan was
conducted at resolution of 72 dpi (0.35 mm per pixel) as recommended
by Ferreira et al. [2009]. The optical density was converted to dose
using a calibration curve obtained during the same measurement
session.
MC simulation corresponding to the measurements were utilized
in order to commission the MLC. The procedure differed between
the two MC codes due to the inherent differences in the codes. The
procedure is described below for each of the two MC codes in turn.
Commissioning of the hard coded MLC in MCSIM consists of fitting
the two parameters MLC–transmission and MLC–leakage to measure-
ments. The former parameters defines the fraction of radiation that
passes through an MLC leaf while the latter corresponds excess radia-
tion due to interleaf leakage Department of Radiation Oncology, Fox
Chase Cancer Center [2008]. The commissioning process of the MLC
in MCSIM is reduced to finding the combination of MLC transmission
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Figure 28: Lateral dose profiles for a 10× 30 cm2 field with a fully closed
MLC. The film measurements illustrate a leaf pair effect (most
distinguished for 6 MV) that was not reproduced by the MCSIM
simulations.
and leakage that results in agreement with measurements. Specifically,
simulations of a field with fully closed leaves was compared with
film measurements. The field size was 10×30 cm2 and all leaf pairs
were fully closed 10 cm off CAX. Corresponding simulations were
performed, using a voxel size of 2.0×0.1×0.5 cm3 for 9×109 histories
with cut off energies of 521 keV (including rest mass) and 10 keV
for electrons and photons, respectively. The only variance reduction
technique switched on was IETRACK (electron track repeating). The
parameters resulting in the best match to measurements (Figure 28) are
given in Table 5. The parameters agree well with the findings reported
by Galvin et al. [1993], where the reported transmission through the
MLC, for 6MV and 15MV of a Varian 2100C linac, was approximately
2% and and additional 0.5% due to interleaf leakage. Klein et al. [1995]
reported an MLC transmission of 1.5–2.0% for 6MV and 1.5–2.5% for
18MV for the same accelerator. The slightly increase in transmission
with energy is concurrent with the findings of this study.
The drawings provided by the manufacturer [Varian Medical Sys-
tems, 1999; Varian Oncology Systems, 2008] holds detailed information
on the MLC dimensions but not on the composition and density. The
commissioning of the MLC as modelled in BEAMnrc using the DYN-
VMLC CM is therefore reduced to finding the composition and density
resulting in agreement between measurements and simulations. The
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Table 5: MLC transmission and leakage parameters for MCSIM
MLC MLC
transmission leakage
6MV 0.015 0.022
15MV 0.017 0.025
composition used by Heath and Seuntjens [2003], a tungsten alloy
consisting of 90% tungsten, 6% nickel, 2.5% copper and 1.5% iron,
was used to model the MLC also in this study. Simulations16, corre-
sponding to the EBT film measurement, were then conducted with
the density varyied between 17.0 and 18.8 g cm−3 in steps of 0.1 g
cm−3. The simulated dose was converted to absolute dose per MU
by Equation 5.3 where the BSF was accounted for by means of Itarget
measurements. The density resulting in best agreemenet, by means of
visual inspection, with measurements was selected. Figure 29 shows
measured and simulated MLC transmission/leakage profiles for the
6MV mode. It can clearly be seen that an increased MLC density
leads to a reduction in MLC transmission, as expected. The density
resulting in the best agreemenet with measurements was 17.3 g cm−3.
The density is slightly lower than that found by Heath and Seuntjens
[2003] (17.7 g cm−3) but within what is recommended for MLCs by
Boyer et al. [2001] (17.0 – 18.5 g cm−3). The difference compared to
Heath and Seuntjens [2003] may be due to differences in the actual
MLC, in the drawings or in the implementations of the them. A trans-
mission of 0.015 cGyMU−1 is equivalent to a transmission of 1.5%,
which is in agreement with the findings of Galvin et al. [1993] and
Klein et al. [1995]. A transmission/leakage profile was simulated for
15MV using the same parameters (Figure 29). Satisfactory agreement
with measurement was found at a slightly higher transmission rate as
expected.
The same composition and density was used for the particle DMLC
code but no dedicated commissioning simulation was conducted.
The inner 40 leaf pairs of the Varian Millennium 120 leaf MLC are
arranged in an alternating pattern of two leaf types. This design results
16 A homogeneous Gammex solid water phantom with voxel sizes 2.0× 0.1× 0.25 cm3
with SSD = 95 cm was defined in DOSXYZnrc. The number of histories were chosen
so that the statistical uncertainty at 5 cm depth was ≈1%. Simulation properties were
ECUT = 521 keV, PCUT = 10 keV, nsplit = 25, esplit = 1 and howfarless turned on. The
treatment head was simulated using source 9 in DOSXYZnrc. Simulation properties
were ECUT = 700 keV, PCUT = 10 keV, direction bremsstrahlung splitting was used
(FS = 30 cm and SSD = 100), NBRSPL was set to 1000, with the splitting plane for
electrons (ZPLANE_DBS) defined as the bottom of the flattening filter and russian
roulette conducted for electron at a plane 0.20 cm above the bottom of the flattening
filter.
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Figure 29: Measured (black) and simulated lateral dose profiles for a 10× 30
cm2 field with a fully closed MLC for 6MV (left) and 15MV (right).
Some simulations have been excluded from the visualization as to
increase readability of the figure.
in transmission and leakage profiles resembling a saw–blade pattern
with alternating tooth heights Heath and Seuntjens [2003]; Siebers
et al. [2002] as seen in the film measurements (Figure 28). The effect
was most distinguished for 6 MV. Due to limitations in leaf shape
modeling, the MCSIM simulations did not reproduce this pattern.
However, the average leaf leakage effect agreed well between film
measurements and simulations (Figure 28). The influence of this on
dose distribution of clinical IMRT and VMAT plan is hard to estimate
but assumed to be small and not considered further in this study. The
MLC transmission/leakage profile simulated using DOSXYZnrc and
DYNVMLC was able to reproduce the saw tooth pattern to a much
higher degree (Figure 29).
3.5 verification
In order to verify the accuracy of the MC model, simulation of a range
of different situations were conducted and compared to measurements.
The measurements were conducted as described on page 51. Addi-
tional measurements were conducted using Gafchromic EBT 2 film
placed in a Gammex 457 solid water phantom (30×30×30 cm2) and
an in–house developed ME40 Scintillator Dosimetry System (DTU,
Roskilde, Denmark). The ME40 system functions by connecting Burr–
Brown ACF2101 switched integrator circuits [Mountford et al., 2008]
to the SYNC BNC contact of the linac. The charge built up in a 100
pF capacitor is held, integrated, and read out before it is reset at the
onset of the next synchronization pulse. The detector used was a 1 mm
diameter, polystyrene–based scintillating fibers (BCF-60, Saint–Gobain
Ceramics & Plastics Inc., France). The scintillating fibers were cut to
a length of 1 mm and coupled to PMMA–based optical fibers (ESKA
GH-4001P, Mitsubishi-Rayon Co.,Japan) of 1 mm core diameter, 2.2
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mm outer jacket diameter and approximately 10 m length, terminated
by an SMA connector. Before coupling, the exposed ends of the scin-
tillator and the optical fiber were polished using aluminum oxide
polishing paper of 5, 3, 1 and 0.3 µm grain size (Thorlabs Sweden AB,
Göteborg, Sweden) and cleaned using water and pressurized air. The
two components were aligned using a mechanical fixation mount and
a stereo microscope, before making the coupling permanent using
UV-curing, refractive index-matching glue (NOA68, Norland Prod-
ucts Inc., USA). Finally, a jacket of black epoxy cement (EPOTEK 320,
EpoxyTechnology Inc., USA) was molded around the exposed junction
to light–tighten the probe. The fiber cable was placed in a Gammex
457 solid water phantom (30×30×30 cm3) with a groove, ensuring
a snug fit for the scintillator probe, drilled in on of the slabs. That
slab was placed at the desired measurement depth. In order to ensure
positioning the scintillator was replaced with a lead piece of the same
size. The beam isocenter was aligned with the lead piece using the
positioning lasers as a first estimate. The actual position of the beam
isocenter was relative to the lead marker was investigated by taking a
portal image, using the linac On–Board Imaging (OBI) device. In case
of an offset, the solid water phantom was carefully repositioned to
correct for the offset. A second portal image was acquired in order to
verify the positioning. If the lead piece still was not aligned with the
beam isocenter, the procedure was reiterated until agreement.
MC simulations reproducing the measurements were conducted
using the model parameters listed in Table 4.
PDD
Simulated17 6MV and 15MV CAX PDDs, for the field sizes 5×5, 10×10
and 20×20 cm2, were compared to measurements using a Wellhöfer-
/IBA CC13 (IBA Dosimetry AB, Uppsala, Sweden) Ionization Chamber
(0.13 cm3 active volume) (Figure 30–31). The PDDs were normalized
at 10 cm depth, using a forth degree polynomial fit in the [5;15] cm
region and multiplied by their respective, measured, ROF. The results
demonstrate that agremment within 1% was achieved beyond dmax
in all but a few voxels and within 2% the remaining voxels. An over-
repsonce of the IC, compared to the MC simulation, was consistently
noted in the build–up region. It is a well known fact that measure-
ments using plane parallel [Velkley et al., 1975] as well as thimble–type
17 DOSXYZnrc was used for phantom simulation with a voxel size of 1.0×1.0×0.25 cm3.
The number of histories were chosen so that the statistical uncertainty along the CAX
and beyond dmax was 0.3–0.6%. Simulation properties were ECUT = 700 keV, PCUT
= 10 keV, nsplit = 25, esplit = 25 and howfarless turned on. The treatment head was
simulated using source 9 in DOSXYZnrc. Simulation properties were ECUT = 521 keV
(700 keV for the collimating jwas), PCUT = 10 keV, direction bremsstrahlung splitting
was used (FS set equal to the side length of the square field, SSD = 100) and NBRSPL
was set to 1000.
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Figure 30: Top: Measured (solid line) and simulated (circles) 6MV PDD for
5×5 (blue), 10×10 (green) and 20×20 (red) cm2. All curves were
normalized at 10 cm depth, using a forth degree polynomial fit in
the [5;15] cm range, and multiplied by the ROF of that field size.
Bottom: relative deviation between MC simulated and measured
6MV PDDs for 5×5 (blue), 10×10 (green) and 20×20 (red) cm2.
ion chambers [Zhu, 2010] leads to a substantial overestimation of the
dose in the build–up region unless dedicated corrections are made. In
fact, the suggested correction for thimble ion chamber measurement
of an effective point of measurment shift of 0.6×rdetector [Almond
et al., 1999; Andreo et al., 2000] might be inaccurate [Kawrakow, 2006;
Tessier and Kawrakow, 2010]. The agreement for depths shallower
than dmax should therefore not be considered in Figure 30–31.
In order to further investigate the validity of the MC model in
the build up region measurements were conducted for a 10×10 cm2
field impinging on a homogenous PMMA phantom described in
Behrens [2006]. A Capintec PS–033 plane–parallel ionization chamber
(Capintec, Inc. , New York, USA) was used to measure dose in steps
of 1 mm from 0 mm to 31 mm depth. The plane–parallel chamber will
over respond in the the build up region due to secondary electrons
scattered from the walls of the chamber [Velkley et al., 1975]. Gerbi and
Khan [1990] reported a correction method for the chamber in question
by comparison with measurements conducted with an extrapolation
chamber. For a given beam quality the correction the detector reading
can be corrected through:
P ′(d) = P(d) − ξ(d) (3.4)
ξ(d) = ξ(0)e−α(d/dmax)
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Figure 31: Top: Measured (solid line) and simulated (circles) 15MV PDD for
5×5 (blue), 10×10 (green) and 20×20 (red) cm2. All curves were
normalized at 10 cm depth, using a forth degree polynomial fit in
the [5;15] cm range, and multiplied by the ROF of that field size.
Bottom: relative deviation between MC simulated and measured
15MV PDDs for 5×5 (blue), 10×10 (green) and 20×20 (red) cm2.
where P ′(d) and P(d) are the corrected and uncorrected measurements,
respectively, and the latter must be normalized to 100% at dmax, ξ(d) is
the over response at depth d. Gerbi and Khan [1990] proposed to use
α = 5.5 and ξ(0) = 4.4 for the Capintec PS–033 plane–parallel ionization
chamber. This correction method was applied to the measurements.
Measurements were also conducted using the ME40 system in the
same geometry. Simulations were conducted using the EGSnrc user
code DOSrz18 where dose to PMMA was scored. The dose was nor-
malized to the maximum dose for each curve independently.
The comparison between MC and measurements are shown in
Figure 32. Deviation of ≈10% are noted at the very surface, but already
at 5 mm depth the deviation is < 2% between MC and any of the
measurement systems. The deviation is within 1% for nearly all, and
well within 2% for all, of the depths beoynd 6 and 10 mm for 6 MV
and 15 MV, respectively.
18 A PMMA phantom of 30 cm depth and an outer radius of 15 cm was used. The central
region had a radius of 0.24 cm and the slab thickness was 0.25 cm. The number of
histories were selected so that the uncertainty along the CAX was ≈0.7% in the [0,5]
cm depth range. Cut off energies were set to 521 keV (including rest mass) and 10
keV for electrons and photons, repsectively. The treatment had was simulated using
source 23 (full treatment head simulation) and simulation properties were ECUT =
521 keV (700 keV for the collimating jwas), PCUT = 10 keV, direction bremsstrahlung
splitting was used (FS = 10, SSD = 100) and NBRSPL was set to 1000.
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Figure 32: Top panel: 10×10 cm2 field CAX PDD in a PMMA phantom
measured with a Capintec PS–033 ionization chamber (black), the
ME40 Scintillator system (red) and MC simulated (blue) for 6 MV
(left) and 15 MV (right), respectively. Bottom panel: Relative local
deviation between MC and IC measurements (black) and MC and
scintillator measurements (red) for 6 MV (left) and 15 MV (right),
respectively. Shown in the figure are also lines corresponding to
±1% deviation (green).
Lateral profiles
Simulated19 lateral profiles field sizes the following field sizes: 5×5,
10×10 and 20×20 cm2 were selected for verifaction. Comparisons were
conducted with diode, Scanditronix/IBA PFD3G (IBA Dosimetry AB,
Uppsala, Sweden) Si–photon diode, measurements.
Agreement between MC simulation and diode measurements was
generally within 1% in the regions where CPE exists. Figure 33–40
19 DOSXYZnrc was used for phantom simulation with a voxel size of 0.25×0.25×0.5
and 0.1×0.1×0.5 cm3. The number of histories were chosen so that the statistical
uncertainty along the CAX was 0.5–0.7% at 5–20 cm depth. Simulation properties
were ECUT = 521 keV, PCUT = 10 keV, nsplit = 25, esplit = 25 and howfarless turned
on. The treatment head was simulated using source 9 in DOSXYZnrc. Simulation
properties were ECUT = 700 keV, PCUT = 10 keV, direction bremsstrahlung splitting
was used (FS set equal to the side length of the square field at SSD = 100), NBRSPL
was set to 1000, with the splitting plane for electrons (ZPLANE_DBS) defined as the
bottom of the flattening filter and russian roulette conducted for electron at a plane
0.20 cm above the bottom of the flattening filter.
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Figure 33: Top: Measured (black) and simulated (blue) lateral crossline pro-
file for 6MV, field size = 5×5 cm2 and at 5 cm depth. Both curves
were normalized at the central axis, using a second degree poly-
nomial fit in the inner [-1.25;1.25] cm region. The errorbars on the
MC simulated dose correspond to the statistical uncertainty (as
calculated by EGSnrc). Bottom: relative deviation between the MC
simulated and measured profile (red). Lines representing ideal
agreement (black) as well as ±1% (green) are also shown.
show measured and simulated profiels as well as residuals for a
number of field sizes and depths.
ROF
ROFs were measured for field sizes ranging from 10×10 cm2 to 0.6×0.6
cm2, using the ME40 Scintillator Dosimetry System, and simulated20.
The combined uncertainty of the simulatied and measured ROFs was
≈1% for a given field size. Agreement between measurements and
simulations were found, within the given relative combined uncer-
tainty, for all field sizes except the smallest where the deviation was
1.5% (Figure 41). It should be noted that effect of positioning errors
increases with decreasing field size and was estimated to be 6% for a
1 mm displacement for the 0.6×0.6 cm2 field [Beierholm et al., 2011].
The field size was not verified specifically for the measurements.
20 A phantom mimicking the measurement situation was built in DOSXYZnrc (see
Figure 42). The number of histories were chosen so that the statistical uncertainty to
the scintillator crystal was ≈0.5%. Simulation properties were ECUT = 521 keV, PCUT
= 10 keV, nsplit = 25, esplit = 25 and howfarless turned on. The treatment head was
simulated using source 9 in DOSXYZnrc. Simulation properties were ECUT = 700
keV, PCUT = 10 keV, direction bremsstrahlung splitting was used (FS set equal to the
side length of the square field for field sizes > 5×5 cm2 and to 5 cm for field sizes <
5×5 cm2, SSD = 100
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Figure 34: Top: Measured (black) and simulated (blue) lateral inline profile
for 6MV, field size = 5×5 cm2 and at 20 cm depth. Both curves
were normalized at the central axis, using a second degree poly-
nomial fit in the inner [-1.25;1.25] cm region. The errorbars on the
MC simulated dose correspond to the statistical uncertainty (as
calculated by EGSnrc). Bottom: relative deviation between the MC
simulated and measured profile (red). Lines representing ideal
agreement (black) as well as ±1% (green) are also shown.
summary on the commissioning
Previous studies state that the parameters necessary to tweak during
calibration of the MC model are the mean energy, spatial distribution
and mean angular divergence of the electrons impinging on the linac
target. Consensus is not found on what situations to compared simu-
lations to measurements for in order to determine the values of said
parameters.
A sensitivity analysis was conducted and it was found that PDDs
are somewhat sensitive to changes on the mean energy, but in princi-
ple insensitive to the other parameters of interest. Wide–field lateral
profiles are on the other hand sensitive to all of the three parameters
(i.e. the mean energy, spatial distribution and mean angular divergence
of the impinging electrons) and in fact more sensitive to changes on
the mean energy than PDDs. Changes on the spatial distribution and
mean angular divergence of the impinging electrons affected the distal
and central parts of the wide–field profiles, respectively (see Figure 9
and Figure 12), while changes on the mean energy affects the entire
profile (see Figure 10).
As oppose to determining each parameter individually a calibration
protocol where a data space containing a range of combinations were
compared to measurements for a 40×40 cm2 field using a χ2–test. All
parameter combinations fulfilling an acceptance criteria were selected
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Figure 35: Top: Measured (black) and simulated (blue) lateral inline profile
for 6MV, field size = 20×20 cm2 and at 5 cm depth. Both curves
were normalized at the central axis, using a second degree poly-
nomial fit in the inner [-2.0;2.0] cm region. The errorbars on the
MC simulated dose correspond to the statistical uncertainty (as
calculated by EGSnrc). Bottom: relative deviation between the MC
simulated and measured profile (red). Lines representing ideal
agreement (black) as well as ±1% (green) are also shown.
for further investigation. ROF for a wide range of field sizes (3×3 to
20×20 cm2) were computed and compared to measurements for all
selected parameter combinations. The set of parameters yielding clos-
est agreement with measured ROFs were then selected. The validity
of the selected mean energy was verified for a 10×10 cm2 PDD, while
the spatial distribution and mean angular divergence of the impinging
electrons was fine tuned individually by comparison against a 40×40
cm2 field. ROF were then resimulated, using the fine tuned parameter
set, and compared to measurements.
Verification was conducted for PDDs and lateral profiles of different
field sizes, small field ROF and dose in the build up region of a
10×10 cm2 field. The agreement with measurements was generally
within 1–2%. The acceptance criteria, ±0.5% for 10×10 cm2 PDD in
the [0;40] cm range and ±1.0% for 40×40 cm2 lateral profiles in the
[0;20] cm range, were achieved. Measured ROFs were reproduced
within 0.9% and 0.6% for 6MV and 15MV respectively. Morover, the
MLC was commissioned seperately. This gives confidencec that any
given treatment plan may be recalculated with good accuracy using
the commissioned MC model.
The commissioning protocol was applied to a Varian 2300iX linac, at
Copenhagen University Hospital, Herlev, using BEAMnrc/DOSXYZnrc,
but could in principle be applied to any linac and MC engine.
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Figure 36: Top: Measured (black) and simulated (blue) lateral crossline pro-
file for 6MV, field size = 20×20 cm2 and at 20 cm depth. Both
curves were normalized at the central axis, using a second degree
polynomial fit in the inner [-2.0;2.0] cm region. The errorbars on
the MC simulated dose correspond to the statistical uncertainty (as
calculated by EGSnrc). Bottom: relative deviation between the MC
simulated and measured profile (red). Lines representing ideal
agreement (black) as well as ±1% (green) are also shown.
The geometry provided by the vendor was considered accurate and
implemented from the provided drawings. Incomplete knowledge of
geometry and material composition (e.g. the internal linac design)
does not allow MC calculation to be performed purely from “first
principles”. The commissioning must be based on fitting of parameters
to achieve agreement with measurements as there are no other viable
options.
It should also be stated that the measurements used to determine
the parameters of the MC model are not independent from the mea-
surements used in the latter verification. The influence of this on the
validity and accuracy of the dose calculated by the MC model is not
further discussed.
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Figure 37: Top: Measured (black) and simulated (blue) lateral crossline pro-
file for 15MV, field size = 5×5 cm2 and at 5 cm depth. Both curves
were normalized at the central axis, using a second degree poly-
nomial fit in the inner [-1.25;1.25] cm region. The errorbars on the
MC simulated dose correspond to the statistical uncertainty (as
calculated by EGSnrc). Bottom: relative deviation between the MC
simulated and measured profile (red). Lines representing ideal
agreement (black) as well as ±1% (green) are also shown.
Figure 38: Top: Measured (black) and simulated (blue) lateral inline profile
for 15MV, field size = 5×5 cm2 and at 20 cm depth. Both curves
were normalized at the central axis, using a second degree poly-
nomial fit in the inner [-1.25;1.25] cm region. The errorbars on the
MC simulated dose correspond to the statistical uncertainty (as
calculated by EGSnrc). Bottom: relative deviation between the MC
simulated and measured profile (red). Lines representing ideal
agreement (black) as well as ±1% (green) are also shown.
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Figure 39: Top: Measured (black) and simulated (blue) lateral inline profile
for 15MV, field size = 20×20 cm2 and at 5 cm depth. Both curves
were normalized at the central axis, using a second degree poly-
nomial fit in the inner [-2.0;2.0] cm region. The errorbars on the
MC simulated dose correspond to the statistical uncertainty (as
calculated by EGSnrc). Bottom: relative deviation between the MC
simulated and measured profile (red). Lines representing ideal
agreement (black) as well as ±1% (green) are also shown.
Figure 40: Top: Measured (black) and simulated (blue) lateral crossline pro-
file for 15MV, field size = 20×20 cm2 and at 20 cm depth. Both
curves were normalized at the central axis, using a second degree
polynomial fit in the inner [-2.0;2.0] cm region. The errorbars on
the MC simulated dose correspond to the statistical uncertainty (as
calculated by EGSnrc). Bottom: relative deviation between the MC
simulated and measured profile (red). Lines representing ideal
agreement (black) as well as ±1% (green) are also shown.
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Figure 41: Top: ROFs, normalized to the 10×10 cm2 field, measured using
the ME40 Scintillator Dosimetry System (black) and MC simulated
(red) as a function of square field side length. Bottom: Relative
deviation between MC simulated and measured ROFs (black).
Included in the figure are also lines corresponding to the statistical
uncertainty of the MC simulated ROFs (red). The uncertainty of
the measurements are not considered.
Figure 42: A schematic drawing of the geometry used for simulation of the
ME40 Scintillator Dosimetry System. A 30×30×30 cm3 Gammex
457 (grey) phantom was used. It had a 3×3 mm2 Polyethylene
(blue) outer jacket running across the phantom, a Polystyrene
(red) crystal of 1×1×1 mm3 located at (0,0,10) cm connected to a
PMMA (green) optical fibers of 1×1 mm inside the outer jacket.
An additional PMMA optical fibers was also placed inside the
outer jacket beyond the scintillating crystal. Drawing is not to
scale.

4
G E N E R AT I N G T H E M O N T E C A R L O C O M P L I A N T
PAT I E N T P H A N T O M
A Monte Carlo code, such as EGSnrc, computes dose based on an
interaction cross–sections database, where the cross–sections depend
on the particle type and energy but also on material composition and
mass density of the medium. In order to perform MCTP in a patient
geometry, it is therefore necessary to compute mass density as well as
the (chemical) composition for each element (voxel) of the patient. The
typical patient imaging modality used in radiotherapy is CT, which
results in a 3D attenuation matrix of the patient. In order to build an
MC compliant representation of the patient geometry it is necessary
to convert the CT data to mass density and composition matrices. This
topic was summarized in a MCTP review article by Reynaert et al.
[2007].
4.1 conversion of ct number to mass density
A calibration curve linking CT numbers to mass density can be ob-
tained by scanning different materials of known densities. The cali-
bration curve will be a bilinear relationship divided into high–Z and
low–Z materials [McCullough and Holmes, 1985]. They found an
overlapping region, in which care should be taken, at HU = 100–150.
Saw et al. [2005] conducted a similar study using a tissue characteriza-
tion phantom, CIRS Model 062 (CIRS Tissue Simulation Technology,
Norfolk, VA) which also established a bilinear relationship between
CT numbers and physical density. The main difference between the
studies being that McCullough and Holmes [1985] used non–tissue
equivalent materials, which might explain the more distinct overlap
region reported in that study. The reported point of discontinuity in
the bilinear curve also varies between the two studies (HU = 0 in Saw
et al. [2005] and HU = 100-150 in McCullough and Holmes [1985]).
Both studies highlight the fact that calibration curves are scanner
specific and that calibration therefore should be performed at each
institute. This has also been reported by others (e.g. Constantinou
et al. [1992] and Vanderstraeten et al. [2007]). Vanderstraeten et al.
[2007] initially assigned a separate linear curve to the region [0,100]
HU, but eventually concluded that they readily could be combined
into a single curve representing air, lung and soft tissues together.
In this work a CIRS Model 062 phantom (CIRS Tissue Simulation
Technology, Norfolk, VA, USA) was used for determination of the
CT–to–density conversion relationship (figure 43). The epoxy–based
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Figure 43: CIRS Model 062 phantom with tissue equivalent inserts.
phantom (ρ = 1.01 gcm−3) accommodate a total of 17 inserts simulta-
neously.
A total of eight different tissue equivalent materials (two of each)
and a water filled syringe were placed in the phantom (table 6). The
phantom was placed in a Phillips Brilliance CT Big Bore (Phillips,
Amsterdam, the Netherlands) such that the iso–center of the scanner
was aligned with the center of the phantom. A clinical protocol with
typical scanning parameters (120 kVp, 2–mm slice thickness) was
selected and the scan was repeated 7 times. The CT images were read
into MATLAB, using the dicomread function. Volume Of Interests
(VOIs) were drawn around each insert for every scan. VOIs was also
drawn outside of the phantom to obtain the CT number for air. The
data was pooled to obtain the average CT number of each insert for
the entire population of scans. The data set was fitted with linear
equations for the soft tissue and bone materials, respectively:
ρ = 10−3 ×
{
1.02H− 7.65 : H < 55
0.58H+ 467.79 : H > 55
(4.1)
The linear fits had R2 greater than 0.99. The results are in agreement
with the findings of Saw et al. [2005].
Figure 44 shows the relationship between CT numbers (H) and
density. The data are plotted as the mean CT numbers1 vs. physical
densities. The size of the markers corresponds to the uncertainty in
CT number (1 SD) and the average standard deviation was 15 HU.
Using dual energy CT–scanners for determination of the effective
atomic numbers, Zeff, and electron densities, ρe, in a CT–image has
been suggested in several studies (e.g. [Bazalova et al., 2008; Torikoshi
et al., 2003, 2004]). The mass density can subsequently be computed
from the electron density through:
ρ = ρw
nρe
nwρew
, (4.2)
1 I.e. the average CT number in the VOI and over all 7 scans
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Table 6: Physical densities and average CT number for the scanned materials.
Uncertainties on CT numbers are given as 1 SD.
Physical
density
Material gcm−3 CT number
Air (20 C) 1.2041× 10−3 -998 (±3)
Water (syringe) 1.00 -7 (±14)
Lung (inhale) 0.20 -801 (±16)
Lung (exhale) 0.50 -494 (±16)
Breast (50/50) 0.99 -33 (±16)
Liver 1.07 55 (±17)
Muscle 1.06 51 (±15)
Adipose 0.96 -64 (±16)
Trabecular Bone 200 mgcm−3 1.16 183 (±18)
Dense Bone 800 mgcm−3 1.53 841 (±19)
where n and nw is the number of atomic units per electron for the
specific material and water respectively and ρew is the electron density
of water [Reynaert et al., 2007]. This was not done in this study since
no dual energy CT scanner was available.
4.2 conversion of ct number to chemical composition
Converting the CT–data to chemical composition matrix is less straight
forward, since it is not possible to establish a direct relationship
through measurements. It is, however, important to assign proper ma-
terials, since media assignment may heavily influences the resulting
dose distribution [du Plessis et al., 1998]. Improper media assignment
has been reported to lead to dose errors on the order of 10% [Ottosson
and Behrens, 2011; Vanderstraeten et al., 2007; Verhaegen and Devic,
2005].
The first automated tool for conversion of CT–data to MC compliant
phantoms was presented by du Plessis et al. [1998]. They demonstrated
that representing the human body with seven different tissue types
were enough to limit the added uncertainty on dose to within 1%. In
the presented method both composition and mass density was fixed
for each tissue type. For bone and lung tissues, however, additional
tissue types was needed to maintain within the 1% limit. This was
accomodated by creating tissue types (21 tissues corresponding to
cortical bone and 31 to lung) with the same atomic composition, but
different physical densities. The protocol suggested by du Plessis et al.
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Figure 44: CT number plotted against physical density for the scanned ma-
terials for soft tissue (hollow circles) and bone material (filled
squares). The size of the markers corresponds to the uncertainty
in CT number (1 SD). Included in the figure are also linear fits to
the data of the soft tissue and bone materials, respectively.
[1998] is limited to the beam energy under consideration and would
need to be applied to all beam energies separetely.
An attempt to establish a link between composition and CT numbers
was introduced by Schneider et al. [1996] and revised by Schneider
et al. [2000]. It is based on a stoichiometric calibration of the CT
scanner using materials of known densities and compositions. Using
the stoichiometric calibration, it is possible to calculate the HU, H, for
a given composition. Dividing the human tissues into soft and bone
tissues, it can be noted that the bone tissues consists of a combination
osseous tissue and bone marrow, whereas soft tissue mainly consists
of combinations of water, fat and protein [White et al., 1987; Woodard
and White, 1982, 1986]. Using the calculated H and a number of
tissues with known composition (air, lung, adipose tissue 3, adrenal
gland, small intestine (wall), connective tissue, red/yellow marrow
and skeleton cortical bone) mass density and composition for a tissue
subset of 24 different media composition were computed through:
ρ =
ρ1H2 − ρ2H1 + (ρ2 − ρ1)H
H2 −H1
(4.3)
wi =
ρ1 (H2 −H)
(ρ1H2 − ρ2H1) + (ρ2 − ρ1)H
(w1,i −w2,i) +w2,i (4.4)
where media 1 and 2 are two of the basis media. w1,i and w2,i is the
weight of element i in media 1 and media 2, respectively, ρ1 and ρ2
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are the densities of media 1 and media 2, respectively and H1 and H2
are the HU of media 1 and media 2, respectively. Equations 4.3 and
4.4 are only valid if the basis media are chosen so that H1 6 H 6 H2.
Vanderstraeten et al. [2007] implemented the stoichiometric calibra-
tion protocol suggested by Schneider et al. [2000] for a large number
of CT–scanners and investigated the dosimetrical impact on the tissue
subset selection. Moreover, they investigated the dosimetrical impact
on the number of tissue types. It was found that 14 tissue types,
whereof 10 corresponding to bone of different densities, was sufficient
to obtain dosimetrical accuracy within 1% for photon beams. It was
also found that proper diffrentiation between air and lung is the most
critical task as misassignment might lead to local dose errors on the
order of 10%.
4.3 algorithms for automated conversion of ct–data to
mc compliant phantoms
The method currently implemented in tools for automated conversion
of CT–data to MC compliant phantoms is based on a method pub-
lished by Ma et al. [1999] and Ma et al. [2002]. In short, the method
consists of defining a number of bins, each corresponding to a media,
over the range of CT numbers. Each bin is assigned a lower and upper
value of CT number and density (this might be mass density or elec-
tron density) and the density is computed through linear interpolation.
The media assignment consists of sorting the voxels on CT numbers
and assigning the media corresponding to the bin it falls within. This
method is implemented in algorithms for automated conversion of
CT data to MC phantoms (e.g. CT–create [Walters et al., 2005] and
the DICOM–RT Toolbox [Spezi et al., 2002]2). Thus, the conversion
to density might depend on the number of media and it is therefore
necessary to use precaution when selecting the points and verifying
them with a measured calibration curve.
The existing tools and protocols for conversion of CT data to MC
parameters are limited to a global list of media, however not all
medias are likely to exist within a given organ or anatomical structure
(hereafter referred to as structures). This might lead to anatomically
incorrect medium assignment (e.g. a dense tumor might be assigned
bone in some voxels or voxels outside of the body may be classified
as lung) and ultimately resulting in an error in dose. Moreover, this
disables the use of media with an overlap in CT numbers, but distinct
elemental compositions.
2 The conversion of CT data to MC phantom is performed by the function DI-
COMRT_ctcreate
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4.4 ctc–ask
A new algorithm, CTC-ask (CT create applying DICOM structure
knowledge), implemented in a MATLAB software solution, enabling
global density conversion using partially linear HU–to–density–relationship
and local media assignment conditions within each structure was de-
veloped and is described in detail in Appendix B. Incorporation of the
delineations contained in the DICOM RS file enables separation into
local compartments based on anatomical regions.
4.4.1 CTCask general work–flow
Figure 45 illustrates the general work–flow of the program. Firstly, the
CT–matrix, CT– and dose–grid are read from the DICOM files. The
bilinear CT–to–density relationship is calculated based on data points
submitted by the user. An option to use a pre–saved relationship is
also provided. The CT matrix is globally converted to a density matrix,
with a grid corresponding to the dose–grid of the DICOM RD file.
The structures in the DICOM RS file are sorted according to structure
types (e.g. PTV, External, Avoidance etc.) and the user is queried for
structure types to be considered. A list of the structures with the de-
sired types is created and presented to the user along with an option
to exclude specific structures. The external body outline is a required
structure and may not be excluded. A logical mask is generated for
each selected structure, that is, a logical matrix of the same shape
as the RD dose grid where true means that the voxel belongs to the
specific structure. The user is requested to input names and upper CT
number bounds for the possible media (hereafter refereed to as a ramp–
function) for each structure (the lower CT number bound of the first
medium defaults to 0, while the ith (i>1) uses the upper CT number
bound of the (i− 1)th medium). An option to use a pre–saved ramp–
function is implemented. As every voxel is allowed to belong to only
one structure, the program iterates over the selected structures and
generates a union–structure in the regions where structure–overlaps
exist. In case of structure–overlaps the ramp–function of the over-
lapping structures are compared. If identical, the structure–union is
assigned the ramp else the user is queried to specify one. The voxels
belonging to the overlapping area are set to false for the overlapping
parent–structures and to true for the generated structure–union. If
any unions were found during the iteration a recursive call of the
function is made. Each structure undergoes a separate conversion of
CT number to media based on their ramp–function. A global media
list is generated and each structure correlated to the global list. An
option to set voxels outside of the external body contour to air with
zero density is implemented in order to emulate the procedure of
treatment planning systems . The media matrices are subsequently
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Figure 45: General work–flow of CTCask.
added to a global media matrix. Finally, the data is written to an
egs4phant file.
4.4.2 Generating a representative media set
Using tabulated composition (NIST [2011a]; White et al. [1987]; Woodard
and White [1986]) of a limited number of tissues and the measured
relationship between density and HU it is possible to generate a repre-
sentative set of media spanning the full range of HU values from air to
cortical bone (Schneider et al. [2000]; Vanderstraeten et al. [2007]). The
scheme suggested by Schneider et al. [2000] was adopted, with one
modification: The soft tissue range was divided in accordance with
Vanderstraeten et al. [2007], which assures dosimetric equivalence
within 1%. In total, 19 media were generated (table 7). The first and
second bins correspond to air and lung, respectively. The composition
of the following bins were calculated according to equation 4.4. The
integral difference between the method presented by Schneider et al.
[2000] and this study is that no stochiometric calibration of the CT
was conducted. The density of a media was obtained through the mea-
sured relationship (equation 4.1 and figure 44), whereas [Schneider
et al., 2000] computes the density through equation 4.3. The media
used for the interpolation were the same as in Schneider et al. [2000],
i.e. adipose tissue 3 and adrenal gland (for bin #3), small intestine
(wall) and connective tissue (for bin #4) and red/yellow marrow and
cortical bone (for bins #5 through #19). The calculated compositions of
the HU–bins are presented in table 7.
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2.9
37.9
0.1
4.1
0.2
0.1
0.1
8.2
H
U
range8
400
–
500
8.0
34.5
3.1
38.8
0.1
5.0
0.2
0.1
0.1
10.0
H
U
range9
500
–
600
7.5
31.6
3.2
39.7
0.1
5.8
0.2
0.1
11.6
H
U
range10
600
–
700
7.1
28.9
3.4
40.4
0.1
6.6
0.2
0.1
13.1
H
U
range11
700
–
800
6.7
26.4
3.5
41.2
0.2
7.2
0.3
14.4
H
U
range12
800
–
900
6.3
24.2
3.7
41.8
0.2
7.8
0.3
15.7
H
U
range13
900
–
1000
6.0
22.1
3.8
42.4
0.2
8.4
0.3
16.8
H
U
range14
1000
–
1100
5.6
20.1
3.9
43.0
0.2
8.9
0.3
17.9
H
U
range15
1100
–
1200
5.3
18.3
4.0
43.5
0.2
9.4
0.3
18.9
H
U
range16
1200
–
1300
5.1
16.6
4.1
44.0
0.2
9.9
0.3
19.8
H
U
range17
1300
–
1400
4.8
15.0
4.2
44.4
0.2
10.3
0.3
20.7
H
U
range18
1400
–
1500
4.6
13.6
4.2
44.9
0.2
10.7
0.3
21.5
H
U
range19
>
1500
4.3
12.2
4.3
45.3
0.2
11.1
0.3
22.2
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Table 8: List of the cases and their main properties.
Case Tumor Treatment Energy
Site Type (MV)
01 Prostate IMRT 15
02 Recti IMRT 15
03 Mammary 3DCRT 6/15
04 Lung IMRT 6
05 Head&Neck IMRT 6
Table 9: Specific instructions applied for conversion with CTC–ask for case 01, a
prostate–case.
Structure HUranges included Specific media H (HU)
Body 1,3–19
Urinary bladder 3-4 Urinary, urine -10 – 10
Urinary, filled 10 – 20
Urinary, empty 20 – 40
Rectum 3-4
Rectum wall 3-4
Caput femur dxt. 4-19 Cartilage 79 – 109
Connective 109 – 144
Femur 633 – 663
Caput femur sin. 4-19 Cartilage 79 – 109
Connective 109 – 144
Femur 633 – 663
4.5 comparison between ctc–ask and
the dicom rt toolbox
Phantoms were created utilizing the 19 media scheme as implemented
in the DICOM RT toolbox as well as in CTC–ask for five patient cases
(table 8). The constraints posed in CTC–ask were that HUrange2 was
only allowed in anatomical structures were lung tissue was present.
The specific instructions for each case and structure for the CTC–
ask–scheme are listed in table 9–13. Additional tissue specific media
were allowed to be included, where applicable, by CTC–ask. Media
composition were taken from [NIST, 2011a; White et al., 1987; Woodard
and White, 1986]. CTC–ask was allowed to use all of the media except
HUrange2 (corresponding to lung) outside of the external (Body)
contour.
Full MC simulation of a clinical treatment plan was subsequently
employed3, using MCSIM, in both of the phantoms. The number of
3 Cut off energies were 521 and 10 keV for electrons and photons respectively. The
only variance reduction technique explicitly employed was electron track repeating.
The number of histories were chosen so that the estimated statistical uncertainty was
≈0.5% for the voxels in the high–dose regions.
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Table 10: Specific instructions applied for conversion with CTC–ask for case 02, a
recti–case.
Structure HUranges included
Body 1,3–19
Blood vessels 3–4
Table 11: Specific instructions applied for conversion with CTC–ask for case 03, a
mammary–case.
Structure HUranges included Specific media H (HU)
Body 1–19 Mammary gland 1 -39 – -9
Mammary gland 2 -9 – 20
Mammary gland 3 30 – 60
Left lung 2–4
Heart 3–4 Heart 2 20 – 50
Cavity 1,3
Table 12: Specific instructions applied for conversion with CTC–ask for case 04, a
lung–case.
Structure HUranges included Specific media H (HU)
Body 1,3–19 Adipose 3 -98 – -73
Adipose 2 -73 – -52
Adipose 1 -52 – -29
Muscle 2 20 – 50
Cartilage 79 – 109
Heart 3–4 Heart 2 20 – 50
Lungs 2–3
Spinal cord 3–4
Table 13: Specific instructions applied for conversion with CTC–ask for case 05, a
head–and–neck–case.
Structure HUranges included Specific media H (HU)
Body 1,3–19 Cartilage 79 – 109
Cranium 962 – 992
Mandible 3–19 Mandible 1083–1113
Spinal cord 3–4
Brain stem 3–4
Larynx 1,3–4
Parotid glands 3–4
simulated histories were chosen so that the estimated statistical uncer-
tainty was ≈ 0.5% for the voxels in the high dose regions. The selected
number of histories resulted in estimated statistical uncertainties be-
low 2%, 8% and 15% for voxels recieving 50%, 20% and 10% of the
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Figure 46: Histograms of the relative difference of dose distributions, calcu-
lated in the CTC–ask and DICOM RT toolbox generated phan-
toms, for cases 01 through 05. Each histogram was plotted with
a binwidth of 0.4%. Voxels with uncertainty larger than 1% were
ignored.
maximum dose, repsectively. The relative statistical uncertainty of the
dose in a voxel is estimated by
σD
D
=
√
n
∑
e2i − (
∑
ei)
2
(n− 1) (
∑
ei)
2
(4.5)
where ei is the energy deposited in the voxel in the ith energy deposi-
tion event and n is the total number of energy deposition events in
the voxel. All doses are reported as dose–to–medium unless otherwise
explicitly stated.
The differences in dose distribution calculated in the CTC–ask and
DICOM RT toolbox generated phantoms shown in figure 46. Voxels
with uncertainty larger than 1% were ignored. The dose distributions
of the HU– and the CTC–ask–scheme are in good agreement, as
indicated by the Gaussian–like distributions around 0%. This is not
surprising as the only difference between the two phantoms are the
media assignment in a relatively small fraction of the voxels (typically
less than 1%). This may be interpreted as CTC–ask being robust and
in agreement with the well documented DICOM RT toolbox.
CTC–ask allows the user to control which media that are allowed
to be assigned to voxels within a given structure. In order to investi-
gate the influence of this on dose distribution in detail, the dose of
voxels assigned specific media as well as voxels differing in terms
of air and lung between the conversion scheme as implemented in
the DICOM RT toolbox and CTC–ask were studied (figure 47). For
specific soft–tissue media (e.g. cartilage) the difference in Dm is small,
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Figure 47: Histograms of the relative difference of dose distributions, for a)
voxels of case 04 assigned to HUrange2 (corresponding to lung)
by the DICOM RT toolbox and a different medium by CTC–ask,
b) voxels of case 01 assigned to HUrange1 (corresponding to air)
by the ICOM RT toolbox and a different medium by CTC–ask, c)
voxels of case 05 assigned to cartilage by CTC–ask and d) voxels
of case 05 assigned to cranium by CTC–ask. Each histogram was
plotted with a binwidth of 0.4%. Voxels with uncertainty larger
than 1% were ignored.
converting to Dw, however, introduces a systematic shift. The same
applies to voxels assigned HUrange2 by the DICOM RT toolbox while
a different media by CTC–ask (most of those voxels where assigned
HUrange3, adipose or mammary gland and not HUrange1 – corre-
sponding to air). For specific dense bone media (e.g. cranium) the
difference in Dm is noticeable. The largest difference is noted for the
voxels assigned to HUrange1 (corresponding to air) by the DICOM RT
toolbox, while HUrange2 (corresponding to lung) by CTC–ask. In this
case the dose–difference distribution is centered around 10% for Dm.
This is however compensated by the differences in stopping power
ratios when converting to Dw.
Computational Environment for Radiotherapy Research (CERR)
[Deasy et al., 2003] was used to produce Dose Volume Hisotgrams
(DVHs) for all cases, the DVHs of case 05 are shown in figure 48.
For case 05, the conversion scheme as implemented in the DICOM
RT toolbox assigned lung (HUrange2) to 9.9% of the voxels inside
the external contour, to 5.2% of the PTV and to 15.1% of the larynx,
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Figure 48: Dose Volume Hisotgram, in terms of Dm, for case 05 for the DI-
COM RT toolbox (solid) and CTC–ask (dashed). The included
structures are total body (blue), PTV (dark green), mandible
(brown), larynx (purple) and the medulla (light green).
whereas CTC–ask did not assign lung (HUrange2) to any of the voxels
for case 05. The larynx–voxels assigned lung by the DICOM RT toolbox
were assigned air by CTC–ask, which led to the decreased dose to the
larynx in the CTC–ask phantom. The same effect is present for the
PTV, but to a lesser extent and altmost non–detectable on the DVHs.
The accuracy of MC dose calculation is strongly influenced by the
conversion of CT–number to density and media. The most crucial
contributor is arguably the density conversion. When assigning media
to voxels, the most critical task is to differentiate between media with
distinct mass attenuation properties. It was demonstrated that misas-
signment between air and lung can introduce a local error in dose in
the order of 10% (figure 47b), which agrees with the findings of e.g.
Verhaegen and Devic [2005]. Compton effect is the dominating effect
for radiotherapy beams and the probability for Compton interaction
is proportional to the electron density. Hydrogen has a higher electron
density than elements with higher Z, therefore the attenuation prop-
erties of media will depend heavily on the hydrogen content. This is
most outspoken when comparing air and lung as lung contain 10.3%
hydrogen, whearas dry air does not contain any [Vanderstraeten et al.,
2007].
Media with distinct composition will likely differ in important
dosimetrical properties (such as stopping power and mass energy
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absorption coefficients). This is best illustrated by figure 47d, where
the voxels assigned Cranium are shifted to a ≈2% lower dose for
the CTC–ask generated phantoms due to lower mass stopping power
of the composition corresponding to Cranium–media than that of
HUrange13, which was the media assigned to the voxels in the DICOM
RT toolbox generated phantom.
Erroneous assignment of media will lead to a local error in dose
(figure 47), which may or may not be partially compensated for, due to
the differences in mass stopping power, if converting to dose–to–water
(Dw). The mass attenuation of the improper media will however also
perturb the beam, leading to an error in dose downstream or laterally.
In addition, an increased backscatter (or lack thereof, depending on if
moving from media with high H– or Ca– content to media with low,
or vice versa) is noted at the boundary. Moreover, the local dose may
be affected by media misassignment of neighboring voxels. None of
those effects are compensated for when converting to Dw.
4.6 ct–artifacts
The accuracy of MCTP relies on precise determination of density
in the patient and/or phantom. In some cases severe artifacts are
introduced in the CT data such that the reconstructed HU differs from
the actual linear attenuation coefficients. Metal streaking artifacts are
observed when high Z materials are present in the scanned volume,
e.g dental cavity fillings or hip prostheses in a patient. Figure 49 shows
a transversal CT slice of a pelvic case with bilateral hip prostheses.
Metal streaking artifacts are seen throughout the slice and in between
the prostheses there is a region where information not only is slightly
distorted, but more or less ascent. Such artifacts may, if not corrected
for, lead to erroneous density assignment, media assignment and
ultimately dose distributions.
Keall et al. [2003] investigated the influence of CT artifacts, due
to a hip prostheses, on the resulting dose distribution by modifying
CT–data of a prostate case without hip prostheses. A spherical vol-
ume with density corresponding to stainless steel was introduced
in a CT–data set to obtain an artifact–free image. Sinograms of the
artifact–free image set were calculated from a number of projections
through the CT–data. Filtered back projections and iterative deblur-
ring methods were applied to reconstruct the image set from the
sinograms. Thus creating reconstructed images with metal streaking
artifacts. MC compliant phantoms were created based on each one
of the CT–data sets. Full MC simulation of a clinical treatment plan
was subsequently employed, using EGS4, in each of the three MC
phantoms. No apparent differences, in terms of iso dose curves or
DVHs, were observed between the simulations. Although the artifacts
did not lead to significant perturbation of the dose distribution in the
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Figure 49: Transversal CT slice of a pelvic case, showing the CT–artifacts due
to a bilateral hip prostheses.
study by Keall et al. [2003] it was concluded that this was not enough
to make general predictions for other patient data.
In this study a 15MV 3DCRT pelvic case with substantial metal
artifacts in the CT scan due to bilateral hip prostheses (figure 49) was
selected in order to investigate the effect of metal artifacts on the result-
ing dose distribution. Phantoms were generated based on the CT–data,
using the 19 media conversion scheme (table 7) as implemented in the
DICOM–RT toolbox (hereafter referred to as uncorrected phantom) as
well as in CTC–ask (hereafter referred to as corrected phantoms). For
the corrected phantom the bilateral hip prostheses were delineated
manually, all voxels belonging to the delineated prostheses were set
to titanium with a density of 4.54 gcm−3 and in the slices containing
artifacts, all voxels inside the external outline not belonging to bone
nor prostheses were set to ICRUTISSUE with a density of 1.00 gcm−3.
Full MC simulation of a clinical treatment plan was subsequently
employed4, using MCSIM, in both of the phantoms. The number of
simulated histories were chosen so that the estimated statistical un-
certainty was ≈ 0.5% for the voxels in the high dose regions. The
selected number of histories resulted in estimated statistical uncer-
tainties below 2%, 8% and 15% for voxels recieving 50%, 20% and
10% of the maximum dose, repsectively. All doses are reported as
dose–to–medium.
3D–dose distributions were converted to DICOM RD files using
CERR [Deasy et al., 2003] and subsequently imported to the TPS (Var-
ian Eclipse 10.0) to generate DVHs (figure 50). A large underdosage
4 Cut off energies were 521 and 10 keV for electrons and photons respectively. The
only variance reduction technique explicitly employed was electron track repeating.
The number of histories were chosen so that the estimated statistical uncertainty was
≈0.5% for the voxels in the high–dose regions.
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Figure 50: Cumulative Dose Volume Hisotgrams for the pelvic case using the
corrected (solid) and uncorrected (dashed) phantoms. DVHs are
plotted for the external outline (green), bones (blue), prostheses
(cyan), PTV (brown) and the PTV excluding the rectum (black).
is noted for the uncorrected PTV and almost the entire PTV volume
receives 5 Gy less dose than compared to the PTV of the corrected
phantom. On the other hand the bone and prostheses structures re-
ceive higher doses in the unconstrained phantom. The substantial
differences on the DVHs are a direct consequence of the erroneous
assignment of media and density due to the CT artifacts.
These findings are in contradiction with those of Keall et al. [2003],
indicating that CT artifacts indeed have a substantial impact on the
dose distribution. However, it should also be stated that the artifacts
in Keall et al. [2003] were substantially less apparent than in figure
49. The impact of CT artifacts on the dose distribution for a much
more similar case (a prostate patient with bilateral hip prostheses)
was presented in Bazalova et al. [2007]. They found underdosage in
the target volume for the uncorrected CT–data on the same order
as in figure 50. The correction method presented in Bazalova et al.
[2007] is, however, more sophisticated than the one used here. In
essence, an image with an unlimited HU scale is produce by filtered
back projection of the sinograms. Voxels corresponding to metal are
extracted to form a “metal only image” using a HU threshold level.
The forward Radon transformation of the metal only image is used
as a mask for the original sinograms and the missing projections
(as defined by the mask) are interpolated at each projection angle.
Filtered back projection of the modified sinogram generates an image
in which the metal artifacts are corrected for whilst not containing
information on the voxels previously identified as metal. The final
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corrected image is obtained by superimposing the metal only image
on the artifact–corrected image [Bazalova et al., 2007].
The similarity in results, despite the difference in correction meth-
ods, indicate that the coarse method used in this study is substantially
better than making no correction at all and may readily be used as a
correction method.

5
C O N V E RT I N G F R O M D O S E T O M E D I U M P E R
I N C I D E N T PA RT I C L E T O D O S E I N WAT E R P E R
M O N I T O R U N I T
EGSnrc reports dose per incident particle which is useful when the
relative dose distribution is of interest. In MCTP the absorbed dose,
in Gy, is generally more relevant. The objective of this chapter is to
present a formalism for converting from dose per incident particle
to Gy. A protocol for conversion from dose per incident particle to
absolute dose was described by Francescon et al. [2000]. In short, a
calibration factor, KMC, needs to be obtained. This is done by a simu-
lation of reference dose, DMCref , which is the dose at a reference point
under reference conditions. Typically one would use the dose at 10 cm
depth along the CAX in homogeneous water phantom experienced by
a 10×10 cm2 field with SSD = 100 cm. The expected reference dose
per MU, Dmeasref , can be measured following procedures in TRS–398
[Andreo et al., 2000]. The calibration factor is then given by
KMC =
Dmeasref
DMCref
(5.1)
The conversion is handled as a post processing step and needs to
be conducted manually. The dose, in Gy, will be given by
DMC,abs = DMC ×KMC ×U, (5.2)
where U is the number of MUs for the irradiation.
In MCSIM, however, a calibration factor corresponding to KMC,
drefmax, is defined for each field. The dose distribution for the field
in question will be converted to absolute dose by multiplication with
drefmax and the number of MU which is specified explicitly for each
field through the MLC sequence file.
5.1 the backscatter effect
For a given irradiation, the linac is instructed to deliver a number of
MUs. This is related to a response in the monitor chamber and once
that response is reached the beam is switched off. The dose experi-
enced by the monitor chamber can be divided into two parts: dose
delivered from the particles moving downstream and dose delivered
by backscattered particles moving upstreams. It has been shown that
the backscattered radiation increases the photon output by about 2% –
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3% when moving from a 3×3 cm3 field to a 40×40 cm3 field on Varian
2100 accelerators [Liu et al., 1997; Verhaegen et al., 2000]. The main
source of the backscattered particles are the jaw collimators, partic-
ularly the upper one. Liu et al. [2000] reported that the backscatter
from the lower jaws amounts to about 10% of that from the upper
jaws. As the backwards component of the dose to the monitor cham-
ber is dependent on the jaw positions it is field size dependent. This
backscatter effect needs to be compensated for and incorporated into
equation 5.2 when converting to absolute dose:
DMC,abs = DMC ×KMC ×BSF(Y,X)×U, (5.3)
where BSF(Y,X) is the BackScatter correction Factor for a field with
jaw settings according to (Y,X).
5.1.1 An experimental formalism
As the monitor chamber reading is affected by both the forward and
backwards component, an alternative measurand is needed in order
to separate the two components. Lam et al. proposed a formalism
to measure, Itarget, the current required to keep the linac gun target
electrically neutral during irradiation [Lam et al., 1998]. Consider the
assumption that the backscatter was field size independent, then the
Itarget required for a given number of MUs would be constant over all
field sizes. As this is not the case the relative backscatter contribution
can be obtained by Itarget ratios:
BSF(Y,X) =
Itarget(Y,X)
Itarget(Yref,Xref)
, (5.4)
where Itarget(Y,X) and Itarget(Yref,Xref) are the integrated charge
over time for an irradiation, for a fixed number of monitor units,
of a field with jaw openings defined by (Y,X) and a reference field,
respectively.
In this work Itarget as a function of jaw settings, for square fields,
were measured for four beam matched Varian 2300 iX linacs (Fig-
ure 51). Measurements were conducted with the in–house developed
ME40 Scintillator Dosimetry System (DTU, Roskilde, Denmark), which
functions by connecting Burr–Brown ACF2101 switched integrator
circuits [Mountford et al., 2008] to the Itarget BNC contact of the linac.
The charge built up in the 100 pF capacitor is held, integrated, and
read out before it is reset at the onset of the next synchronization
pulse. The charge over all gun pulses within an irradiation with colli-
mator settings (Y,X) is accumulated to yield Itarget(Y,X). A detailed
description of the methodology is given in Beierholm et al. [2011]. The
backscatter correction factors were largely consistent across the linacs
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Figure 51: Measured Itarget ratios for four beam matched Varian 2300 iX linacs.
The 10×10 cm2 field is used as the reference field and uncertainties
are given as 1 SD based on 10 repeated measurements.
studied. The standard deviation of the mean of the population was
0.06%, while the maximum deviation was 0.14%. Possible sources of
error are differences in geometry between the linacs and inconsistent
jaw calibrations. Hereafter Itarget measurements of linac 1 are used,
since that was the linac that the MC model was commissioned to.
Charge as a function of time is shown in Figure 52 for 10× 10 cm2
fields. The Itarget reading is obtained by integrating the charge over
time for a fixed number of monitor units.
5.1.2 A Monte Carlo formalism
Popescu et al. [2005] published a formalism for absolute dose cal-
culations in MC under which the field size dependent backscatter
effect is taken into account. In short, it involves splitting the treatment
head simulation into two parts (Figure 53): i) the static upper part of
the treatment head (target through mirror), BEAMA, and ii) the field
specific part of the treatment head (monitor chamber through beam
limiting devises), BEAMB. The phase space generated by BEAMA
is used as input in BEAMB and in both simulation the dose to the
monitor chamber is scored.
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Figure 52: Charge as a function of time for 10× 10 cm2 fields in 6MV mode
(left) and 15MV mode (right). The signal has been normalized to
its peak charge to increase readability.
Figure 53: Schematic sketches of BEAMA and BEAMB on the left and right
hand side, respectively. The red arrows indicate typical parti-
cle tracks that make up the forward, Dforwch , and the backward,
Dbackch , dose components to the monitor chambers, respectively.
(Adapted from Popescu et al. [2005] with permission)
Going through the equations presented in Popescu et al. [2005] (and
maintaining the nomenclature), the backscatter correction for a field
with jaw settings (Y,X) is given by
BSF(Y,X) =
Dforwch +D
back
ch (Yref,Xref)
Dforwch +D
back
ch (Y,X)
, (5.5)
where Dforwch is the dose deposited in the monitor chamber during
the BEAMA simulation, Dbackch (Yref,Xref) is the dose deposited in
the monitor chamber during the BEAMB simulation for the reference
field (10×10 cm2) and Dbackch (Y,X) is the dose deposited in the monitor
chamber during the BEAMB simulation for an arbitrary field.
The formalism published by Popescu et al. [2005] was developed
prior to the introduction of DBS [Kawrakow et al., 2004] into EGSnrc.
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Figure 54: Backscatter correction factors as a function of square field side
length for Itarget measurements, black, the MC–formalism (Equa-
tion 5.5 with, red, and without, green, DBS turned on. The size
of the markers corresponds to the uncertainties, which for the
measurements are given as 1 SD and the for the MC simulations
as statistical uncertainty reported by DOSXYZnrc. The dashed
lines show fits to the data using a third degree polynomial and
linear fit to the measured and MC data, respectively.
In order to investigate the validity of the formalism BSF were simu-
lated1 with and without DBS turned on for a range of 6MV field sizes
Figure 54. The monitor chamber dose was scored, using a dose scoring
region encompassing the air layers of the monitor chambers, in both
BEAMA and BEAMB for simulations with and without DBS. The BSF
were calculated according to Equation 5.5. No statistical significance
was found between the two simulation types, which ensures that the
formalism is vaild also with the use of DBS. Meanwhile the simulated
BSF did not agree with the measured.
In order to investigate and rectify the disagreement with measure-
ments three possible MC factors were considered: i) the mean energy
of the impinging electrons, ii) the spot size FWHM of the impinging
electrons and iii) the approximation of placing the jaw collimators at a
fixed distance from the source and perpendicular to the beam direc-
tion in the BEAMnrc model. The first two factors were investigated
1 Simulations were conducted with ECUT = 521 keV, PCUT = 10 keV, NBRSPL = 1000.
For simulations using DBS, the splitting field radius was set to twice the length of
the squared field. Uniform bremsstrahlung splitting was used for the simulations
not employing DBS. The number of histories were selected so that the statistical
uncertainty of the dose to the monitor chamber was between 0.9% and 1.0%.
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Figure 55: Backscatter correction factors as a function of impinging electron
mean energy (left) and as a function impinging electron spot size
FWHM (right). Data are shown for two field sizes: 3×3 cm2 (red
circles) and 20×20 cm2 (blue squares). The figures show relative
deviation from the average value of the dataset in question.
by simulating2 BSF with i) a varying mean energy, while a constant
spot size FWHM and ii) vice versa. Simulations were limited to a large
(20×20 cm2) and a small (3×3 cm2) field size. It was demonstrated that
the BSF was rather insensitive (variation were within 0.1%) within the
range of impinging electron mean energy and spot size FWHM that
were considered (Figure 55). This is in agreement with the findings of
Verhaegen et al. [2000], where it was demonstrated that the backscatter
contribution as a function of field size changes no more than a percent
for two different beam qualites (6 MV and 10 MV). The effect of such
small changes in impinging electron beam parameters investigated
in this study is therefore expected to have little, or even neglectable,
impact.
The third factor considered, the approximation of placing the jaw
collimators at a fixed distance from the source and perpendicular to
the the beam direction, is justified by conclusions drawn in previous
studies. An empirical formalism for calculation of monitor chamber
backscatter was derived by Liu et al. [2000]. They conclude that the
majority of the backscatter radiation originate from the jaw collimators,
the upper collimator in particular, for a Varian 2100 linac. Moreover,
they showed that the backscattered radiation consist mostly of low
energy photons and electrons. Liu et al. [1997] concluded that the
backscatter is dependent on the accelerator geometry. The approxi-
mation to model the jaw collimators as perpendicular to the beam
direction placed at a fixed distance from the source might be justifi-
able when investigating lateral profiles, but not for a parameter that is
highly dependent on the precise geometry of the linac treatment head
in general and the collimator jaws in particular.
2 Simulations were conducted with ECUT = 521 keV, PCUT = 10 keV, NBRSPL = 1000
and using uniform bremsstrahlung splitting. The number of histories were selected
so that the statistical uncertainty of the dose to the monitor chamber was between
0.9% and 1.0%.
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The upper collimators on a Varian 2100 and 2300 are in fact pivoting
on an axis Verhaegen and Liu [2001]. There is, however, currently no
CM able to model pivoting jaws available in EGSnrc. The existing CMs
that model the collimator jaws (JAWS and SYNCJAWS) all employ the
approximation of using a surface perpendicular to the beam direction.
This infers that the effective distance between the collimating jaws
and the monitor chamber varies with collimation settings. The relative
change in distance can be accounted for by shifting the jaw position
in z–direction in the MC model. The following equations3 yields the
shifted jaw positions for the collimation setting in question:
htY2 = zrady ∗ SAD/
√
y22 + SAD2
htY1 = zrady ∗ SAD/
√
y12 + SAD2
htY = (htY2+ htY1)/2
hbY2 = htY2+wjaws ∗ SAD/
√
y22 + SAD2
hbY1 = htY1+wjaws ∗ SAD/
√
y12 + SAD2
hbY = (hbY2+ hbY1)/2,
htX1 = zradx
htX2 = zradx−wjaws ∗ 20/
√
20.02 + SAD2
htX = (htX2+ htX1)/2
hbX2 = htX+wjaws ∗ SAD/
√
x22 + SAD2
hbX1 = htX+wjaws ∗ SAD/
√
x12 + SAD2
hbX = (hbX2+ hbX1)/2
(5.6)
where zrady is the distance between the source and the upper jaws,
SAD is the Source to Axis Distance (SAD) (the distance between the
target and the ISO–center), y1 and y2 define the field opening, in
y–direction, at SAD, htY1 and htY2 is then the jaw position corre-
sponding to the accurate effective distance between the source and
the upper collimator jaws. Analogously zradx is the distance between
the source and the lower jaws, x1 and x2 define the field opening,
in x–direction, at SAD, htX1 and htX2 is then the jaw position corre-
sponding to the accurate effective distance between the source and
the lower collimator jaws, while wjaws is the nominal thickness of the
jaws, As it is not possible to define a pair of collimator jaws as located
at different z–locations in BEAMnrc, the average distance, htY or htX,
is used. Simulations4, with compensated z–positions of the upper colli-
mator, were conducted and results compared to Itarget measurements
3 Equations derived by IA Popescu and C Shaw, published with permission.
4 Simulations were conducted with ECUT = 521 keV, PCUT = 10 keV, NBRSPL = 1000.
DBS was turned on and the splitting field radius was set to twice the length of the
squared field. The number of histories were selected so that the statistical uncertainty
of the dose to the monitor chamber was between 0.9% and 1.0%.
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Figure 56: Backscatter correction factors as a function of square field side
length for Itarget measurements, black, the MC–formalism (Equa-
tion 5.5 with DBS turned on, red. The size of the markers corre-
sponds to the uncertainties, which for the measurements are given
as 1 SD and the for the MC simulations as statistical uncertainty
reported by DOSXYZnrc. Third degree polynomial fits to the data
are shown as dashed lines.
(Figure 56). When compensating for the effective distance between
the jaws and the monitor chamber, much better agreement was found
between measurements and simulations. The deviation was within
0.2%, but seemed to follow a trend where the deviation increased
when moving furhter away from the reference field (10×10 cm2). This
is likely due to the fact that the jaws are modeled as perpendicular
to the source as oppose to pivoting on an axis. Developement of a
CM able to simulate the non–perpendicular jaws may improve the
simulation of BSFs for Varian linacs.
5.1.3 Backscatter correction in MCSIM
As stated on page 99, drefmax, is defined for each field in MCSIM.
This means that the field specific BSF correction can be implicitly
handled by MCSIM. This comes at the cost of the need for prior
knowledge of the BSF correction for any collimating aperture. Liu et al.
[2000] derived empirical formula for the backscattered radiation to the
monitor chamber as function of jaw settings for a Varian 2100 linac. A
simplified study was in this work conducted to obtain prior knowledge
5.1 the backscatter effect 107
Table 14: Measured and MCSIM simulated ROFs for a range of field sizes.
Field opening 6 MV 15 MV
(Y×X) Measured Simulated Difference Measured Simulated Difference
(cm) ROF ROF (%) ROF ROF (%)
10.0×10.0 1.000 1.000 0.0 1.000 1.000 0.0
3.0×10.0 0.878 0.888 1.1 0.907 0.913 0.7
5.0×10.0 0.930 0.937 0.8 0.952 0.958 0.6
8.0×10.0 0.979 0.981 0.2 0.986 0.988 0.2
12.0×10.0 1.015 1.013 -0.2 1.010 1.008 -0.2
15.0×10.0 1.032 1.027 -0.5 1.020 1.016 -0.4
20.0×10.0 1.048 1.041 -0.7 1.031 1.024 -0.7
30.0×10.0 1.067 1.055 -1.1 1.045 1.036 -0.9
10.0×3.0 0.886 0.892 0.7 0.914 0.911 -0.3
10.0×5.0 0.939 0.940 0.1 0.960 0.958 -0.2
10.0×8.0 0.984 0.982 -0.2 0.990 0.991 0.1
10.0×12.0 1.012 1.013 0.1 1.007 1.007 0.0
10.0×15.0 1.024 1.026 0.2 1.014 1.014 0.0
10.0×20.0 1.037 1.038 0.1 1.022 1.021 -0.1
10.0×30.0 1.051 1.049 -0.2 1.029 1.023 -0.6
of the BSFs. Simulations were conducted using MCSIM5 (with drefmax
set to 1) where the upper, Y, collimater was fixed at defining a 10 cm
field opening (at ISO center) and the lower, X, collimator was varied
between defining a field openings of 3 and 30 cm. Corresponding
simulations in which the reciprocal conditions were applied to the
collimators were also conducted. The dose to water voxel, at 10 cm
depth, in a homogenous water phantom with SSD = 90 cm was used
to compute ROFs (Table 14). The MC simulated ROFs were compared
the corresonding measured ROFs, under the same conditions, and the
difference was assumed to be due to monitor chamber backscatter.
The backscatter effect for each field setting was expressed as the
ratio between the measured and simulated ROF. The ratio between
measured and simulated ROF were plotted as a function of field
opening and fitted to a third degree polynomial function (Figure 57).
The data points conform nicely to the polynomial functions and they
may therefore be used as to asses the back scatter effect for a given
field setting. Two statements made by Liu et al. [2000] were taken
into consideration when computing back scatter effects for combined
settings of Y– and X–jaws: The off–axis location does not significantly
impact the back scatter effect. The lower jaws contribute approximately
10% of the ammount of backscatter compared to the upper jaws. With
that, the off–axis was neglected and only the field opening considered
and contribution from the upper jaws was set to 1/1.1, while the
5 A dose scoring grid of 0.5× 0.5× 0.5cm3 was used, ECUT and PCUT were set to 700
keV and 10 keV, respectively. The source input was an energy specific phase space file
scored directly below the flattening filter. The number of histories were selected so
that the statistical uncertainty along the CAX (past build up) was less than 0.5%.
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Figure 57: The ratio between simulated and measured ROFs for 6 and 15
MV for various field sizes. For the simulations with varying X–jaw
settings, the Y–jaws were fixed at defining an opening of 10 cm
(at ISO center) and vice versa. Included in the figure are also third
degree polynomial fits to the data points (dashed lines) as well as
the equations for the resulting functions.
contribution from the lower jaws were set to 1-1/1.1. Part of the
backscattered radiation from the lower jaws will not reach the monitor
chamber, but instead be blocked by the upper jaws. This perturbation
is dependent on the upper jaw settings in question. This effect was
also studied by Liu et al. [2000] but is neglected here.
The backscatter for a given field is computed using the fitted poly-
nomial functions of the individual collimators for the field opening in
question. In effect the backscatter correction given by:
BSF6MV = (1/1.1)(k11(FSY)
3 + k12(FSY)
2 + k13(FSY) + k
1
4) (5.7)
+(1− 1/1.1)(k21(FSX)
3 + k22(FSX)
2 + k23(FSX) + k
2
4)
BSF15MV = (1/1.1)(k31(FSY)
3 + k32(FSY)
2 + k33(FSY) + k
3
4)
+(1− 1/1.1)(k41(FSX)
3 + k42(FSX)
2 + k43(FSX) + k
4
4)
with
k =

1.1978× 10−6 3.6353× 10−6 −1.9456× 10−7 −1.3665× 10−6
−8.8111× 10−5 −1.8138× 10−4 −1.3234× 10−5 −1.8138× 10−4
2.5453× 10−3 2.6158× 10−3 1.2454× 10−3 2.6158× 10−3
0.9820 0.9887 0.9888 0.9887

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Figure 58: Measured and calculated backscatter correction factors. Measure-
ments not conducted yet. For now 6MV Itarget measurements for
those field sizes available are included.
for 6MV and 15MV, respectively and where FSY and FSX are the
projected field openings defined by the upper and lower collimators,
respectively.
Backscatter correction factors calculated using Equation 5.7 were
compared to relative Itarget measurements (see Section 5.1.1). Measured
and calculated back scatter correction factors are shown in (Figure 58).
The error introduced by the calculated BSF is small, especially for
intermediate field sizes. Most of the fields simulated with MCSIM
throughout this study was between 5×5 and 20×20 cm2. No fields
smaller than 3×3 or larger than 30×30 cm2 were encountered and
thus no extrapolation was conducted.
5.2 converting from dose–to–media to dose–to–water
EGS4 and EGSnrc both report dose–to–media, Dm, whereas most
TPS report dose–to–water, Dw Knöös et al. [2006]; Ottosson, Karlsson
and Behrens [2010]. In order for an intercomparison between MC,
reporting Dm, and a TPS, reporting Dw, a conversion method between
them is needed. An analytical procedure based on Bragg–Gray cavity
theory was proposed by Siebers et al. [2000]. They concluded that
Spencer–Attix mass restricted collision stopping–power ratios can
be used as conversion factors between the two quantities. Moreover,
they concluded that a single correction factor can be used for each
particular media throughout the field for a given photon beam energy.
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The exception from this is for air, but as we are rarely interested in
dose to air in clinical considerations and that the conversion is done
locally for each voxel this can be disregarded from. An empirical
formula relating the nominal acceleration potential to the effective
energy is provided:
Eeff = 0.081P+ 0.41, (5.8)
where P is the nominal acceleration potential. Conversion factors are
then calculated as the ratio of tabulated stopping power for water and
the medium in question at Eeff.
The EGSnrc user code SPRRZnrc calculates Spencer–Attix mass
restricted collision SPR for a given geometry and beam. Thus it can
readily be used, as an alternative method, to obtain the factors needed
to convert between Dm and Dw. As an example, SPRRZnrc was
used to simulate6 Spencer–Attix mass restricted collision stopping–
power ratios for tissue vs water as defined by ICRU [NIST, 2011b]
(ICRUTISSUE521ICRU and H2O521ICRU, respectively) using a cylindrical
beam, with a radius of 5 cm for a parallel spectra corresponding to a
6 MV beam (Figure 59). The results show that the Spencer–Attix mass
restricted collision stopping–power ratio is constant over the voxels
occupied by tissue although the energy spectra is not (not shown).
This is a verification of the conclusion made by Siebers et al. [2000],
that a single correction factor can be used for each particular media
throughout the field for a given photon beam energy.
Conversion factors were calculated for the 18 media (excluding
HUrange1, corresponding to air) listed in Table 7 using the method
described by Siebers et al. [2000] and for an effective energy according
to Equation 5.8. SPRRZnrc was used to simulate7 stopping power
ratios for the same set of media. SPRRZnrc uses a fixed track end term
cut off energy, ∆, of 10 keV, which is relevant for air–water–SPR but
less so for media that can not be considered Spencer Attix cavities.
Therefore SPRRZnrc was modified to use the ∆ corresponding to the
dimension of the voxel of interest each medium. The energies were
selected using the continious slowing down approximation ranges
calculated by the ESTAR code [NIST, 2011b]. The resulting corrections
factors from the two methods are listed in Table 15. Conversion factors
computed for the two methods follow the same trend and are in
6 A parallel beam incident from the front with a radius of 5 cm using the mo-
han6.spectra was employed in the simulation. ECUT was set to 521 keV, while
PCUT was set to 10 keV. Default EXACT parameters were used for the boundary
crossing algorithm
7 An energy specific phase space file corresponding to a 10 × 10cm2 field of the
commissioned MC linac was incident on a water phantom with a voxel (radius
= 0.25 cm, thickness = 0.5 cm) of the medium to be investigated at 10 cm depth
and along the CAX. Cut off energies were set to 521 keV and 10 keV for electrons
and photons respectively. The number of histories were chosen so that the relative
statistical uncertainty was below 0.2% in the voxel of interest.
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Figure 59: The figure shows Spencer–Attix mass restricted collision stopping–
power ratios as a function of depth along the central axis (r =
1.0 cm). Inserted is a schematic sketch of the geometry, which
shows that the voxels between 6 and 15 cm, along the CAX, are as-
signed ICRUTISSUE521ICRU. The calculated Spencer–Attix mass
restricted collision stopping–power ratios are constant over those
voxels.
agreement for most of the medias. For the densest media, however,
disagreement on the order of 2% are noted. It should be stated that
the expression for Eeff (Equation 5.8) corresponds to the linacs used
in the study conducted by Siebers et al. [2000] and is not neccessarily
applicable to linacs in this study. The SPRRZnrc method employs no
fits to data (apart from the selection of ∆) and/or approximation and
is therefore likely to be more reliable. Moreover, conversion factors
can be obtained for the actual linac in question directly.
In conclusion, conversion from Dm to Dw for the beam quality, Q,
and medium, m, can be conducted using the following equation:
Dxyzw = D
xyz
m × SPRwm(Q,m) (5.9)
where Dxyzw and D
xyz
m is the dose to voxel xyz in dose–to–water
and dose–to–medium, respectively and SPRwm(Q,m) is the SPRRZnrc
simulated Spencer–Attix mass restricted collision stopping–power
ratio.
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Table 15: Analytically calculated and SPRRZnrc simulated dose–to–medium
to dose–to–water conversion factors for the two linac potentials
considered in this study and range of tissue equivalent media
covering the span in density from lung to cortical bone.
Media 6MV 15MV
Analytical SPRRZnrc Difference (%) Analytical SPRRZnrc Difference (%)
HUrange2 0.9989 0.9977 0.1 0.9808 0.9843 -0.4
HUrange3 0.9936 0.9832 1.1 0.9968 0.9825 1.5
HUrange4 1.0130 1.0088 0.4 1.0143 1.0066 0.8
HUrange5 1.0185 1.0104 0.8 1.0199 1.0085 1.1
HUrange6 1.0268 1.0217 0.5 1.0279 1.0192 0.9
HUrange7 1.0207 1.0334 -1.2 1.0228 1.0305 -0.7
HUrange8 1.0330 1.0443 -1.1 1.0343 1.0406 -0.6
HUrange9 1.0563 1.0541 0.2 1.0544 1.0503 0.4
HUrange10 1.0641 1.0632 0.0 1.0617 1.0589 0.3
HUrange11 1.0714 1.0727 -0.1 1.0684 1.0672 0.1
HUrange12 1.0794 1.0811 -0.2 1.0753 1.0756 -0.0
HUrange13 1.0856 1.0894 -0.3 1.0810 1.0825 -0.1
HUrange14 1.0926 1.0972 -0.4 1.0880 1.0909 -0.3
HUrange15 1.0984 1.1136 -1.4 1.0932 1.1136 -1.8
HUrange16 1.1035 1.1196 -1.4 1.0977 1.1191 -1.9
HUrange17 1.1094 1.1266 -1.5 1.1030 1.1259 -2.0
HUrange18 1.1134 1.1325 -1.7 1.1070 1.1311 -2.1
HUrange19 1.1193 1.1390 -1.7 1.1123 1.1379 -2.2
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T H E M C T P W O R K F L O W
The term Monte Carlo Treatment Planning is currently limited to the
act of using an MC dose engine to recalculate an existing treatment
plan, hence the actual treatment planning is done a priori and is not a
part of MCTP.
The three cornerstones of MCTP are i: the linac model (Chapter 3),
ii: the patient (or phantom) representation (Chapter 4) and iii: the
translation of the treatment plan parameters, as given by the TPS, to
MC compliant input files. The realization of dynamic delivery (i.e.
changing with time during irradiation) in MC must be given special
consideration. Separate building blocks aiming at solving the three
cornerstones exist, but in order to routinely perform MCTP, an auto-
mated workflow considering the three tasks needs to be constructed.
No such package is available to date. Furthermore, in–house con-
structed building blocks may increase flexibility and be better suited
to the desired functionalities. This chapter describes the MCTP work-
flow developed and employed in this study. A schematic drawing of
the MCTP workflow is given in Figure 60.
6.1 workflow outline
The starting point of the MCTP workflow is the conventional TPS,
from which the following DICOM files are exported:
RP which holds all the information of the treatment plan parameters
(e.g. gantry, collimator and couch angles, jaw collimator and
MLC settings etc.)
CT the planning CT scan of the patient, which holds the HU matrix
of the patient geometry
RD which holds information on the TPS calculated dose distribution
RS which holds information on all delineated structures
The set of DICOM files is imported to Computational Environment
for Radiotherapy Research [Deasy et al., 2003] and saved for later
usage.
A MC compliant representation of the patient is generated using
either the DICOM RT–toolbox [Spezi et al., 2002] or CTC–ask [Ottos-
son and Behrens, 2011] as described in Chapter 4. Either of the two
methods will maintain the dose grid set in the TPS.
MC dose engines are generally not integrated in the commercial TPS.
Moreover most MC codes do not accept treatment plan information as
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Figure 60: A schematic drawing of the MCTP workflow developed and em-
ployed in this study.
exported from the TPS (e.g. DICOM data) as input directly. Therefore
it is necessary to translate the plan specific data (such as collimator
settings, MLC sequence, gantry angle, iso center position etc.) to a
format compatible with the MC code.
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Full MC dose calculation is then conducted, using either MCSIM
or BEAMnrc/DOSXYZnrc, resulting in a 3D dose distribution given
as dose in medium per incident particle. The 3D dose distribution
is converted to absolute dose (either as dose to medium or dose to
water) and imported to CERR, which is capable of exporting the MC
computed dose distribution in DICOM format.
The end point of the workflow described here is a MC computed
3D dose matrix in DICOM format, RDMC, which has the same size
and resolution as the TPS calculated dose distribution, RDTPS.
6.2 translating the treatment plan parameters to monte
carlo input
The following section addresses the issues one encounters when con-
structing a input file compatible with MCSIM or EGSnrc based on
treatment plan parameters in DICOM format. Various tools for reading
DICOM files exist (e.g. VEGA DICOM library [Locke and Zavgorodni,
2009], pydicom [Mason, 2011]), in this study the intrinsic MATLAB
function DICOMinfo was used. DICOMinfo takes a single input argu-
ment: the path of the DICOM compliant file in question and returns
the metadata in a data structure.
MATLAB scripts were created for extraction of the plan specific
data and construction of input files for BEAMnrc, DOSXYZnrc and
MCSIM. The following issues needed to be considered:
I/ DICOM lists all distances in mm, whereas EGSnrc and EGS4
user codes expects cm.
II/ The information on beam limiting devices is found under the
DICOM field “BeamSequence” under which each individual
beam is listed as a subfield. The information on fractionation
(i.e. the number of MU per beam) is located under the DICOM
field “FractionGroupSequence” under which each individual
beam is listed as a subfield. It is however important to realize
that the individual beams are not necessarily listed in the same
order with regards to beams. The individual beams are linked
through the variables “ReferencedBeamNumber” in the Fraction-
GroupSequence and “BeamNumber” in the BeamSequence. This
relates to DICOM files generated by the Varian Eclipse TPS, but
might be implemented differently in other Treatment Planning
System.
III/ The coordinate system differs between DICOM and that of
EGSnrc and EGS4.
IV/ The MLC positions are listed as a single vector, as oppose to a
vector for each MLC bank, for each control point.
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V/ A DICOM file lists a set of static control points, whereas the
delivery simulated may be dynamical.
The first and second issues are easily negotiated and does not merit
further mentioning. The latter three issues will be discussed below.
6.2.1 Coordinate system transformation
The DICOM RP file holds information on the gantry, couch and colli-
mator angles, whereas DOSXYZnrc utilizes the parameters θ, φ and
φCol. Definitions of the three parameters depend on the source type
in question. The source types used in this study are 2 (Phase-Space
Source Incident from Any Direction), 9 (BEAM Treatment Head Simu-
lation Incident from Any Direction), 20(Simulation through moving
MLC with multiple variable settings) and 21(Full BEAM treatment
head simulation through moving MLC with multiple variable settings),
which all share the same coordinate system A set of equations rotating
the TPS coordinate system to that of DOSXYZnrc was reported by
Bush [2009]; Bush and Zavgorodni [2010]; Thebaut and Zavgorodni
[2006]. However, the origin of the phase space file used in these studies
was scored in negative z–direction, which is in contradiction with the
origin of the source types used in this study. The particles travel in
positive zdirection for θ=0 and φ=0. [Spezi et al., 2002] derived another
set of equations for the coordinate transformation. The equations were
not published in that paper but can be found in the source code of the
DICOM–RT toolbox.
θ = 90 (6.1)
φ = −90+ θgantry (6.2)
φCol = −90− θcollimator (6.3)
where θgantry and θcollimator are the gantry and collimator angles,
respectively. The drawback of the transformation equations is that
they are valid for coplanar treatments only.
MCSIM uses the same coordinate system as described above, but
conveniently also offers the possibility to use the DICOM coordinate
system.
6.2.2 Field specific treatment head simulation
The in–house written MATLAB scripts took the RP file as input and
produced MC input files for either MCSIM or BEAMnrc/DOSXYZnrc
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(using DOSXYZnrc source 2 for non–VMAT and source 20 for VMAT
simulations). In either case the simulation starts from an energy spe-
cific phase space file scored below the monitor chamber (BEAMA).
The simulations were conducted using cut off energies of 521 keV (in-
cluding rest mass) and 10 keV for electrons and photons, respectively.
Uniform bremsstrahlung splitting was turned on, using NBRSPL =
1000 (maximum splitting factor). In order to maintain good electron
statistics in the build up region, Russian roulette was switched off. This
phase space was used directly as input in the patient simulations in
MCSIM, while for patient simulations utilizing DOSXYZnrc, a second
phases space file (BEAMB) was scored at a distance of 60 cm from the
target. Cut off energies were 521 keV (including rest mass) and 10 keV
for electrons and photons, respectively. Directional bremsstrahlung
splitting was employed, with SSD = 100 cm, NBRSPL = 1000 and FS1
equal to the largest field side length defined by the jaw collimators (as
projected at an SSD of 100 cm).
6.2.3 The MLC position
An MLC consists of two opposing banks of leafs: A and B. For the Var-
ian Millennium MLC each bank houses 60 leafs. The two immediately
opposing leafs are called a leaf pair and the opening of a leaf pair is
governed by the distance2 between the opposing leafs. An MLC leaf
sequence file as exported from the TPS holds the lateral distance from
the CAX of each leaf for every control point. This value refers to the
projected distance at the ISO–center as oppose to physical position.
Each leaf is represented by a number and the bank it belongs to (the
leafs in bank A are referred to as [1A,2A,...,N-1A,NA] and the leafs
in bank B are referred to as [1B,2B,...,N-1B,NB]). In the DICOM file
the MLC positions are given by a vector of length 2N. Apart from
being given in mm, there are two distinct differences between the
MLC sequence file and the DICOM vector: i the (projected) distance
from the CAX of the B–bank leafs are given by elements [1;N], while
the (projected) distance from the CAX of the A–bank leafs are given
by elements [N+1;2N] and ii the (projected) distance from the CAX
of the B–bank leafs are given with inverted sign in the MLC sequence
file compared to that of the DICOM file (figure 61). The interpretation
of this is that a directional vector is assumed for each leaf bank in
the MLC sequence file and that they are directed away from the CAX.
In the DICOM RP file where all leaf positions are given in a single
vector this is obviously not possible and therefore the (projected) leaf
position, relative to the CAX, must be given for the two banks.
1 The radius of field into which bremsstrahlung photons must be directed if they are
to be split
2 Two distance are of concern: the physical distance and the distance projected at the
ISO–center plane.
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Figure 61: MLC positions for a typical Rapid Arc control point as listed in
the DICOM RP file (left) and in the MLC sequence file (right).
The single vector of leaf positions in the DICOM RP file have
been separated into bank A and B. It can be seen that the bank A
positions are identical whereas the bank B positions differ in sign.
Both MCSIM and the particle dMLC library takes, slightly, modified
MLC leaf sequence files as input. The DYNVMLC CM also takes a
slightly modified MLC leaf sequence file as input with one distinct
difference: the lateral distance from the CAX for an individual leaf is
the actual distance as oppose to the projected distance. This can be
computed using simple trigonometry.
6.2.4 The realization of dynamic delivery in Monte Carlo
Advance radiotherapy (e.g. IMRT and VMAT) is often delivered dy-
namically, i.e. one or more component of the linac are moving during
the irradiation. For dynamic IMRT3 (also referred to as sliding win-
dow IMRT) the MLC is dynamically moving during the irradiation.
For VMAT, in addition to MLC movement, the gantry and the colli-
mator may also be rotating during irradiation. In the DICOM files,
the motion is expressed as a number of control points which dictate
the state of each linac component at a specific point in the delivery
process. Attributed to each control point is also the fraction of the total
accumulated MU to be delivered when arriving at the state dictated
by the specific control point. This effectively sets the time scale of the
dynamic delivery.
MCSIM
In order to implement the time scale in the MC simulation, interme-
diate control points are typically computed between two adjacent
control points (as given by the DICOM file). This was implemented
directly in the in–house script generating the MC input file for MCSIM.
3 IMRT may also be delivered by multiple static segments - so called “step and shoot
IMRT”.
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Each leaf moves with constant speed between positions specified by
two adjacent control points [Siebers et al., 2002]. Intermediate control
points were thus computed at the mid–point between two adjacent
original control point and the fractional delivery index associated to
the ith intermediate control point was taken as the average of the
fractional delivery index for the adjacent original control points. This
is a justifiable approximation if, and only if, the difference between
any two adjacent control point is small.
Testing of MLC movement between control points
The MLC leaf movement between control points was in this study
investigated for 100 clinical IMRT beams covering the most common
treatment sites (e.g. head and neck, rectum, prostate and lung). The
maximum movement of any individual leaf (between any two adjacent
control points) was between 0.14 and 0.19 cm, while the average leaf
movement was between 0.03 and 0.05 cm (static leafs disregarded
from the average). Considering that the maximum leaf movement
is on the order of the positioning accuracy for a detector and that
the average movement is on the order of the precision of the MLC
positioning, the approximation can be justified. The dynamic gantry
angle was treated analogously, which is justified by the fact that it is
the dose rate, rather than the gantry rotation speed, that is adjusted
to ensure the correspondence between gantry angle and fractional
photon fluence delivered (as stated by the control points). Thus, it may
be assumed that the gantry rotates at a constant speed between two
adjacent control points. Dose rate is not considered in MC, since there
is no notation of time. Therefore the intermediate control points were
assigned the average of the angles of two adjacent control points of
the original data set. Thus, a beam specified by N control points is
simulated as N− 1 static segments. The cumulative MU index was
renormalized for the intermediate control points so that it ranged
from 0 (for the the first segment) to 1 (for the last segment).
DYNVMLC and particle DMLC
The dynamic MLC as modelled in DYNVMLC [Heath and Seuntjens,
2003] and the particle DMLC [Siebers et al., 2002] operates in a similar
fashion as MCSIM, but computes an intermediate control point for
each particle. This is realized by drawing a random number that is
related to a fractional MU index, and the leaf position is then linearly
interpolated from the positions specified by the original control points.
DOSXYZnrc sources 20/21
Simulation of a VMAT treatment plan can be achieved with the
DOSXYZnrc sources 20/21 as introduced by Lobo and Popescu [2010].
The input files lists a number of control points each attributed with a
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set of angles, describing the gantry, couch and collimator angles in the
BEAMnrc coordinate system (see Section 6.2.1) and a fractional index.
A random number between 0 and 1 is drawn, which becomes the
MU index of the particle to be simulated. The corresponding settings
for the MLC is interpolated, as described above, and the particle is
transported through it and then directed onto the phantom by using
angles (θG, θT and θC) interpolated from the input file corresponding
to that index.
MLC simulation example
Figure 62 shows the MLC settings for four control points of a clinical
IMRT beam. Simulations were conducted for the dynamic plan, a step
and shoot plan based on intermediate control points as described
above as well as for the 74th and 75th segments (in static mode).
All simulations were performed using BEAMnrc and DOSXYZnrc.
The treatment head was simulated using BEAMnrc, and the MLC
simulated using DYNVMLC, scoring a phase space file, containing
≈5×107 particles, at 90 cm distance from the target. The electron cut off
energies (ECUTIN) of the jaw collimators and the MLC leaves were set
to 1.8 MeV in order to reduce computation time. This effectively means
that all electrons entering, or produced in, the collimator jaws and/or
the MLC leaves were terminated. This is justifiable if comparisons are
done at depths larger than the range of those electrons. The phase
space file was incident on a homogenous water phantom (SSD =
100 cm) and gantry, collimator and couch angles were adjusted to
0◦ in DOSXYZnrc. The number of histories simulated were 3.6×108,
thereby recycling each particle of the phase space seven times. The
resulting statistical uncertainty for relative dose levels above 20%
was less than 0.7%. The resulting dose distributions are illustrated
in Figure 63. As can be expected, when viewing the MLC settings,
the two adjacent control points yeild very similair dose distributions.
The relative difference between the clinical IMRT plan simulated fully
dynamically and in “step and shoot” mode using intermediate control
points is shown in Figure 64. The relative difference for voxel (i,j,k) was
computed as (DstepNshooti,j,k - D
dynamic
i,j,k )/D
dynamic
i,j,k *100 and voxels
with uncertainty > 1% in either of the dose distributions were omitted.
The difference histogram exhibited close to normal distribution. A fit
to a normal distribution yielded a standard deviation of 0.9%, while
the average deviation was 0.5%. As the average deviation as well as
the standard deviation was found to be small, one can infer that the
error introduced by using intermediate static segmenets, as oppose
to fully dynamic delivery, also is small. The error will however scale
with the modulation of the treatment plan.
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Figure 62: The figure shows the MLC settings for four control points ( top
left: segment 1/150, top right: segment 150/150, bottom left:
segment 74/150 and bottom right: segment 75/150) of a clinical
IMRT beam.
6.3 mc simulation in patient geometry
MC simulation in patient geometry can be conducted utilizing MCSIM
or DOSXYZnrc. Common for the two methods is that the patient
specific MC compliant phantom is used to defined the geometry.
For simulations in MCSIM, the BEAMA phase space file is used as
input and simulation of beam modifiers (jaw collimators and MLC) are
integrated in the patient dose simulation. Therefore, the information of
jaw collimator and MLC settings is required in the patient simulations
utilizing MCSIM. The only variance reduction technique switched on
was IETRACK (electron track repeating) and cut off energies were set
to 521 keV (including rest mass) and 10 keV for electrons and photons,
respectively.
For simulation of clinical treatment plans in DOSXYZnrc different
approaches were applied for simulations of VMAT and non–VMAT
plans. In the first case the simulation started from BEAMA scoring a
secondary phase space file (BEAMB) below the jaw collimators using
BEAMnrc and subsequently the MLC simulated using DOSXYZnrc
source 20 to score dose to the patient while utilizing the particle DMLC
code to simulate the MLC. For non–VMAT plans the beam modifiers
were simulated using BEAMnrc, scoring a phase space file (BEAMB)
at a distance of 60 cm from the target and the MLC was simulated
using DYNVMLC. The DOSXYZnrc simulation was then conducted
using source 2. In both cases photon and electron splitting was set to
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Figure 63: Relative 2D–dose distributions at 10 cm depth in a homoge-
nous water phantom simulated by DOSXYZnrc. The ISO dose
lines corresponds to 10% (dark yellow), 20% (pink), 30% (cyan),
40% (green), 50% (olive) and 60% (yellow) of Dmax, respectively.
Shown in the figure are dose distribution from a clinical IMRT
plan simulated fully dynamically (top left), in “step and shoot”
mode using intermediate control points (top right), statically for
segment 74/150 (bottom left) and for segment 75/150 (bottom
right).
25, PCUT was set to 10 keV while ECUT was computed using the rule
of thumb4 given in Rogers et al. [2009].
4 Choosing ECUT so that the range of electrons at ECUT is less than approximately
a third of the smallest dimension in the dose scoring region ensures that energy is
transported and deposited in the proper region
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Figure 64: Local relative dose difference between the clinical IMRT plan
simulated fully dynamically and in “step and shoot” mode using
intermediate control points (taking the fully dynamical simulation
as a reference). Voxels with uncertainty > 1% in either of the dose
distributions were disregarded. The histogram is plotted using a
bin widht of 0.2%.
Particles in the phase space file may originate from the same primary
electron and thus be correlated. A latent variance [Sempau et al., 2001]
in the phase space file may propagate to the final dose calculations
leading to an underestimation of the uncertainty [Walters et al., 2002].
This is taken into account in the uncertainties reported by DOSXYZnrc
[Kawrakow and Watlers, 2006; Walters et al., 2005], but not for MCSIM.
The probability of two correlated phase space particles depositing
dose in the same voxel is difficult to estimate, but considered small.
In order to minimize the effect of the propagation of latent variance
the recycle rate of phase space particle was limited by using a phase
space containing a large number of particles. In MCSIM no phase
space particle was used more than once, for each field, during the
patient simulations while in DOSXYZnrc the particle were allowed to
be recycled maximum 5 times. The difference was necessary in order
to reduce disk space since the patient and field specific BEAMB phase
space files utilized by DOSXYZnrc are on the order of 5–10 Gb in file
size.
6.4 converting the mc dose distribution
to dicom format
The resulting 3D–dose distribution was imported to CERR using an in–
house written MATLAB script. In short the 3ddose file was read into
MATLAB using the DICOM RT–toolbox function dicomrt_read3ddose
and converted to absolute dose as described in Chapter 5. This does
not pose a problem for multiple beam IMRT simulations utilizing MC-
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SIM as a field specific calibration factor can be applied to each field
individually and thereby correcting for monitor chamber backscat-
ter effects (see Section 5.1). For multiple beam IMRT simulations
using DOSXYZnrc a field specific post correction, as described in Sec-
tion 5.1.2, is needed. In DOSXYZnrc each IMRT beam/VMAT arc was
simulated individually, resulting in a dose distribution per field/arc,
which simply was added to a dose distribution corresponding to the
full treatment. Uncertainties were computed using error propagation
procedures, assuming that the covariance between the beams was zero.
The procedure results in a conservative estimate of the uncertainty.
The previosly imported CERR plan was loaded and if the same dose
grid was used, the TPS calculated dose was replaced by the MC calcu-
lated one. If the dose grids did not match, the CERR parameters were
conformed to that of the MC dose grid. The MC dose distribution
was multiplied by the number of planned fractions for the treatment.
The CERR plan was saved (as a new file) and the CERR DICOM ex-
port, modified so as to only export the DICOM RD file, was executed
yielding a DICOM RD file.
computation details
EGSnrc computations were conducted on a dedicated 47 node, stan-
dard dual core 3.0 GHz PCs, cluster using a PBS queue system. A
typical IMRT–BEAMB simulation in BEAMnrc took ≈147 hours (≈3.7
hours running on 40 nodes) resulting in a phase space file of ≈5.0×107
particles (depending on collimator and MLC settings). A typical IMRT
field simulated in DOSXYZnrc using the BEAMB phase space had
NCASE set to 3.6×108, ran for 150 hours (i.e. ≈3.8 hours running on
40 nodes) and resulted in a statistical uncertainty of ≈0.7% in the high
dose regions. A VMAT–BEAMB simulation in BEAMnrc took ≈15
hours ( ≈0.4 hours running on 40 nodes) resulting in a phase space file
of ≈6×105 particles per cm2. A typical single arc Rapid Arc treatment
plan simulated in DOSXYZnrc using the BEAMB phase space had
NCASE5 set to 5.0×107, ran for ≈60 hours (i.e. ≈1.5 hours running on
40 nodes) and resulted in a statistical uncertainty of ≈0.6% in the high
dose regions.
MCSIM simulations were conducted on a stand alone dual core 3.0
GHz computer. A typical IMRT simulation (using Nbeams fields) had
NCASE set to 2×109/Nbeams and ran for ≈54 hours, resulting in an
uncertainty of ≈0.7% in the high dose regions.
5 The actual number of histories to simulate is determined by deviding NCASE by
the MLC survival fraction, which is computed by making a presimulation of 1×106
histories
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M C T P V S C L I N I C A L D O S E C A L C U L AT I O N
A L G O R I T H M S
Currently available dose calculation algorithms (e.g. PBC and AAA)
rely on approximations which might compromise accuracy of the final
dose distribution (see Section 1.3.3.1). MC methods consider all aspects
of the particle transport through the linac and in the patient and is
therefore the most accurate dose calculation method. For that very
reason it is of interest to compared dose distributions generated by MC
to those calculated by clinical dose calculation algorithms. Such studies
have been conducted by many groups [Aarup et al., 2009; Arnfield
et al., 2000; Chow et al., 2003; Fogliata et al., 2007; Fotina et al., 2011,
2009; Francescon et al., 2000; Gagne et al., 2008; Hasenbalg et al., 2007;
Jeraj et al., 2002; Keall et al., 2001; Knöös et al., 2006; Krieger and Sauer,
2005; Linthout et al., 2002; Ma et al., 1999; Ottosson and Behrens, 2011;
Ottosson, Karlsson and Behrens, 2010; Paelinck et al., 2005; Reynaert
et al., 2005; Seco et al., 2005; Sterpin et al., 2009; Vanderstraeten et al.,
2006; Wang et al., 2002] in heteregenous phantoms as well as in patient
geometry. Some of the studies focus on extreme cases where a single
beam progresses through a boundary between high and low density
materials.
7.1 review of literature
Paelinck et al. [2005] compared two different superposition/convolu-
tion algorithms to MC for single beam impinging on a polystyrene
phantom with a large centrally placed cavity consisting of a lung–
equivalent material. For one of the algorithms agreement was found
within the lung cavity whereas an over response of 3.6% was noted
behind the cavity. The second algorithm was in better agreement with
MC behind the cavity but showed an underresponce of 5.6% within
the lung cavity. MC was in agreeement with radiochromic film in the
lung cavity as well as behind it.
Arnfield et al. [2000] compared a generalized Batho algorithm and a
superposition/convolution algorithm to MC and Thermo Luminescent
Dosimeter (TLD) and IC measurements for beams impinging on a
tissue–equivalent phantom with a centrally placed cavity consisting
of a lung–equivalent material. The comparison was done for PDDs
along the CAX. Agreement was found between measurements and MC
while both algorithms over responded in the lung cavity. The effect
was inversely proportional to field size proportional to the energy of
the impinging photons.
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Francescon et al. [2000] compared MC simulation to a superposi-
tion/convolution algorithm for mediastinal and breast treatment plans.
Deviations between MC and the TPS were in the range of 0% to 2.6%
even in areas of large density inhomogeneities as well as for single
beam calculations.
Reynaert et al. [2005] compared a superposition/convolution algo-
rithm to two different MC dose engines for a head and neck IMRT
treatment. The superposition/convolution algorithm agreed with one
of the MC simulations whereas deviations of up to 10% were noted
between the two different MC simulations. This illustrates the impor-
tance of accurately modeling the linac. The difference was thought
to be due to improper commissioning of the MLC model for the MC
dose engine not in agreemnet with the superposition/convolution
algorithm. It should be noted that the deviating MC dose enginge was
a beta release.
Sterpin et al. [2009] compared a superposition/convolution al-
gorithm to MC simulations both in idealized phantom geometries
as well as for patient calculations. Dose was calculated for a beam
impinging on a heterogeneous phantom consisting of two slabs of
polystyrene separated with Styrofoam and compared to radiochromic
film measurements. The deviation for the transversal dose plane, of
the polystyrene slab, was within 2%/1 mm for a 1.25×2.5 cm2 field.
Similar agreement was found between MC and the superposition/-
convolution algorithm for the transversal dose plane. Compared to
MC, an overresponce of the superposition/convolution alogorithm of
up to 8% was noted behind the polystyrene/styrofoam interface. The
largest deviation was found for the smallest field size investigated.
The deviation between TPS calculated and MC computed dose was,
however, within 2% in most situations.
The lesson learned from previous studies are, unsurprisingly, that
the largest deviations are found in the extreme situations were a sin-
gle beam is progressing through a phantom with large cavities. The
deviations increase with increasing photon energy and decreasing
field sizes. Better agreement is found when comparing situations re-
sembling clinical treatment plans (e.g. multiple beams, real patient
geometry). Finally, superposition/convolution algorithms are gener-
ally in better agreement with MC than less sophisticated algorithms
(e.g. PBC and Batho methods).
In the following sections comparisons between commercially avail-
able algorithms and MC are presented for clinical treatment plans.
7.2 comparison for clinical treatment plans
In order for a comparison between MC dose calculation algorithms
and TPS to be fair a number of circumstances needs to be considered.
The dose calculation algorithms in commercial TPS usually report
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Dw [Knöös et al., 2006], while MC report Dm. The method for con-
version between the quantities was discussed in Section 5.2 and is
well documented in the literature [Siebers et al., 2000]. Moreover the
commercially available dose calculation algorithms treat voxels dif-
ferently depending on weather they are located within the external
contour or not. Typically voxels outside the external outline are set to
a density corresponding to 0 HU. Corrections methods for support
structures (e.g. the couch and immobilization devices) may be con-
ducted based on transmission measurements. For some commercial
algorithm, advanced models of support structures may be incorpo-
rated in the treatment planning. In MC the dose calculation grid is
typically defined so that the patient couch is omitted, but the voxels
outside the external outline is typically not considered differently than
those inside during the CT to phantom conversion. As discussed on
page 86 a function for setting voxels outside the external contour to air
with a density of 1.2041×10−3 gcm−3 was implemented in CTC–ask.
Thus, replicating the typical procedure of commercial dose calcula-
tion algorithms. As for support structures, if no reliable drawings
can be obtained and converted to a structure in the MC simulation a
pragmatic solution is to omit them in the dose calculation all together.
In order to investigate the influence of setting voxels located outside
the external outline to air with a density of 1.2041×10−3 gcm−3 a head
and neck case planned for IMRT was converted to a MC compliant
phantom using CTC–ask, and the media set described in Section 4.4.2.
Two phantoms were generated, one where all voxels outside the exter-
nal contour were explicitly set to air with a density of 1.2041×10−3
(phantA) and one where they were not (phantB). The phantoms were
idenctical for all voxels inside the external contour. The MCTP work-
flow illustrated in Figure 60 was employed in order to recalculate the
treatment plan using an MC dose algorithm. The MCSIM dose engine
was selected1, conversion to Dw was conducted.
It can clearly be seen that the dose outside of the external contour
is higher for the simulation based on phantA than compared to that
of phantB (Figure 65). Apart from the decreased dose outside of the
patient geometry, two effects can be noted for the simulation based
on phantB: (i) the surface dose of the actual patient is lower as the
build–up region is effectively shifted deeper into the patient and (ii) a
higher dose in the central regions of the patient. Shifting the build–up
region deeper implies that the beam will be less attenuated at a given
distance beyond dmax and thus will give rise to a higher dose. This
is illustrated by a shift towards higher doses for the centrally located
structures, predominantly the PTV and the CTV, as seen on the DVHs
in Figure 66. This effect will be somewhat compensated for distal
1 Cut off energies were 521 and 10 keV for electrons and photons respectively. The
only variance reduction technique explicitly employed was electron track repeating.
The number of histories were chosen so that the estimated statistical uncertainty was
≈0.5% for the voxels in the high–dose regions.
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Figure 65: MC simulated isodose lines for a head and neck IMRT case. Simu-
lations conducted using MCSIM for a phantom were no consid-
erations were made for the voxels outside the external outline
(left) and a phantom were the voxels outside the external outline
were set to air with a density of 1.2041×10−3 gcm−3. The isodose
lines corresponds to 10% (brown), 20% (green), 30% (red) and 50%
(blue) of the prescribed dose.
voxels when using opposing beams while it will be further enhanced
for central voxels.
Assigning all of the voxels outside the external contour to air might
not be accurate from a dosimetric point of view since the patient might
be covered by a mask, be placed in a fixation and the treatment couch
might be in the beam. For inter comparison between MC and TPS
dose calculation algorithms it is a sound strategy if such a feature is
implemented in the TPS. In CTC–ask, delineated support structures
may, like any other delineated structure, be assigned the actual density
and media composition should it be known.
7.2.1 Monte Carlo vs AAA
MC simulation was conducted for five clinical dual arc RapidArc and
two IMRT treatment plans all calculated with AAA as implemented
in Varian Eclipse TPS build 8.2.24.10720 (Varian Medical Systems, Inc.
Palo Alto, CA, USA). DICOM files were exported form the TPS and
imported to CERR. The MCTP workflow illustrated in Figure 60 was
employed in order to recalculate the treatment plan using an MC dose
algorithm. MC compliant phantoms were generated from the DICOM
files using the 19 media set (described in Section 4.4.2) implemented
in CTC–ask. Voxels outside the external contour were explicitly set to
air with a density of 1.2041×10−3 for all phantoms. The DOSXYZnrc
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Figure 66: DVHs for MC simulations for a head and neck IMRT based on two
different geometries, one where all voxels outside of the external
contour actively was set to air with a density of 1.2041×10−3
gcm−3 (dashed) and another where no special considerations
were made for the voxels located outside the external contour
(solid). DVHs of the following structures are shown: CTV(red),
PTV (blue), parotis dx (cyan), parotis sin (magenta), larynx (green),
brain stem (yellow), spinal cord (black), lung (grey).
dose engine was selected2 and conversion to Dw was conducted. The
resulting dose distributions were imported to CERR. The CT data and
structures imported to CERR from the TPS DICOM files were used in
the computation of DVHs.
In geometries with small variations in density the AAA calculated
and MC simulated dose distributions are in good agreement (Fig-
ure 67). The voxels failing the 2D gamma evaluation (2% dose, 0.2%
mm Distance To Agreement (DTA)) for a prostate dual arc RapidArc
case are all either located in the build up region or at bone–tissue
interfaces (Figure 67). For the lung IMRT case shown in Figure 68, dif-
ferences are found at lung–tisue interfaces as well. Dose differences of
up to 6% were found at the lung–heart and the lung–tumor interfaces
for the lung IMRT case.
The difference in agreement between AAA and MC for cases with
(e.g. lung) or without (e.g. prostate) large regions of substantial vari-
ation in density and elemental composition, can clearly be seen on
DVHs (Figure 69 and Figure 70). For the lung IMRT case (Figure 70),
the MC DVHs of the PTV and the CTV are shifted to lower doses
2 Cut off energies were 700 and 10 keV for electrons and photons respectively. Photon
splitting and electron splitting were set to a value of 25. The number of histories
were chosen so that the estimated statistical uncertainty was ≈0.5% for the voxels in
the high–dose regions. Source 20 was selected and particle Dmlc was employed to
simulate the MLC
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Figure 67: Top panel: A transversal CT slice of a prostate dual arc Rap-
idArc case calculated by AAA (left) and MC simulated using
DOSXYZnrc (right). The isodose lines corresponds to 10% (or-
ange), 30% (green), 50% (red), 70% (cyan), 80% (purple), 90%
(gold), 95% (light blue) and 100% (deep red). Bottom: 2D gamma
analysis (2%/0.2 mm). Voxels outside the external contour were
set to gamma = 0.
compared to AAA (mean doses were 0.7 and 0.5 Gy lower, respec-
tively). This is explained by the over estimation of scattered dose from
lung in AAA. For the prostate case, however, no monotonous shift is
noted for the PTV or the CTV, instead the MC DVHs of these struc-
tures are tilted about the average dose. Part of this is a result of the
stochastic nature of MC. The effect exists for all structures, but is less
clearly visible for structures receiving lower doses. The mean doses
of the structures considered agreed within 0.3 Gy for the structures
considered (Table 16).
[Fippel, 2003; Jiang et al., 2000; Kawrakow, 2002; Naqa et al., 2005;
Smedt et al., 2006] investigate the possibility of using smoothing filters
on MC simulated dose distribution as a mean of reducing the influence
of statistical noise. Jiang et al. [2000] proposed an iterative algorithm,
in which the uncertainty of the MC simulation is used to construct a
blurring function, which in turn is used to produce noiseless DVHs.
They found that the influence of noise was largest for structures with
steep DVH gradient (e.g. typically the target volumes). Moreover they
stated that the influence of the statistical noise, depending on the un-
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Figure 68: Top panel: A transversal CT slice of a head and neck dual arc
RapidArc case calculated by AAA (left) and MC simulated using
DOSXYZnrc (right). The isodose lines corresponds to 10% (orange),
30% (green), 50% (red), 70% (cyan), 80% (purple), 90% (gold), 95%
(light blue) and 100% (deep red). Bottom: 2D gamma analysis
(2%/0.2 mm). Voxels outside the external contour were set to
gamma = 0.
Figure 69: DVHs for a prostate dual arc RapidArc case calculated by AAA
(solid) and MC simulated using DOSXYZnrc (dashed). The DVHs
shown correspond to CTV (red), PTV (blue), rectum (magenta),
bladder (green), caput femur sin (black) and caput femur dx (cyan)
.
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Figure 70: DVHs for a seven field IMRT lung case calculated by AAA (solid)
and MC simulated using DOSXYZnrc (dashed). The DVHs shown
correspond to CTV (red), PTV (blue), the right lung (cyan), the left
lung (magenta), the oesephagos (green), the spinal cord (black)
and the heart (grey)
.
certainty of the simulation, could be of clinical importance. Smoothing
of dose distribution and DVHs were, however, not employed in this
study.
An aspect worth mentioning is that AAA calculates the dose as N
static segments (where N is the number of control points), whereas
the MC, as implemented here, calculates the dose as being delivered
fully dynamically. Thus, it might seem like a case of comparing apples
and oranges, but in fact is not since the approach employed in the
AAA dose calculation is an inherent limitation of the algorithm itself.
The approximation of calculating a dynamical delivery as N static seg-
ments also infers that the difference between AAA and MC calculated
dose will increase with the modulation of the treatment plan if N is
kept constant as for RapidArc treatment plans.
7.3 high vs low energy for lung treatments
PBC dose calculation is frequently used for lung cancer treatment
planning. If PBC based treatment plans generated with high and
low energy (e.g. 15 MV or 18 MV and 4 MV or 6 MV, respectively)
are compared, the ones based on the higher energies will in many
cases appear more favorable. However, it is well known that the
inaccuracies introduced by the PBC dose calculation generally are
larger for higher energies and depend on several parameters such
as field size and geometry (e.g. [Behrens, 2006], [Klein et al., 1993],
[Tsiakalos et al., 2006], [Vanderstraeten et al., 2006], [Krieger and Sauer,
2005]). Therefore, usually low energy is chosen as default for lung
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Table 16: Average dose to specific structures for a dual arc RapidArc prostate
case as calculated by AAA and MC. The MC dose was considered
as the reference.
Structure AAA MC Difference
(Gy) (Gy) (Gy)
CTV 78.0 78.3 -0.3
PTV 78.0 78.1 -0.1
Bladder 35.9 35.7 0.3
Rectum 39.9 40.1 -0.2
Caput femur dx 12.3 12.5 -0.1
Caput femur sin 13.0 12.8 0.2
Figure 71: NSCLC cases (A)–(D). Transversal and coronal CT slices, illustrat-
ing the tumor location and extension. Red and light blue lines are
delineations of the GTVs and PTVs, respectively.
treatments. This begs the question whether this always is the best
choice. For some cases, treatment plans based on higher energies may
be more favorable. In order to address this question, more accurate
dose calculation methods (e.g. MC) must be employed. PBC and a
more sophisticated superposition/convolution algorithm, AAA, were
compared to MC–based dose calculations clinical IMRT and AP–PA
lung treatments.
Four non-small cell lung cancer (NSCLC) cases with apparent dif-
ferences in tumor location, were selected for this study. The cases
exhibited geometrical properties where one could expect a significant
discrepancy between analytical and MC dose calculation algorithms
(Figure 71). CTV and OAR were delineated by a radiologist. PTV mar-
gins were added in accordance with the protocol used at Copenhagen
University Hospital Herlev.
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7.3.1 Treatment Planning
For inverse planning, Varian EclipseTM build 8.2.24.10720 (Varian
Medical Systems, Inc. Palo Alto, CA, USA) modeling a Varian 2300 iX
(Varian Medical Systems, Inc., Palo Alto, CA, USA) was used.
35 × 2 Gy was prescribed to the PTV and a maximum dose con-
straint of 45 Gy was applied to the spinal cord. The lungs were as-
signed a dose volume constraint of V20 6 50%, while the constraints
for the heart were V30 6 100%, V45 6 65% and V60 6 25%.
As an initial step of the treatment planning, the optimal numbers
of beams, gantry and collimator angles were determined individually
for each case and energy (6 and 15 MV) by Varians geometrical op-
timization module utilizing the Plan Geometry Optimization (PGO)
algorithm (Varian Medical Systems 2007). The PGO takes the specific
geometry of the case and the DVO constraints into account.
Hereafter, a number of isocentric dynamic (sliding window) IMRT
treatment plans, ranging from PTV conformity weighted to normal
tissue sparing weighted, were created for each case and beam energy.
Thus, the PTV coverage, from one plan to the next, deteriorated as
sparing of the normal tissue in general, and the lungs specifically,
increased. In total 31 treatment plans, distributed amongst the 4 cases,
were created. For the optimization, a PBC algorithm was used as
Eclipse offers no other option. Full dose calculation was undertaken
for each treatment plan, employing the Eclipse PBC algorithm and the
AAA using identical MLC settings and monitor units.
7.3.2 Monte Carlo simulations
Voxalized phantoms were created via the DICOM RT toolbox using
the planning CT set as input. The phantom grid was matched to the
dose grid of the TPS. A set of in–house MATLAB scripts was used to
generate input files for MCSIM from the DICOM RP files. Thus, all
parameters of the treatment plans were recreated in the simulations.
The treatment plan simulations were performed in MCSIM using
an energy specific phase space, scored above the jaw collimators, as
source input. A total number of 0.5–1×109 histories was simulated for
each treatment plan, resulting in a statistical uncertainty of 0.3–0.6% at
the global dose maximum. Cut off energies of 521 keV (including rest
mass) and 10 keV for electrons and photons, respectively were used.
The only variance reduction technique switched on was IETRACK
(electron track repeating). Backscatter corrections were calculated for
each field using the method described in Section 5.1.3.
Since the TPS reports dose to water and MCSIM dose to media,
a conversion was necessary in order to ensure a fair comparison.
The procedure suggested by Siebers et al. [2000] as implemented in
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the DICOM RT toolbox was employed in order to convert the MC-
calculated dose into dose to water.
7.3.3 Evaluation
For each treatment plan and algorithm, DVHs were created. The
DVHs were used to evaluate the volume of the PTV receiving less
than 95% of the prescribed dose
(
1− VPTV95
)
. The lung NTCP for
pneumonitis was calculated using an Equivalent Uniform Dose (EUD)-
based formalism Gay and Niemierko [2007]. The parameters used for
the NTCP calculation were a = 1, γ50 = 2, TD50 = 24.5 Gy and α/β =
3 Gy, as suggested by [Gay and Niemierko, 2007].
The results were evaluated using a Pareto front comparison method
Ottosson et al. [2009]; Steneker et al. [2006]. The general idea of this
concept is to compare sets of plans, belonging to different classes
(e.g. high versus low energy) as opposed to a traditional plan-to-plan
comparison procedure. Comparative treatment planning has hitherto
often been rather inconclusive. For instance, when comparing different
IMRT delivery techniques (e.g. step and shoot versus sliding windows),
it may have been found that one of the techniques is capable of better
target coverage, while the other is better at sparing risk organs. This
leaves room for a subjective interpretation. By sampling the entire
Pareto front for a case, it may be possible to make a much more
just and comprehensive comparison of the two systems. Utilizing
this concept elements such as treatment planner dependence and
misfortunate plan selections can be minimized.
In order to visualize the comparison between energies and algo-
rithms, Pareto fronts based on
(
1− VPTV95
)
and the lung NTCP were
produced for all algorithms and cases. Plans belonging to the same
class (beam energy and algorithm) constitute the Pareto front for that
specific class, enabling comparison of class to class rather than plan to
plan.
7.3.4 Results
All algorithms (PBC, AAA and MC) used identical setups for each
treatment plan and all differences in the resulting dose distributions
were solely due to discrepancies between the dose calculation algo-
rithms. Throughout this study MC is considered the golden standard
or “ground truth”. Unless explicitly stated all references to dose distri-
butions or dose differences are based on the MC calculations.
Considering MC as the golden standard, the inaccuracy of the other
algorithms, in terms of NTCP and PTV underdosage, is illustrated
and quantified by the Pareto fronts. The results illustrate that PBC
significantly miscalculates the dose for all treatment plans, indepen-
dent of tumor geometry. AAA is in much better agreement with MC.
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Figure 72: Pareto fronts for NSCLC cases (A)–(D). Treatment plans a and b
for case A (marked in the plot) illustrate the potential problem
in a plan to plan comparison study. Which one is the better plan,
and should we prefer 6 or 15 MV? This question is impossible to
answer based on these two treatment plans alone. However, when
the Pareto fronts are plotted, it is clear that 6 MV is preferable to
15 MV for this case.
Generally, the differences between PBC and AAA/MC are larger for
15 MV. PBC and AAA overestimate the dose to the PTV, compared
to MC (Figure 72). Even a small overestimation in dose can lead to a
large impact on
(
1− VPTV95
)
due to the conformal nature of the dose
distribution.
The dose to the total lung volume was significantly higher for case
A. This is due to the fact that the PTV in case A is located in the
mediastinum and extends into both lungs. For cases B–D, the PTV
is confined to one lung, making it possible to spare the contralateral
lung to a large extent. The NTCP(lung) values for cases B–D are
very low. However, plotting V20 as a function of
(
1− VPTV95
)
yields
results similar to those illustrated in figure 5 and leads to the same
conclusions. For the MC calculations, the ranges of V20 values are
[34;53], [12;19], [18;29], [21;25]%, for cases A, B, C, and D, respectively.
For cases A–C, 15 MV appears favorable as compared to 6 MV
based on the PBC treatment plans, while for case D, no significant
difference is observed. However, this is not the case as more accurate
dose calculation algorithms are employed. All cases exhibit a better
combination of target coverage and NTCP(lung) for 6 MV than for 15
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MV, i.e. for a range of treatment plans, the Pareto front for 6 MV MC
is closer to origin than the corresponding 15 MV MC front (Figure 72).
The difference is least pronounced for case C. From the treatment
plans generated, it is clear that 6 MV is more favorable than 15 MV in
general.
Even though 6 MV was generally found to be more favorable for
the cases studied, one should not set aside the possibility of using
higher energies, as there might be cases or classes of cases benefiting
from high energy–based treatment plans. It would be advantageous
if patients could be sorted prior to treatment planning, identifying
those with potential benefit from high energy–based treatment. Sorting
criteria could include patient size and tumor location, tumor size and
proximity to other structures, etc. For example, due to the larger dose
deposition at depth, high energy-based treatment plans might be more
advantageous for deep seated tumors. However, several other factors
are important, e.g. the larger penumbra region and primary and
secondary build-up effects for the higher energy. A large secondary
build–up effect might be advantageous when a beam passing through
lung enters high-density healthy tissue, while a small build–up effect
is beneficial when a beam passing through lung enters high density
tumor tissue. Based on the present work, it has not been possible to
identify suitable sorting criteria. Possibly, too many different effects
interplay and the potential benefit for a patient is based on the exact
geometry of the case including the specific beam configuration. One
might find that for some patients and a given beam configuration,
high energy might be advantageous while low energy is advantageous
for another beam configuration. In fact, it might be that some patients
could benefit from a mixed energy setup, i.e. using high energy for
some gantry angles and low energy for others. This is beyond the
scope of this work and the subject of future investigations.
7.3.5 Conclusions
This study clearly demonstrates that the PBC dose calculation algo-
rithm is clinically insufficient for patient geometries such as cases A–D.
This is line with the study by [Jeraj et al., 2002] where the conclusion
was that PBC algorithms should be replaced by superposition/con-
volution algorithms or MC for inverse treatment planning. AAA is
generally in closer agreement with MC than PBC, which also was the
result of the study conducted by [Knöös et al., 2006].
For the more simple AP–PA treatment plans both the AAA and PBC
calculation algorithms predicts the trends in the differences between
15 and 6 MV plans, except in the lungs for the PBC algorithm. Both
the AAA and the PBC algorithm sufficiently accurately predicts the
absolute dose levels for the palliative patients studied. This indicate
that PBC still may be a viable choice in the case of forward planning.
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A number of the PBC–calculated treatment plans appeared signifi-
cantly better for 15 MV than for 6 MV. However, considering MC as
the golden standard, the dose distributions that would actually be
delivered to the patient are significantly better for 6MV for the IMRT
plans. Yet, one should not completely set aside the possibility of using
higher energies for sites covering the lungs or other inhomogeneous
sites, as there might be cases, or classes of cases, where the resulting
plans prove to be better. However, it is still advisable to use low ener-
gies as default for tumor sites involving large inhomogeneities unless
a precise dose calculation algorithm is available.
7.4 the influence of the fitted parameters of the monte
carlo model
Although the particle transport in MC does not rely on inherent ap-
proximations, it is important to remember that the calibration of the
linac model typically is conducted by tweaking parameters of the
particles incident on the linac target until an acceptable agreement
between simulations and measurements is achieved. Moreover, the
validation typically encompasses only a limited number of simulation
geometries. It is by no means trivial to translate the influence of the
uncertainty on the fitted model parameters to differences on dose
distribution in a heterogeneous patient geometry and for a complex
treatment delivery. [Chetty et al., 2005] investigated the influence of
the model parameters of an Equivalent Path Length algorithm for a
conformal treatment plan involving the thorax region. An initial model
was determined by choosing a set of parameters so that agreement
was found with an MC simulation along the CAX of a heterogeneous
phantom. The model parameters were subsequently optimized so that
agreement with MC simulation was found also in the penumbra– and
low dose regions. The optimized Equivalent Path Length (EPL) model
calculated dose well within ±3% of the MC calculated dose distribu-
tion, wheras deviations of 10% to 15% were noted when comparing
the dose predicted by the initial model with that of the MC algorithm.
The statistical tests employed in the calibration of the MC model de-
scribed in Section 3.3 estimate not only the optimal parameter values
but the standard deviation of each parameter value. The value minimiz-
ing the χ2/NDF corresponds to the optimal value while one standard
deviation of that parameter is the value resulting in min(χ2/NDF)+1
[Berendsen, 2011; Hughes and Hase, 2010]. The optimal value was
chosen by fitting a second degree polynomial to a data set representing
χ2/NDF as a function of spot size FWHM and the value corresponding
to +1 SD is that resulting in min(χ2/NDF)+1 (Figure 73). Although
the optimal value was revised later in the calibration protocol the
value of the SD may still be representable.
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Figure 73: χ2/NDF as a function of spot size FWHM, for X (red square) and
Y (blue circle) direction individually, for the 6MV model. A second
degree polynomial fit to the data is included (dashed). The values
minimizing the χ2/NDF as well as those corresponding to +1 SD
are included in the figure (diamonds and triangles, respectively).
In order to investigate the influence of the fitted parameters of the
model, MC simulation was conducted for five clinical dual arc Rap-
idArc treatment plans. The MCTP workflow illustrated in Figure 60
was employed in order to recalculate the treatment plan using an
MC dose algorithm. MC compliant phantoms were generated from
the DICOM files using the 19 media set (described in Section 4.4.2)
implemented in CTC–ask. The DOSXYZnrc dose engine was selected3
and conversion to Dw was conducted.
Simulations were conducted for two MC models: MCopt where
parameters were chosen in accordance with the previously conducted
commissioning (i.e. mean impinging electron energy: 6.00 MeV, radial
spot size FWHM: 0.155 and 0.170 cm for the X– and Y–directions,
respectively) and MC1SD where the spot size FWHM was chosen as
+1 SD (i.e. mean impinging electron energy: 6.00 MeV, radial spot size
FWHM: 0.188 and 0.194 cm for the X– and Y–directions, respectively).
The lateral dose profiles is not heavily sensitive to changes in spot size
FWHM even for field sizes of 20×20 cm2 (see Figure 8). Therefore no
large deviations are to be expected between the dose distributions.
Looking at iso dose lines for a dual arc RapidArc prostate case
(Figure 74) the limited difference observed can be confirmed. The
3 Cut off energies were 700 and 10 keV for electrons and photons respectively. Photon
splitting and electron splitting were set to a value of 25. The number of histories
were chosen so that the estimated statistical uncertainty was ≈1.0% for the voxels in
the high–dose regions. Source 20 was selected and particle Dmlc was employed to
simulate the MLC
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Figure 74: Top panel: A transversal CT slice of a prostate dual arc RapidArc
case simulated with an optimal MC model (left) and one were the
electron spot size FWHM was set to +1SD (right). The isodose lines
corresponds to 10% (blue), 30% (cyan), 50% (green), 70% (lime),
80% (yellow), 90% (orange), 95% (deep orange), 100% (light pink),
105% (pink) and 110% (deep pink). Bottom panel: Difference of
the dose distributions computed as 200−DMC1SD/DMCopt × 100.
Only voxels with dose > 10% of the prescribed dose in both of
the simulates were considered. The dose colorwash ranges from
95% (i.e. a 5% lower dose in the MCopt simulation) (blue) to 105%
(i.e. a 5% higher dose in the MCopt simulation) (red).
difference dose map in Figure 74 illustrates that for most voxels the
dose is well within 2% and at most 5% occuring occasionally for
distal voxels where the abslute dose is lower. Looking at the DVHs
no substantial difference between the two models are observed either
(Figure 75). The dose recieved by 90% and 95% of the PTV and the
CTV was slightly higher for the MC1SD model. This is expected since
penumbra widening is one of the effects of an increased spot size.
The resulting dose distributions for the two MC models of a dual
arc RapidArc head and neck case also show no dramatic differences
(Figure 76). However, small islet of "hot–" and "cold–spots" can be
observed on the dose difference map. Moreover, the differences appear
within the high dose regions. The treatment plan delivered for a head
and neck case is typically more modulated than a prostate case and
is therefore more susceptible to changes of the model. The maximum
dose difference was however within 5% for all voxels. Looking at the
resuting DVHs no substantial difference can be observed (Figure 77).
Some fractional volumes of the PTV and the CTV receive higher
doses in the MCopt simulation, while for other fractional volumes the
MC1SD simulation results in higher doses. This can be possibly partly
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Figure 75: DVHs for a prostate dual arc RapidArc case simulated with an
optimal MC model (solid) and one were the electron spot size
FWHM was set to +1SD (dashed). The DVHs shown correspond
to CTV (red), PTV (blue), bladder (magenta), rectum (cyan) and
the entire external outline (green)
.
be explained by the stochastical nature of MC. Observing the dose
difference map (Figure 76) more closely it can be seen that the large
deviations are found either in regions where the absolute dose is low
or in high dose regions where the density is far from unity.
The finding of this study indicate that a suboptimal MC model
potentially can lead to dose deviations of 5% even in the high dose
regions. The deviations seems to be larger in regions with large density
variations. Moreover, the difference is most likely proportional to
the modulation of the treatment plan. This is so since the largest
difference between lateral profiles for models with different spot sizes
are observed at the field edges and in the penumbra regions. With
incerasing modluation, the relative penumbra dose contribution to the
total dose will increase. In order to draw any clear conclusions of the
impact of the MC model parameters on the resulting dose distributions
for clinically relevant cases a large study including several cases is
needed. The statistical uncertainty should also be low so that the any
real effects can be clearly seperated from effects due to statistical noise.
142 mctp vs clinical dose calculation algorithms
Figure 76: Top panel: A transversal CT slice of a seven field IMRT lung
case simulated with an optimal MC model (left) and one were the
electron spot size FWHM was set to +1SD (right). The isodose lines
corresponds to 10% (blue), 30% (cyan), 50% (green), 70% (yellow),
80% (orange), 90% (light pink), 95% (pink) and 100% (deep pink).
Bottom panel: Difference of the dose distributions computed as
200−DMC1SD/DMCopt × 100. Only voxels with dose > 10% of
the prescribed dose in both of the simulates were considered. The
dose colorwash ranges from 95% (i.e. a 5% lower dose in the
MCopt simulation) (blue) to 105% (i.e. a 5% higher dose in the
MCopt simulation) (red).
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Figure 77: DVHs for a head and neck dual arc RapidArc case simulated with
an optimal MC model (solid) and one were the electron spot size
FWHM was set to +1SD (dashed). The DVHs shown correspond
to CTV (red) and PTV (blue), bladder (magenta), rectum (cyan)
and the entire external outline (green).
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E N E R G Y A N D P E RT U R B AT I O N FA C T O R S F O R
D O S I M E T RY I N S M A L L , M V P H O T O N
R A D I O T H E R A P Y B E A M S
Alanine/EPR has been suggested as a suitable system for radiother-
apy dosimetry ([Anton, 2005, 2006]), in particular, for non–reference
situations, such as for small field sizes and composite beam delivery
(e.g. IMRT and VMAT). The appealing features of alanine are close–
to–water equivalent interaction properties, dose linearity up to the
kGy range, small energy and dose rate dependence, limited influence
of environmental factors, non destructive read out, and small size.
The EPR signal from the detector irradiated with an unknown dose
is related to dose to water through a calibration curve obtained by
measuring the EPR signal from detectors irradiated to known doses
in a large 60Co field under conditions of Charged Particle Equilibrium.
Sanches-Doblado et al. [2003] demonstrated that the beam energy
spectrum are significantly different for small field sizes compared to a
10×10 cm2 field size situation. For small field sizes, lateral CPE does
not even exist along the CAX and Li et al. [1995] found that it requires
a field diameter of at least 2.6 cm to have lateral CPE along the CAX
in a 6 MV photon beam. The photon spectrum emitted by the linac
will also differ between small and large field sizes due to differences
in scatter contribution [Sanches-Doblado et al., 2003]. Moreover, the
perturbation on the field by the detector itself becomes increasingly
important with decreasing field size [Das et al., 2008]. The energy
dependence of alanine in the MV photon range has been studied pre-
viously (Anton et al. [2008]; Bergstrand et al. [2003]; Waldeland and
Malinen [2011]; Zeng et al. [2004]), but the studies have been limited
to situations under which reference conditions apply (i.e. large fields,
high dose, low gradient, CPE), which may not be the case in IMRT
and small fields.
In small–field MV photon beam dosimetry (e.g. output factor mea-
surements), the general aim is to determine the absorbed dose, D,
at a single mathematical point. Alanine detectors, however, have a
finite size and they therefore provide an average dose over the de-
tector volume, D [Aspardakis et al., 2010]. For large, homogeneous
irradiation fields, D and D are identical, but for small fields, correction
factors are needed to estimate D from D. The volume averaging effect
can be eliminated if the detector is made sufficiently small or if the
EPR–spectrometer only reads parts of the detector signal [Anton et al.,
2011].
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Two important factors that influences the dose to the detector com-
pared to that of water are: i) the energy dependence of the active part
of the detector material and ii) the perturbation of the beam induced
by the detector itself. In this work the ratio of the volume–averaged
dose to the alanine detector versus the volume–average dose over a
voxel of water of the same size as the detector (f ≡ Dalan/DH2O)
was studied as function of detector and field size and depth. This was
accomplished by Monte Carlo simulation of the relevant geometries
in a 6 MV photon beam.
Harwell alanine probes (batch AM 576C) (Harwell Dosimeters, Har-
well, UK) were considered as these are used by the authors for dose
measurements. The nominal composition of Harwell alanine probes
(90.9% L–α–alanine and 9.1% parrafin binder) were processed through
EGSnrc (Kawrakow [2000a,b]) to compute interaction cross sections.
The density was determined by weighing and measuring 15 probes
from the same batch and found to be ρ=1.24 gcm−3.
DOSrz was employed to score the dose to an alanine voxel (Dalan)
in an otherwise homogeneous water phantom with an outer radius of
20 cm. Each simulation geometry was reproduced for a homogeneous
water phantom, using the same dimensions, and thereby obtaining
the dose to water, DH2O. The center of the alanine/H2O voxel, where
the dose was recorded, was located at a depth of 10 cm on the central
axis. The 6 MV photon spectrum previously published by Mohan et al.
[1985] was used as the input for the simulation throughout the study.
The advantage of using this spectrum is that it is well documented
and public available as it is distributed with EGSnrc. Moreover it is
computationally efficient to use a spectrum file, rather than a phase
space file and/or a beam treatment head simulation, as input to
DOSrz. The spectrum in question corresponds to the bremsstrahlung
spectrum for a 10×10 cm2 field emitted by a Varian Clinac (in 6 MV
mode). The spectrum file was used in combination with DOSrz source
0 (i.e. parallel beam incident from the front). The number of histories
were chosen so that the statistical uncertainty was no larger than 0.4%
in the voxel of interest. The only variance reduction turned on was
photon forcing (for the first generation particles only) and cut off
energies were 521 keV (including rest mass) and 10 keV for electrons
and photons, respectively.
The ratio of volume averaged doses f ≡ Dalan/DH2O was stud-
ied as function of the field diameter for two different detector sizes
i.e. with detector diameter (ø) and height (h): (ø,h)=(5,2.5) mm and
(ø,h)=(1,2.5) mm, respectively (figure 78). A correction factor of f ≈
0.98 is needed to correct Dalan to DH2O for fields with a diameter of
≈ 1 cm and above for both detector sizes. However, f increases more
rapidly for the larger detector as the field diameter decrease below
1 cm, e.g. f ≈ 1.03 and f ≈ 1.00 for a field diameter of 0.5 cm for the
larger and smaller detector, respectively.
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Figure 78: The ratio of volume averaged doses, f, as function of field diame-
ter for two detector sizes. f ≈ 0.98 for fields with a diameter of ≈ 1
cm and above. Error bars are the combined statistical uncertainty
of the MC simulations.
In order to further study the dependency of f on field– and detector
size, f was evaluated for a range of detector sizes for three field
diameters: 0.5, 1.0, 4.0 cm (Figure 79). For the two largest fields f ≈ 0.98
for all detector sizes except, possibly, for the smallest detector (ø=1
mm). However, for the smallest field size (0.5 cm) f increases with the
detector diameter, illustrating that the detector needs to be very small
for such a small field size.
In order to evaluate whether f is depth dependent, f was evaluated
as a function of depth for a 10 cm diameter field and a detector size of
(ø,h)=(5,2.5) mm (figure 80). f is fairly constant for depths >1 cm, but
deviates for shallower depths. A correction factor of 0.9779(±0.0067)1
was found for depths >1 cm. A ratio of volume averaged doses of
0.9779 is on the order of what to be expected when looking at ala-
nine/water restricted mass stopping power ratios and mass energy
absorbtion coefficient ratios.
A depth independent detector is a much desired feature as mea-
surements may be conducted at any depth without additional con-
siderations. Depth invariance is to be expected as alanine is rather
1 The reported uncertainty is the standard deviation of the average value for depths
>1 cm.
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Figure 79: The ratio of volume averaged doses, f, as function of detector
diameter (ø) for three field sizes. f is fairly constant over the range
of detector sizes for the larger two field sizes whereas this does not
hold true for the smallest field size. Error bars are the combined
statistical uncertainty of the MC simulations.
water equivalent. For the shallowest depth, however, f was ≈ 1.01.
This might be due to the substantially different energy spectrum at
such a shallow depth. The result may not be accurate as contaminat-
ing electrons, which contribute to the dose at shallow depths, were
omitted in the simulation. The impact of contaminating electrons on f
for shallow depths was not further studied.
If alanine is to be used as a detector for radiotherapy the correction
factor f needs to be constant or its variation known. Obviously, in the
ideal case f is constant and thus calibrated out of the equation and one
does not need to think further thereof. Second best, is that its variation
as function of e.g. field size and detector size is known. The results
of this study illustrates that f is constant for a large range of field
sizes, detector sizes and depths. However, as the field size becomes
of the order of the detector size or the field size becomes very small
(e.g. a diameter of 0.5 cm) this breaks down. The detector cannot be
made infinitely small. One practical obstacle is that the handling of the
detector becomes cumbersome if it is too small and further the signal
to noise ratio gets lower as the detector becomes smaller. However, a
detector size of (ø,h)=(5,2.5) mm is easily handled and as illustrated
f is constant down to field sizes of the order of ø=1 cm for such a
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Figure 80: The ratio of volume averaged doses, f, as function of depth (d)
for a field with a diameter of 10 cm and detector size (ø,h)=(5,2.5)
mm. The ratio of volume averaged doses, f, was fairly constant at
depths >1 cm, with an average of ≈ 0.98. For the shallowest depth
(0.5 cm), a value of ≈ 1.01 was needed in order to correct Dalan
to DH2O. Error bars are the combined statistical uncertainty of
the MC simulations. The average f for 1 6 d 6 15 cm is included
in the figure (dashed line).
detector size. This will most likely be sufficient for most applications
within radiotherapy. Even for field sizes of this order, and certainly
for smaller field sizes, other problems arise anyhow such as position
inaccuracies of the detector in the beam. For instance, Beierholm et al.
[2011] states that a 1 mm misalignment between the isocenter and a 1
mm wide scintillator probe for a 0.6×0.6 mm2 square field leads to a
dose measurement error (at 20 cm’s depth) in the order of 6%.
This work demonstrates that f is constant for a large range of depths,
detector– and field sizes. This range is sufficient for most applications
in radiation therapy. Thus, only in extreme cases are f of concern in
dosimetry for radiotherapy and in those cases can f potentially be
determined by Monte Carlo simulations.
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O N T H E P O T E N T I A L U S E O F A N A L A N I N E - B A S E D
P R O T O C O L F O R S M A L L F I E L D R E L AT I V E O U T P U T
FA C T O R D E T E R M I N AT I O N I N H I G H E N E R G Y
P H O T O N B E A M S
Dosimetry in small fields is problematic for a number of reasons
[Aspardakis et al., 2010]. A trivial, but important, reason is that the
positioning of the detector device becomes increasingly important
when the field size decreases. For a 10×10 cm2 field a displacement
of 1 mm will not significantly influence the detector signal, but for a
field size of 0.6×0.6 cm2 it can lead to a signal decrease in the order
of 6% [Beierholm et al., 2011]. The purturbation introduced by the
detector becomes increasingy apparent with decreasing field sizes,
this is further enhanced if wires or cables are attached to the detec-
tor. Furthermore, as the size of the field becomes comparable to the
range of the secondary electrons lateral CPE is no longer fulfilled [Liu
et al., 1997]. Loss of lateral CPE leads to changes in the fluence spectra
compared to a 10×10 cm2 field which typically is used as a reference
[Sanches-Doblado et al., 2003; Yin et al., 2004]. The change in the flu-
ence spectra is not a dosimetrical issue per se, however many detector
systems are calibrated, and thus only valid, using a fluence spectra
corresponding to that of a 10×10 cm2. Moreover, the photon fluence
spectra will change with field size, due to beam hardening effects and
different scatter contributions. Chosing a detector material with high
water equivalence implies that it also is insensitive to changes in the
fluence spectra. Moreover, the perturbation effect decreases for highly
water equivalent detector materials. Loss of lateral CPE also has im-
plications in terms of the so called volume averaging effect. The dose
reading of a detector will be the average signal over the entire sensitive
volume. This is a non–issue in the case of a 10×10 cm2 field since the
lateral profiles are flat. However, as the field size grows smaller, the
lateral penumbra regions will be more centrally located. When lateral
CPE is lost, the opposing penumbrae will overlap resulting in dose
gradients over the entire lateral dose profile. As the dose at a specific
point typically is what is sought after, this becomes an issue since the
average dose over the sensitive volume of the detector no longer will
be representative of the point dose.
Figure 81 shows restricted mass Stopping Power Ratio and mass
energy absorption coefficient ratios, compared to water, for a range
of common detector materials. It can clearly be seen that alanine
indeed is a potentially suitable detector material since it is highly
water equivalent in terms of restricted mass stopping power and mass
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Figure 81: Top panel: Mass Stopping Power Ratio for a range of common
detector materials compared to water. Bottom panel: Mass en-
ergy absorption coefficient ratios for a range of common detector
materials compared to water. Data taken from NIST [2011b,c]
energy absorption coefficient. Moreover, it is possible to fabricate
alanine detectors in small sizes.
Monte Carlo has the potential to overcome all of the above men-
tioned issues, since an ideal detector can be defined for any given
situation. However, an MC model is often calibrated using measure-
ments of large field only and is not necessarily validated for small
fields. Moreover, the validity of an MC model is limited to the specific
linac it is calibrated against. Therefore, a more practical approach is
to conduct MC simulations of a measurement system and validate the
results by measurements on the very same linac. Concurrent results
should give confidence of the validity of the measurement system,
which in turn can be used for measurements on any given linac.
In this chapter such a comparison will be conducted for an alanine/EPR
dosimetry system on a Varian 2300 iX linac, which has been accurately
modeled and validated for MC (see Chapter 3).
9.1 alanine measurements
Alanine dosimeters from Harwell Dosimeters (Batch AM576C) were
used. These dosimeters consisted of 90.9% L–α–alanine and 9.1%
parrafin binder. The cylindrical dosimeters were 4.83 mm in diameter
and 2.54 mm in thickness1.
Measurements were conducted on a Varian 2300 iX linac located
at the Copenhagen University Hospital, Herlev. All measurements
were conducted with the linac operating in 6 MV mode and with the
dose repetition rate set to 600 MU/min, which corresponds to the
maximum dose repetition rate. Gammex 457 solid water slabs with a
total outer dimension of 30×30×30 cm3 were placed at the table top.
1 The physical dimensions were measured for 15 individual dosimeters and the varia-
tion were ±0.00 mm and ±0.02 mm in diameter and thickness, respectively.
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Figure 82: Schematic illustration of the modifications made on Gammex 457
solid water Farmer chamber dummy. All measures are in mm
In order to increase friction and thereby reduce the risk of the phantom
moving during and/or between irradiations, a rubber mat was placed
under the bottom solid water slab. The phantom was positioned at
a SSD of 90 cm using a front pointer attached to the linac head. The
Gammex 457 slabs were arranged so that a 10 cm thick slab, with a
hole suited for a Farmer ionization chamber insert, was located with
its hole at 10 cm depth (i.e at the beam isocenter). The arrangement
was conducted so that a Farmer chamber insert could slide in and out
of the phantom without disturbing the positioning.
A Gammex 457 solid water Farmer chamber dummy was modified
so that it could house three alanine dosimeters (Harwell Dosimeters
Batch AM576C) (Figure 82). A single alanine dosimeter was placed
in the holder, surrounded by disks of Gammex 457 ensuring that
the entire cavity was filled. The alignment with the beam CAX was
conducted by replacing the alanine dosimeter with an in–house made
lead marker of the same dimensions. The Farmer chamber dummy,
with the lead marker inserted, was positioned in the phantom and
the phantom was approximately aligned with the beam CAX using
the treatment room laser guide markers. The OBI system was used
to take a portal image of the phantom. The high density lead marker
was highly visible on the portal image and was aligned with the field
center by carefully repositioning the phantom. A second portal image
was acquired in order to verify the positioning. If the lead piece still
was not aligned with the beam isocenter, the procedure was reiterated
until agreement. The positioning procedure was conducted for the
smallest (i.e. 0.6×0.6 cm2) field size.
Each individual dosimeter was irradiated to a dose in the range of
10 Gy, using estimated Relative Output Factors. The number of MUs
was logged for later purposes. Three consecutive measurements were
conducted for each measurement and the 10×10 cm2 was repeated
three times during the measuring session.
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9.2 epr spectroscopy
The EPR spectroscopy was conducted in accordance with the method
described in Helt-Hansen et al. [2009]. A Bruker EMX–micro EPR
spectrometer (Bruker, Billerica, MA, USA) was used for measurements
of the alanine dosimeters. The alanine resonance spectra were acquired
by placing the individual dosimeters in a quartz tube which was
positioned in the rectangular cavity of the spectrometer. For each
dosimeter, six repeated scans were conducted prior to removing the
dosimeter from the cavity. The acquisition parameters were:
microwave power: 9.0 mW
modulation amplitude: 1.0 mT
time constant: 20.5 ms
conversion time: 20.5 ms
The resonance spectrum of un–irradiated, control, dosimeters are
subtracted from the dosimeters in order to produce background free
spectra. The central peak position is determined from a spectrum from
a dosimeter irradiated to a known dose (100 Gy). The EPR intensities
between the central peaks of the dosimeter in question is plotted as a
function of the corresponding intensities of the EPR spectrum of the
reference dosimeter. A slope is found by performing a least–square
fit to a linear function of the part of the curve that is most linear (i.e.
yields the highest R2 value). The absorbed dose is then determined by
multiplying the amplitude of the slope with the known dose.
The mass of each individual dosimeter is taken into account when
computing the dose of a given dosimeter. The dose is then normalized
by the MUs the individual detector was irradiated to. As demonstrated
in Chapter 8, no field size specific correction factor is needed over the
range of field sizes studied (with a possible exception for the smallest
field size).
9.3 monte carlo simulation
EGSnrc (Kawrakow [2000a,b]) was used to compute interaction cross
sections for the alanine dosimeters and the Gammex 457 solid water
material. The nominal composition of Harwell alanine probes (90.9%
L–α–alanine and 9.1% parrafin binder) was used and the density was
determined by weighing and measuring 15 probes from the same
batch and found to be ρ=1.24 gcm−3. For the Gammex 457 phantom,
calibration protocols of the actual Gammex 457 phantom slabs used
during the measurements were used to determine the composition
and density.
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Table 17: Relative Output Factor measured with alanine/EPR and IC for
a range of field sizes. The alanine/EPR measurements were con-
ducted in Gammex 457 solid water whereas the IC measurements
were conducted in liquid water. The difference was calculated as
(ROFalanine-ROFIC)/ROFIC*100.
Field size ROF Difference
(cm2) Alanine ICt (%)
10×10 1.000 1.000 —
8×8 0.963 0.963 0.0
5×5 0.887 0.891 -0.5
3×3 0.824 0.827 -0.4
A Gammex 457 phantom with outer dimensions of 30×30×30 cm3
with an alanine dosimeter (2.54×4.83×4.83 mm3) placed at 10 cm
depth along the central line of the phantom was defined. Simula-
tions were conducted using DOSXYZnrc2. The linac model defined
in BEAMnrc corresponded to the Varian 2300 iX linac used during
mesurements (see Section 3.3). The center of the alanine dosimeter
was defined to be at the beam isocenter and at an SSD of 90 cm. The
BSF was accounted for using relative Itarget measurements as described
in Section 5.1.1.
9.4 resutls
The results of the alanine measurements were initially validated
against IC measurements3 for field sizes in the range of 10×10 to
3×3 cm2 (Table 17). Agreement within 0.5% was found.
The comparison between simulated and measured ROFs is shown in
Table 18. The agreement was generally within 2%. However, statistical
significant difference was found for all field sizes 6 2.5×2.5 cm2. The
2 The number of histories were chosen so that the statistical uncertainty for the alanine
voxel was ≈0.3%. Simulation properties were ECUT = 521 keV, PCUT = 10 keV, nsplit
= 25, esplit = 25. The treatment head was simulated using source 9 in DOSXYZnrc.
Simulation properties were ECUT = 700 keV, PCUT = 10 keV, direction bremsstrahlung
splitting was used (FS, defined at SSD = 100 cm, was set equal to the side length of
the square field for field sizes > 5×5 cm2 and to 5 cm otherwise), NBRSPL was set
to 1000, with the splitting plane for electrons (ZPLANE_DBS) defined as the bottom
of the flattening filter and russian roulette conducted for electron at a plane 0.20 cm
above the bottom of the flattening filter.
3 Measurements were with a Wellhöfer/IBA CC13 (IBA Dosimetry AB, Uppsala, Swe-
den) Ionization Chamber (0.13 cm3 active volume) in a Blue Phantom (IBA Dosimetry
AB, Uppsala, Sweden) 48×48×48 cm3 water tank (± 0.1 mm position accuracy) and
the data acquisition was controlled by the OmniPro Accept v.6.5A (IBA Dosimetry
AB, Uppsala, Sweden) software. An SSD of 90 cm was used and the measurements
were conducted at 10 cm depth.
156 on the potential use of an alanine-based protocol for small field relative output factor determination in high energy photon beams
Table 18: MC simulated and measured ROFs for a range of field sizes. The re-
ported uncertainties computed using common uncertainty propaga-
tion considering the statistical uncertainties for the individual simu-
lations combined with the uncertainty of the relative Itarget measure-
ment for MC and the standard deviation of measurements for the
field in question as well as the reference field (10×10 cm2). The dif-
ference was calculated as (ROFMC-ROFmeasured)/ROFmeasured*100.
Field size ROF Difference
(cm2) MC Alanine (%)
10×10 1.000(±0.005) 1.000(±0.015) —
5×5 0.895(±0.004) 0.887(±0.007) 0.9(±1.1)
3×3 0.834(±0.003) 0.824(±0.007) 1.2(±1.4)
2.5×2.5 0.818(±0.004) 0.804(±0.008) 1.8(±1.6)
2×2 0.793(±0.003) 0.781(±0.003) 1.5(±0.8)
1.5×1.5 0.756(±0.005) 0.749(±0.001) 0.9(±0.7)
1×1 0.660(±0.002) 0.672(±0.003) -1.8(±1.1)
0.6×0.6 0.460(±0.001) 0.503(±0.005) -8.5(±3.3)
actual position of the jaw collimators was not not monitored during
the measurements, thereby there is an uncertainty on the field size
that is not accounted for. The relative uncertainty will increase as the
field size decreases. This does not explain the 8.5% deviation for the
smallest field size, nor can it be explained by a positioning error since
the alignment was conducted for that very field setting. Part of the
discrepancy might be due to differences between the actual geometry
and that modeled in the simulation. Particularly the dosimeter which
in the simualtion is modeled as a cube, wheras it in fact is a cylinder.
The deviation can be explained by the inhomogene sensitivity profile
over the EPR cavity used (see Figure 83). The sensitivity profile is
unimportant if the dosimeter is homogeneously irradiated, but becoms
importat if a dose graident is present over the detector volume. This
is indeed the case for field sizes < 3×3 cm2 and as a consequence the
dose reported by the EPR spectroscopy will overestimate the dose. In
order to correct for the inhomogeneous sensitivity profile one would
have to know the exact shape of the dose profile, which, for the reasons
discussed on page 151, is not easy to measure accurately for small
fields.
9.5 conclusions
Alanine/EPR measured ROFs agreed well with ROFs measured with
an IC as well as with MC simulations in the field size range 10×10
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Figure 83: The sensitivity profile, normalized at the center of the cavity, at
the horizontal plane for a Bruker EMX–micro EPR spectrometer
cavity. The data were provided by Bruker.
to 3×3 cm2. For smaller field sizes significant differences between
measurements and MC simulations were observed. The deviation was
largest for the smallest field sizes. The deviation can, at least partly, be
explained by the inhomogeneous sensitivity profile of the EPR cavity.
Results of alanine/EPR dosimetry needs to be corrected for if the dose
gradient over the detector becomes apparent. This is by no means a
trivial correction as the actual dose profiles needs to be known.
Alanine/EPR dosimetry is suitable for field sizes where the dose
profile over the detector is homogeneous, i.e. > 3×3 cm2 for 6 MV
photon beams. For smaller field sizes, correction factors that are not
commonly know or easily derived.
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cancer is investigated using Pareto front analysis. The included dose
calculation algorithms are the Pencil Beam Convolution algorithm, the
Analytical Anisotropical Algorithm and Monte Carlo.
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Abstract
The pencil beam dose calculation method is frequently used in modern
radiation therapy treatment planning regardless of the fact that it is documented
inaccurately for cases involving large density variations. The inaccuracies
are larger for higher beam energies. As a result, low energy beams are
conventionally used for lung treatments. The aim of this study was to analyze
the advantages and disadvantages of dynamic IMRT treatment planning for high
and low photon energy in order to assess if deviating from the conventional low
energy approach could be favorable in some cases. Furthermore, the influence
of motion on the dose distribution was investigated. Four non-small cell lung
cancer cases were selected for this study. Inverse planning was conducted
using Varian Eclipse. A total number of 31 dynamic IMRT plans, distributed
amongst the four cases, were created ranging from PTV conformity weighted to
normal tissue sparing weighted. All optimized treatment plans were calculated
using three different calculation algorithms (PBC, AAA and MC). In order to
study the influence of motion, two virtual lung phantoms were created. The
idea was to mimic two different situations: one where the GTV is located
centrally in the PTV and another where the GTV was close to the edge of the
PTV. PBC is in poor agreement with MC and AAA for all cases and treatment
plans. AAA overestimates the dose, compared to MC. This effect is more
pronounced for 15 than 6 MV. AAA and MC both predict similar perturbations
in dose distributions when moving the GTV to the edge of the PTV. PBC,
however, predicts results contradicting those of AAA and MC. This study
shows that PB-based dose calculation algorithms are clinically insufficient for
patient geometries involving large density inhomogeneities. AAA is in much
better agreement with MC, but even a small overestimation of the dose level
by the algorithm might lead to a large part of the PTV being underdosed. It
is advisable to use low energy as a default for tumor sites involving lungs.
However, there might be situations where it is favorable to use high energy.
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In order to deviate from the recommended low energy convention, an accurate
dose calculation algorithm (e.g. MC) should be consulted. The study underlines
the inaccuracies introduced when calculating dose using a PB-based algorithm
in geometries involving large density variations. PBC, in contrast to other
algorithms (AAA and MC), predicts a decrease in dose when the density is
increased.
(Some figures in this article are in colour only in the electronic version)
1. Introduction
Pencil beam (PB) dose calculation algorithms are the most widespread in modern treatment
planning for radiation therapy. The accuracy of these algorithms is in many cases sufficient
and the difference in dose distribution calculated with PB and more sophisticated methods
such as Monte Carlo (MC) is not of clinically importance. However, in cases involving
significant density variations, such as metal implants, air cavities and low density lung tissue,
the inaccuracies in dose distribution calculated with the PB algorithms may become clinically
significant. The accuracy of the PB algorithms depends on several parameters such as beam
energy, field size and geometry as reported in numerous studies (e.g. Behrens (2006), Klein
et al (1993), Tsiakalos et al (2006), Vanderstraeten et al (2006), Krieger and Sauer (2005)).
PB dose calculation algorithms are, nevertheless, frequently used for lung cancer treatment
planning. If PB-based treatment plans generated with high and low energy (e.g. 15 or 18 MV
and 4 or 6 MV, respectively) are compared, the high energy-based dose distributions will in
many cases appear more favorable. However, it is well known that the inaccuracies introduced
by the PB dose calculation in general are larger for higher energies. As a result, low energy-
based treatment plans are chosen as default for lung treatments. This begs the question whether
this is always the best choice. For some cases, treatment plans based on higher energies may
be more favorable. In order to address this question, more accurate dose calculation methods
(e.g. MC) must be employed. Studies aiming at this have been published (e.g. Tsiakalos et al
(2006), Vanderstraeten et al (2006), Krieger and Sauer (2005), McDermott et al (2003), Weiss
et al (2007), Madani et al (2007)). However, only a few involve MC calculation methods for
IMRT treatment planning (e.g. Vanderstraeten et al (2006), McDermott et al (2003), Madani
et al (2007)) and most consider static as opposed to dynamic IMRT.
The aim of this study was to analyze the advantages and disadvantages of high and low
photon energy dynamic IMRT treatment planning for lung tumors. Furthermore, the influence
of motion on the dose distribution was investigated.
PB and a more sophisticated dose calculation algorithm, the anisotropic analytical
algorithm (AAA), were compared to MC-based dose calculations utilizing a Pareto front
comparison method (Ottosson et al 2009, Steneker et al 2006). The general idea of this concept
is to compare sets of plans, belonging to different classes (e.g. high versus low energy) as
opposed to a traditional plan-to-plan comparison procedure. Comparative treatment planning
has hitherto often been rather inconclusive. For instance, when comparing different IMRT
delivery techniques (e.g. step&shoot versus sliding windows), it may have been found that
one of the techniques is capable of better target coverage, while the other is better at sparing
risk organs. This leaves room for a subjective interpretation. By sampling the entire Pareto
front for a case, it may be possible to make a much more just and comprehensive comparison
of the two systems. Utilizing this concept elements such as treatment planner dependence and
misfortunate plan selections can be minimized.
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Figure 1. NSCLC cases (A)–(D). Transversal and coronal CT slices, illustrating the tumor location
and extension. Red and light blue lines are delineations of the GTVs and PTVs, respectively.
2. Materials and methods
Four non-small cell lung cancer (NSCLC) cases, with apparent differences in tumor location,
were selected for this study (figure 1). The cases exhibited geometrical properties where one
could expect a significant discrepancy between analytical and MC dose calculation algorithms.
CTV and OAR were delineated by a radiologist. PTV margins were added in accordance with
the protocol used at Copenhagen University Hospital Herlev.
2.1. Treatment planning
For inverse planning, Varian EclipseTM build 8.2.24.10720 (Varian Medical Systems, Inc.,
Palo Alto, CA, USA) modeling a Varian 2300 iX (Varian Medical Systems, Inc., Palo Alto,
CA, USA) was used.
35 × 2 Gy was prescribed to the PTV and a maximum dose constraint of 45 Gy was
applied to the spinal cord. The lungs were assigned a dose volume constraint of V20 6 50%,
while the constraints for the heart were V30 6 100%, V45 6 65% and V60 6 25%.
As an initial step of the treatment planning, the optimal numbers of beams, gantry and
collimator angles were determined individually for each case and energy (6 and 15 MV)
by Varians geometrical optimization module utilizing the plan geometry optimization (PGO)
algorithm (Varian Medical Systems 2007). The PGO takes the specific geometry of the case
and the DVO constraints into account.
Hereafter, a number of isocentric dynamic (sliding window) IMRT treatment plans,
ranging from PTV conformity weighted to normal tissue sparing weighted, were created for
each case and beam energy. Thus, the PTV coverage, from one plan to the next, deteriorated
as sparing of the normal tissue in general, and the lungs specifically, increased. In total 31
treatment plans, distributed amongst the 4 cases, were created. For the optimization, a PB
algorithm was used as Eclipse offers no other option.
Full dose calculation was undertaken for each treatment plan, employing the Eclipse
pencil beam (PBC) algorithm and the AAA using identical MLC settings and monitor units.
2.2. Monte Carlo modeling
EGSnrc and BEAMnrc (Kawrakow 2000a, 2000b, Rogers et al 2005) were used to build and
commission Monte Carlo models for each energy of the Varian 2300 iX linear accelerators
(6 and 15 MV). The commissioning procedure utilized the same measurements as the
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configuration and commissioning of the PBC and AAA algorithms for the TPS. The MC
commissioning followed the protocol suggested by Pena et al (2004), where the general idea
is to compare simulated central-axis (CAX) depth–dose profiles and lateral dose profiles to
corresponding measurements. The commissioning procedure included 10 × 10 and 20 ×
20 cm2 open fields in water. Furthermore, the MC model was tested for a large number
of quadratic and rectangular field sizes ranging from 3 × 3 to 30 × 30 cm2. Once a
satisfactory agreement between simulations and measurements was obtained, BEAMnrc was
used to simulate the treatment head. A phase space file (PHSP) was scored just below the
flattening filter for each beam energy. The PHSPs were scored by simulation of 2.5 × 106
histories with cut off energies of 521 keV (including rest mass) and 10 keV for electrons and
photons, respectively. Directional bremsstrahlung splitting was turned on, using the following
parameters: SSD = 100 cm, NBRSPL = 1000 (maximum splitting factor) and FS = 30 cm
(radius of field into which bremsstrahlung photons must be directed if they are to be split).
In order to maintain good electron statistics in the build up region, Russian roulette was
switched off.
The beam modifiers were simulated in MCSIM (Jin et al 2007, Ma et al 2002), using
the PHSP as a source input. Since the MLC geometry in MCSIM is hard coded, employing
a set of specific input parameters (inter- and intra-MLC leaf leakage), it was commissioned
separately. Specifically, a field with fully closed leaves was compared with film measurements.
GafChromic EBT film (International Specialty Products, NJ, USA) was placed at 5 cm depth
in a Gammex 457 solid water phantom (Gammex–RMI, Nottingham, UK) with an SSD of
95 cm. The field size was 10 × 30 cm2 and all leaf pairs were fully closed 10 cm off CAX.
Corresponding simulations were performed, using a voxel size of 2.0 × 0.1 × 0.5 cm3 for
9 × 109 histories with cut off energies of 521 keV (including rest mass) and 10 keV for
electrons and photons, respectively. The only variance reduction technique switched on was
IETRACK (electron track repeating).
2.3. Monte Carlo simulations
Voxalized phantoms were created via the DICOM RT toolbox (Spezi et al 2002) using the
planning CT set as input. The phantom grid was matched to the dose grid of the treatment
planning system (TPS). For two of the cases (A and C), the CT slice thickness was larger than
the dose grid spacing. The voxel sizes were expanded, in the slice direction, to match the CT
scan grid for those cases. The final voxel size was 2.5 × 2.5 × 2.5 mm3 and 2.5 × 2.5 ×
5.0 mm3 for cases B and D, and cases A and C, respectively. A set of in-house MATLAB scripts
was used to generate input files for MCSIM from the DICOM RP files. Thus, all parameters
of the treatment plans were recreated in the simulations. The treatment plan simulations were
performed in MCSIM using the BEAMnrc-simulated PHSP as a source input. A total number
of 1×109 histories was simulated for each treatment plan, resulting in a statistical uncertainty
of 0.3–0.6% at the global dose maximum. Particles in the PHSP may originate from the same
primary electron and thus be correlated. A latent variance (Sempau et al 2001) in the PHSP
may propagate to the final dose calculations leading to an underestimation of the uncertainty
(Walters et al 2002). This was not taken into account in the reported MC uncertainties. The
probability of two correlated PHSP particles depositing dose in the same voxel is difficult to
estimate, but considered small. In order to minimize the effect of the propagation of latent
variance no phase space particle was used more than once, for each field, during the patient
simulations. Cut off energies and variance reduction techniques were applied as described
in subsection 2.2. Backscatter corrections were calculated for each field using the formalism
described by Liu et al (2000).
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Since the TPS reports dose to water and MC dose to media, a conversion was necessary
in order to ensure a fair comparison. The procedure suggested by Siebers et al (2000) as
implemented in the DICOM RT toolbox was employed in order to convert the MC-calculated
dose into dose to water.
2.4. Evaluation
All algorithms (PB, AAA and MC) used identical setups for each treatment plan and all
differences in the resulting dose distributions were solely due to discrepancies between the
dose calculation algorithms. For each treatment plan and algorithm, dose–volume histograms
(DVHs) were created. The DVHs were used to evaluate the volume of the PTV receiving
less than 95% of the prescribed dose
(
1 − V PTV95
)
. The lung normal tissue complication
probability (NTCP) for pneumonitis was calculated using an equivalent uniform dose (EUD)-
based formalism (Gay and Niemierko 2007). The parameters used for the NTCP calculation
were a = 1, γ 50 = 2, TD50 = 24.5 Gy and α/β = 3 Gy, as suggested by Gay and Niemierko
(2007). In order to visualize the comparison between energies and algorithms, Pareto fronts
based on
(
1 − V PTV95
)
and the lung NTCP were produced for all algorithms and cases.
2.5. Influence of motion
The GTV and CTV move within the PTV due to respiratory motion and other anatomical
changes. Usually part of the PTV receives less than the prescribed dose. Thus, part of the
GTV and CTV might be underdosed. However, the dose distribution is perturbed due to
motion of the GTV and CTV. In order to study this effect, two phantoms (PhA and PhB) were
created in the TPS and for MC dose calculations (figure 2). In PhA the GTV was located in
the center of the PTV while for PhB the GTV was moved 1.5 cm in three dimensions to the
corner of the PTV (figure 2). The Hounsfield units (HU) for the lungs were set to −800 while
HU = 0 was used for the rest of the phantoms, including the GTV. This corresponds to the
densities of ∼0.2 g cm−3 and ∼1 g cm−3, respectively.
One 6 MV dynamic IMRT treatment plan (TPPh) was generated. In order to stress the
optimization algorithm similar to a clinical situation, cubic optimization structures mimicking
the heart and the spine were utilized in addition to constraints for the lungs and PTV. TPPh
was normalized to 35 fractions of 2 Gy mean dose to the PTV, based on the PBC calculation.
Final dose calculation of TPPh was undertaken for PBC, AAA and MC on both phantoms.
The volume containing the solid tumor in PhA is denoted as GTVA while the volume
containing the solid tumor in PhB is denoted as GTVB. Thus, the HU for GTVA on PhA
is GTVAHU|PhA = 0 and GTVBHU|PhB = 0. Since the overlap between GTVA and GTVB
is 12.5% of the GTV volume, the HU for GTVA on PhB is GTVAHU|PhB = −800 and
GTVAHU|PhB = 0 for 87.5% and 12.5% of the GTVA volume, respectively (and analogously
for GTVB on PhA).
The same MC settings, except the number of histories, as in the patient treatment plan
simulations were used in the phantom study. In total 2 × 109 histories were simulated for
each plan. This together with the fact that only five fields were utilized in the phantom study
caused a restart of the PHSP twice per field. Thus, the uncertainty in the uncertainty estimate
is larger. Nevertheless, the uncertainty in the calculated dose is expected to be less than or
equal to that obtained for the patient simulations.
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Figure 2. Superimposed illustrations of the two lung tumor phantoms PhA and PhB. For PhA the
lower red cube represents the GTV in the center of the PTV (black line), while for PhB the GTV
is displaced 1.5 cm cranial, right and anterior to the corner of the PTV. HU = −800 in the lungs
and HU = 0 for the rest of the phantoms (including the GTV). The phantoms measure (left/right,
anterior/posterior, cranial/caudal): 33 × 19 × 29 cm3, the lungs: 9 × 13 × 20 cm3 and the GTV
3 × 3 × 3 cm3. The beam arrangement for the treatment plan (TPPh) used is also visible in the
transverse plane.
3. Results and discussion
3.1. Monte Carlo model
The combination of the incident electron beam parameters resulting in the best fit to
measurements was found to be 6.0 MeV; 3%; 0.05 cm and 14.4 MeV; 3%; 0.12 cm
(mean electron energy; FWHM Gaussian energy spread; target spot size) for 6 and 15 MV,
respectively. For the CAX depth–dose profiles, agreement was within 2% beyond 1.2 cm for
both energies (figure 3). For the lateral dose profiles, 98.2% and 100% of the data points
were within 2%/2 mm (dose difference/distance to agreement) for 6 and 15 MV, respectively,
for doses higher than 15% of the maximum dose (Dmax(d)) for that depth (figure 3). The
corresponding percentages were 98.2; 90.5 and 98.8; 91.7 for 1.5%/1.5 mm and 1%/1 mm
for 6 and 15 MV, respectively. For comparison, the PBC and AAA algorithms agreed with
the measurements within 2% for the CAX depth–dose profiles beyond 0.6 cm and 0.9 cm
for 6 and 15 MV, respectively, whereas for the lateral dose profiles, agreement was within
2%/2 mm for doses higher than 15% of Dmax(d).
The inner 40 leaf pairs of the Varian Millennium 120 leaf MLC are arranged in an
alternating pattern of two leaf types. This design results in transmission and leakage profiles
resembling a saw-blade pattern with alternating tooth heights (Heath and Seuntjens 2003,
Siebers et al 2002) as seen in the film measurements (figure 3). The effect was most
distinguished for 6 MV. Due to limitations in leaf shape modeling, the MC simulations
did not reproduce this pattern. However, the average leaf leakage effect agreed well between
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Figure 3. Top left: CAX depth–dose profiles for 10 × 10 and 20 × 20 cm2 square fields for 6 MV
(black: left to right) and 15 MV (red: right to left). Top right: lateral dose profiles for a field with
a fully closed MLC. The film measurements illustrate a leaf pair effect (most distinguished for
6 MV) that was not reproduced by the MC simulations. Bottom (left 6 MV; right 15 MV): lateral
dose profiles for 10 × 10 and 20 × 20 cm2 square fields at dmax, 5 cm, 10 cm and 20 cm depth.
The left-hand side of the figures shows the 10 × 10 cm2 fields, while the right-hand side shows the
20 × 20 cm2 fields.
film measurements and simulations. The small discrepancy is unlikely to have any significant
effect on the reported DVH parameters below.
3.2. Cases A–D
The PTV coverage deteriorated as the dose to the total lung volume decreased. Thus, for a
treatment plan with high PTV conformity, the lung dose will be higher compared to a treatment
plan with a less conformal PTV dose (figure 4).
In order to visualize the comparison between energies and algorithms, the Pareto fronts
for cases A–D are shown in figure 5. The abscissa indicates the percentage of the PTV volume
that receives less than 95% of the prescribed dose
(
1 −V PTV95
)
, while the ordinate indicates the
calculated NTCP for the lungs.
Plans belonging to the same class (beam energy and algorithm) constitute the Pareto front
for that specific class, enabling comparison of class to class rather than plan to plan. Treatment
plans a and b for case A (figure 5) illustrate the potential problem in a plan-to-plan comparison
4528 R O Ottosson et al
0 20 40 60 80 100
0
20
40
60
80
100
Dose [%]
Vo
lu
m
e 
[%
]
NSCLC case A, 6 MV, PBC
PTV
Total
lung
Plan 1
Plan 2
Plan 3
Plan 4
Figure 4. The 6 MV PBC DVHs of case A. Note the deterioration of the PTV coverage as the
dose to the lungs is decreased.
study. Which one is the better plan, and should we prefer 6 or 15 MV? This question is
impossible to answer based on these two treatment plans. However, when the Pareto fronts
are plotted, it is clear that 6 MV is preferable compared to 15 MV for this case.
Considering MC as the golden standard, the inaccuracy of the other algorithms, in terms
of NTCP and PTV underdosage, is illustrated and quantified by the Pareto fronts. The results
illustrate that PBC significantly miscalculates the dose for all treatment plans, independent
of tumor geometry. AAA is in much better agreement with MC. Generally, the differences
between PBC and AAA/MC are larger for 15 MV. PBC and AAA overestimate the dose to
the PTV, compared to MC (figure 5). Even a small overestimation in dose can lead to a large
impact on
(
1 − V PTV95
)
due to the conformal nature of the dose distribution.
The dose to the total lung volume was significantly higher for case A. This is due to the
fact that the PTV in case A is located in the mediastinum and extends into both lungs. For
cases B–D, the PTV is confined to one lung, making it possible to spare the contralateral lung
to a large extent. The NTCP(lung) values for cases B–D are very low. However, plotting V20
as a function of
(
1 − V PTV95
)
yields results similar to those illustrated in figure 5 and leads to
the same conclusions. For the MC calculations, the ranges of V20 values are [34;53], [12;19],
[18;29], [21;25]%, for cases A, B, C, and D, respectively.
For cases A–C, 15 MV appears favorable as compared to 6 MV based on the PBC
treatment plans, while for case D, no significant difference is observed. However, this is not
the case as more accurate dose calculation algorithms are employed. All cases exhibit a better
combination of target coverage and NTCP(lung) for 6 MV than for 15 MV, i.e. for a range
of treatment plans, the Pareto front for 6 MV MC is closer to origin than the corresponding
15 MV MC front (figure 5). The difference is least pronounced for case C. From the treatment
plans generated, it is clear that 6 MV is more favorable than 15 MV in general.
Even though 6 MV was generally found to be more favorable for the cases studied, one
should not set aside the possibility of using higher energies, as there might be cases or classes of
cases benefiting from high energy-based treatment plans. It would be advantageous if patients
could be sorted prior to treatment planning, identifying those with potential benefit from
high energy-based treatment. Sorting criteria could include patient size and tumor location,
tumor size and proximity to other structures, etc. For example, due to the larger dose
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Figure 5. Pareto fronts for cases (A)–(D). Treatment plans a and b for case A (marked in the
plot) illustrate the potential problem in a plan to plan comparison study. Which one is the better
plan, and should we prefer 6 or 15 MV? This question is impossible to answer based on these two
treatment plans. However, when the Pareto fronts are plotted, it is clear that 6 MV is preferable
compared to 15 MV for this case.
deposition at depth, high energy-based treatment plans might be more advantageous for deep-
seated tumors. However, several other factors are important, e.g. the larger penumbra region
and primary and secondary build-up effects for the higher energy. A large secondary build-up
effect might be advantageous when a beam passing through lung enters high-density healthy
tissue, while a small build-up effect is beneficial when a beam passing through lung enters high-
density tumor tissue. Based on the present work, it has not been possible to identify suitable
sorting criteria. Possibly, too many different effects interplay and the potential benefit for a
patient is based on the exact geometry of the case including the specific beam configuration.
One might find that for some patients and a given beam configuration, high energy might be
advantageous while low energy is advantageous for another beam configuration. In fact, it
might be that some patients could benefit from a mixed energy setup, i.e. using high energy
for some gantry angles and low energy for others. This is beyond the scope of this work and
the subject of future investigations.
It is important to remember that the plans were generated utilizing the implemented
PB-based optimization algorithm in Eclipse. Thus, it is possible that better treatment plans
could be generated had MC been implemented in the optimization algorithm itself (Mihaylov
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Figure 6. Closed symbols are for PhA (central tumor, GTVAHU = 0) and open symbols are for
PhB (displaced tumor, GTVBHU = 0). For both phantoms: squares and circles represent GTVA
and GTVB, respectively.
and Siebers 2008). Moreover, it is possible that having a more precise optimization algorithm
at hand would lead to some high energy-based treatment plans being more favorable than those
based on low energy.
3.3. Influence of motion
As shown, part of the PTV may be underdosed for a given treatment plan. Neither from the
DVHs nor the Pareto fronts is it possible to evaluate where, within the PTV, the underdosage
is. However, this may be clinically important. In many cases, the underdosage is found near
the edges of the PTV surrounded by lung tissue and in the vicinity of critical normal tissue,
e.g. the heart. In principle, the underdosage only becomes a problem if the GTV or CTV at
some point during irradiation moves into the underdosed region. This can happen for several
reasons, such as setup errors, changes in anatomy and inter- and intra-fractional motion of
the GTV and CTV relative to the structures used for patient setup. For some lung patients,
respiratory intra-fractional motion of the GTV (and CTV) may be several centimeters. If a
solid tumor moves into an underdosed volume previously occupied by lung tissue, the dose
distribution will be perturbed.
When moving from PhA to PhB, which corresponds to moving the tumor from the center
to the edge of the PTV (figure 2), the PBC algorithm incorrectly predicts a decrease in dose for
GTVB (figure 6). Knowing the limitations of the PBC algorithm, this is expected. However,
the AAA algorithm as well as MC predicts an increase in dose in accordance with what is
expected based on the principles of physics. The relatively high density tumor ‘enhances’ the
dose in the volume previously occupied by lower density lung tissue (figure 7) and vice versa.
Therefore, the underdosage of the GTV, as it moves to a low dose region previously occupied
by lung tissue, will not be as large as predicted by the AAA or MC dose calculation in PhA
(table 1). Thus, the underdosage of the PTV may be less critical than predicted if only looking
at the original CT set (PhA). However, as the GTV moves into a lower dose region so may the
CTV. Volumes with a relatively low number of clonogenic cells, possibly with lower density
and incidence of hypoxic subvolumes, such as the CTV, may not require as high a dose as
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Figure 7. Dose distributions calculated utilizing PBC (first column), AAA (second column) and
MC (third column) for the same treatment plan (TPPh) on PhA (upper row) and PhB (lower row).
The red squares in the lower-right and upper-left corners (of each of the six illustrations) represent
GTVA and GTVB, respectively. The lower colorwash dose limit was set to 95%, i.e. the visible
dose cloud has a calculated dose>95% of the prescription dose.
Table 1. Summary of PBC, AAA and MC calculated 1 − V GTV95 values for the two volumes
GTVA and GTVB for the same treatment plan (TPPh) calculated on the two virtual phantoms: PhA
and PhB.
1 − V GTV95 PBC AAA MC
(%) PhA PhB PhA PhB PhA PhB
GTVA 0 0 2 8 24 37
GTVB 5 12 84 34 86 51
the solid tumor. Further investigation of these issues is beyond the scope of this work. The
fractions of the GTV receiving less than 95% of the prescribed dose
(
1 − V GTV95
)
are listed in
table 1. The predicted perturbation of the dose distribution moving from PhA to PhB is similar
for AAA and MC. However, the general dose level is overestimated by ∼1.5% by the AAA
algorithm (figure 6), i.e. if the AAA-calculated dose is lowered by 1.5%, the DVHs will be
similar to those for the MC-calculated dose distributions.
As the tumor moves during respiration, the lung density will change, which will have
further influence on the dose distributions (e.g. Aarup et al (2009)). This effect was not
considered in the present work.
4. Conclusions
This study clearly demonstrates that the PBC dose calculation algorithm is clinically
insufficient for patient geometries such as cases A–D. AAA is generally in closer agreement
with MC than PBC. However, the inaccuracies in the calculated dose distributions are clinically
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significant for both PBC and AAA. The results indicate that the AAA algorithm is in better
agreement with the MC calculations for lower photon beam energies. Both AAA and PBC
overestimate the dose to the PTV. Due to the conformity of the PTV dose, even a small
overestimation of dose may lead to a large decrease in PTV dose coverage and tumor control
probability.
A number of the PBC-calculated treatment plans appeared significantly better for 15 MV
than for 6 MV. However, considering MC as the golden standard, the dose distributions that
would actually be delivered to the patient are significantly better for 6 MV. Therefore, it is still
advisable to use low energies as default for tumor sites involving large inhomogeneities unless
a precise dose calculation algorithm is available. Yet, one should not completely set aside the
possibility of using higher energies for sites covering the lungs or other inhomogeneous sites,
as there might be cases, or classes of cases, where the resulting plans prove to be better. This
study only encompasses MC-recalculated IMRT plans that were optimized using a simplistic
PB-based algorithm. It is plausible that better treatment plans could have been generated had
the optimization been based on an MC algorithm. Thus, the results indicate that it may be
advantageous to have a more precise dose calculation algorithm, e.g. MC, implemented in the
optimization process itself. Moreover, it is possible that having a more precise optimization
algorithm at hand would lead to some high energy-based treatment plans being more favorable
than those based on low energy.
The phantom study illustrates that as the relative high density GTV moves within the
PTV to a location previously occupied by low density lung tissue, the dose in that volume is
enhanced, as predicted by MC and AAA. In contrast, PBC predicts a decrease in dose when
the density is increased. Thus, the phantom study underlines the inaccuracies introduced when
calculating dose using a PB-based algorithm in geometries involving large density variations.
The relative increase predicted by AAA is similar to what is predicted by MC, even though
AAA overestimates the dose in absolute terms. However, the study of the effects this has on
TCP and NTCP values is beyond the scope of this work. Additionally, the changes in lung
density and other geometrical deformations were not considered and are the subject of further
investigations.
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Abstract
One of the building blocks in Monte Carlo (MC) treatment planning is to convert
patient CT data to MC compatible phantoms, consisting of density and media
matrices. The resulting dose distribution is highly influenced by the accuracy
of the conversion. Two major contributing factors are precise conversion of CT
number to density and proper differentiation between air and lung. Existing
tools do not address this issue specifically. Moreover, their density conversion
may depend on the number of media used. Differentiation between air and lung
is an important task in MC treatment planning and misassignment may lead to
local dose errors on the order of 10%. A novel algorithm, CTC-ask, is presented
in this study. It enables locally confined constraints for the media assignment
and is independent of the number of media used for the conversion of CT
number to density. MC compatible phantoms were generated for two clinical
cases using a CT-conversion scheme implemented in both CTC-ask and the
DICOM-RT toolbox. Full MC dose calculation was subsequently conducted
and the resulting dose distributions were compared. The DICOM-RT toolbox
inaccurately assigned lung in 9.9% and 12.2% of the voxels located outside
of the lungs for the two cases studied, respectively. This was completely
avoided by CTC-ask. CTC-ask is able to reduce anatomically irrational media
3 Author to whom any correspondence should be addressed.
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assignment. The CTC-ask source code can be made available upon request to
the authors.
(Some figures in this article are in colour only in the electronic version)
1. Introduction
One of the building blocks in Monte Carlo (MC) treatment planning is to convert CT numbers
to an MC compatible phantom, consisting of a density and a media matrix. A protocol for
automatic conversion was suggested by du Plessis et al (1998). That protocol is, however,
limited to the beam quality under consideration. The MC framework EGSnrc is distributed
with a tool called ctcreate for this task (Walters et al 2005, Kawrakow 2000a). The modus
operandi for this tool is to read and sort CT files from a directory, prompt the user for a subset
and resample the data on a user-specified grid. The actual conversion is performed by sorting
the CT numbers into a user-specified number of bins corresponding to different media. All
voxels are assigned the medium of the bin its CT number belongs to. Each bin has a lower and
upper value in terms of CT number and density. A linear relationship between CT number and
density is established within each bin. Thus, the conversion to density might depend on the
number of media. The DICOM-RT toolbox (Spezi et al 2002) has its own version of this tool.
The general workflow is similar and the conversion is performed using the same principles.
The DICOM-RT toolbox allows the user to read the dose grid of a DICOM RD file and use
it as the voxel grid. This ensures that the MC simulation will be on the same grid as dose
calculated by the treatment planning system (TPS).
A stoichiometric calibration protocol establishing a direct relationship between medium
composition and Hounsfield units (HU) was suggested in Schneider et al (1996) and Schneider
et al (2000). Moreover, they suggested that the media within the human body readily can
be represented by a limited number of media. Vandersraeten et al (2007) showed that
the number of media can be chosen so that the error in dose, due to media assignment,
is less than 1%. Implementation of the protocol suggested by Schneider et al (2000)
requires measurements as well as access to tissue-like materials with precise known chemical
composition. Vandersraeten et al (2007) highlight the importance of differentiating between
media with discrepancies in H and Ca content as this has a significant impact on the attenuation
properties of a medium. They suggest tweaking of the CT-number boundaries between air and
lung for each tumor site, depending on the presence of lung.
Using dual-energy CT scanners for the determination of the effective atomic numbers, Z,
and the relative electron densities, ρe, in a CT image has been suggested in several studies
(e.g. Bazalova et al 2008, Torikoshi et al 2003, 2004).
The existing tools and protocols for conversion of CT data to MC parameters are limited
to a global list of media; however, not all media are likely to exist within a given organ or
anatomical structure (hereafter referred to as structures). This might lead to anatomically
incorrect medium assignment (e.g. a dense tumor might be assigned bone in some voxels or
voxels outside of the body may be classified as lung) and ultimately resulting in an error in
dose. Furthermore, this disables the use of media with an overlap in CT numbers, but distinct
elemental compositions.
The purpose of this work was to develop, evaluate and test a new algorithm, implemented
in a MATLAB (Mathworks, Natlick, MA, USA) software solution, enabling global density
conversion using piece-wise linear HU-to-density relationship while using structure specific
media conversion ramps (i.e. the list of media eligible for assignment and their HU ranges).
R O Ottosson and C F Behrens N265
Table 1. Physical densities and average CT number for the scanned materials. Uncertainties on
CT numbers are given as 1 SD.
Material Physical density (g cm−3) CT number
Air (20 C) 1.2041 × 10−3 −998 (±3)
Water (syringe) 1.00 −7 (±14)
Lung (inhale) 0.20 −801 (±16)
Lung (exhale) 0.50 −494 (±16)
Breast (50/50) 0.99 −33 (±16)
Liver 1.07 55 (±17)
Muscle 1.06 51 (±15)
Adipose 0.96 −64 (±16)
Trabecular bone 200 mg cm−3 1.16 183 (±18)
Dense bone 800 mg cm−3 1.53 841 (±19)
Incorporation of the delineations contained in the DICOM RS file enables separation into local
compartments based on anatomical regions.
2. Materials and methods
2.1. CT calibration
A CIRS Model 062 phantom (CIRS Tissue Simulation Technology, Norfolk, VA, USA) was
used for the determination of the CT-to-density conversion relationship. The epoxy-based
phantom (ρ = 1.01 g cm−3) accommodates a total of 17 inserts simultaneously.
A total of eight different tissue equivalent materials (two of each) and a water-filled syringe
were placed in the phantom (table 1). The phantom was placed in a Phillips Brilliance CT
Big Bore (Phillips, Amsterdam, the Netherlands) such that the iso-center of the scanner was
aligned with the center of the phantom. A clinical protocol with typical scanning parameters
(120 kVp, 2 mm slice thickness) was selected and the scan was repeated seven times. The CT
images were read into MATLAB, using the dicomread function. Volumes of interest (VOIs)
were drawn around each insert for every scan. VOIs were also drawn outside of the phantom
to obtain the CT number for air. The data were pooled to obtain the average CT number of
each insert for the entire population of scans. The data set was fitted with linear equations for
the soft tissue and bone materials, respectively:
ρ = 10−3 ×
{
1.02H − 7.65: H 6 55
0.58H + 467.79: H > 55. (1)
The linear fits had R2 greater than 0.99. The results are in agreement with the findings of Saw
et al (2005).
2.2. Generating a representative media set
Using tabulated composition (Woodard and White 1986, White et al 1987, NIST 2011) of
a limited number of tissues and the measured relationship between density and HU, it is
possible to generate a representative set of media spanning the full range of HU values from
air to cortical bone (Schneider et al 2000, Vandersraeten et al 2007). The scheme suggested by
Schneider et al (2000) was adopted, with one modification: the soft tissue range was divided
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Table 2. The binning-scheme used for this study. The HU range was divided into 19 bins, the first
corresponding to the composition of air and the second to lung. The compositions of the following
bins were determined by equation (2) where the media used for the interpolation were adipose
tissue 3 and adrenal gland (for bin 3), small intestine (wall) and connective tissue (for bin 4) and
red/yellow marrow and cortical bone (for bins 5 through 19).
Elemental weight (wi)
Media H H C N O Na Mg P S Cl Ar K Ca
HUrange1 −1000 to −950 75.7 23.2 1.3
HUrange2 −950 to −100 10.3 10.5 3.1 74.9 0.2 0.2 0.3 0.3 0.2
HUrange3 −100 to 15 11.2 50.8 1.2 36.4 0.1 0.1 0.1
HUrange4 15 to 129 10.0 16.3 4.3 68.4 0.4 0.4 0.3
HUrange5 129 to 200 9.7 44.7 2.5 35.9 2.3 0.2 0.1 0.1 4.5
HUrange6 200 to 300 9.1 41.4 2.7 36.8 0.1 3.2 0.2 0.1 0.1 6.3
HUrange7 300 to 400 8.5 37.8 2.9 37.9 0.1 4.1 0.2 0.1 0.1 8.2
HUrange8 400 to 500 8.0 34.5 3.1 38.8 0.1 5.0 0.2 0.1 0.1 10.0
HUrange9 500 to 600 7.5 31.6 3.2 39.7 0.1 5.8 0.2 0.1 11.6
HUrange10 600 to 700 7.1 28.9 3.4 40.4 0.1 6.6 0.2 0.1 13.1
HUrange11 700 to 800 6.7 26.4 3.5 41.2 0.2 7.2 0.3 14.4
HUrange12 800 to 900 6.3 24.2 3.7 41.8 0.2 7.8 0.3 15.7
HUrange13 900 to 1000 6.0 22.1 3.8 42.4 0.2 8.4 0.3 16.8
HUrange14 1000 to 1100 5.6 20.1 3.9 43.0 0.2 8.9 0.3 17.9
HUrange15 1100 to 1200 5.3 18.3 4.0 43.5 0.2 9.4 0.3 18.9
HUrange16 1200 to 1300 5.1 16.6 4.1 44.0 0.2 9.9 0.3 19.8
HUrange17 1300 to 1400 4.8 15.0 4.2 44.4 0.2 10.3 0.3 20.7
HUrange18 1400 to 1500 4.6 13.6 4.2 44.9 0.2 10.7 0.3 21.5
HUrange19 >1500 4.3 12.2 4.3 45.3 0.2 11.1 0.3 22.2
in accordance with Vandersraeten et al (2007), which assures dosimetric equivalence within
1%. In total, 19 media were generated (table 2). The first and second bins correspond to air
and lung, respectively. The compositions of the following bins were calculated according to
equation (18) in Schneider et al (2000):
wi = ρ1(H2 − H)
(ρ1H2 − ρ2H1) + (ρ2 − ρ1)H (w1,i − w2,i ) + w2,i (2)
with
H1 6 H 6 H2,
where H is the average HU of the bin, ρ is the density of the media and wi is the weight of
element i. The media used for the interpolation were the same as in Schneider et al (2000),
i.e. adipose tissue 3 and adrenal gland (for bin 3), small intestine (wall) and connective tissue
(for bin 4) and red/yellow marrow and cortical bone (for bins 5 through 19). The calculated
compositions of the HU bins are presented in table 2.
2.3. CTC-ask general work-flow
A MATLAB program, called CTC-ask (CT Create Applying DICOM RS Knowledge), was
developed. CTC-ask uses the DICOM-RT toolbox to a large extent, either through function
calls or by direct reuse of code segments. Figure 1 illustrates the general work-flow of the
program.
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Figure 1. General work-flow of CTC-ask.
Firstly, the CT matrix, CT and dose grid are read from the DICOM files. The bilinear CT-
to-density relationship is calculated based on data points submitted by the user. An option to
use a pre-saved relationship is also provided. The CT matrix is globally converted to a density
matrix, with a grid corresponding to the dose grid of the DICOM RD file. The structures in
the DICOM RS file are sorted according to structure types (e.g. PTV, External, Avoidance
etc) and the user is queried for structure types to be considered. A list of the structures with
the desired types is created and presented to the user along with an option to exclude specific
structures. The external outline is a required structure and may not be excluded. A logical
mask is generated for each selected structure, that is, a logical matrix of the same shape as
the RD dose grid where true means that the voxel belongs to the specific structure. The user
is requested to input names and upper CT number bounds for the possible media (hereafter
referred to as a ramp function) for each structure (the lower CT number bound of the first
medium defaults to −1000, while the ith (i > 1) uses the upper CT number bound of the
(i − 1)st medium). An option to use a pre-saved ramp function is also implemented. As
every voxel is allowed to belong to only one structure, the program iterates over the selected
structures and generates a union structure in the regions where structure-overlaps exist. In the
case of structure-overlaps, the ramp functions of the overlapping structures are compared. If
identical, the structure union is assigned the ramp, else the user is queried to specify one. The
voxels belonging to the overlapping area are set to false for the overlapping parent structures
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and to true for the generated structure union. If any unions were found during the iteration,
a recursive call of the function is made. Each structure undergoes a separate conversion of
CT number to media based in its ramp-function. A global media list is generated and each
structure correlated to the global list. An option to set voxels outside of the external outline to
air with zero density is implemented in order to emulate the procedure of TPSs. The media
matrices are subsequently added to a global media matrix. Finally, the data are written to an
egs4phant file.
2.4. Patient cases
Two cases where one may expect improvements due to the specific considerations in CTC-ask
were selected: a 15 MV 3D-CRT pelvic case with substantial metal artifacts in the CT scan due
to bilateral hip prostheses and a 6 MV IMRT head and neck case including lung as well as air-
filled cavities. Phantoms were generated based on the CT-data, using the 19-media conversion
scheme as implemented in the DICOM-RT toolbox (hereafter referred to as unconstrained
phantoms) as well as in CTC-ask (hereafter referred to as constrained phantoms). For the
constrained pelvic phantom, the bilateral hip prostheses were delineated, all voxels belonging
to the delineated prostheses were set to titanium with a density of 4.54 g cm−3 and in the
slices containing artifacts, all voxels inside the external outline not belonging to bone nor
prostheses were set to ICRUTISSUE with a density of 1.00 g cm−3. For the constrained head
and neck phantom, only voxels belonging to the lungs were allowed to be assigned lung.
Voxels inside the external outline, not belonging to any other specific structure, were allowed
also to be assigned Cranium. As the mandible was outlined, voxels belonging to that structure
were allowed to be assigned mandible as well. Compositions and densities of specific media
were taken from Woodard and White (1986). A second constrained phantom was generated
for the head and neck case (hereafter referred to as the constrainedair outside phantom) where,
in addition to previously mentioned considerations, all voxels outside of the external outline
were assigned HUrange1 (corresponding to air) with a density of 1.2041 × 10−3 g cm−3. The
rationale behind this was to exclude the neck support tray and the fixation mask from the MC
simulation.
2.5. MC simulation
The MC simulations followed the procedure reported in Ottosson et al (2010). In short,
EGSnrc and BEAMnrc (Kawrakow 2000a, 2000b, Rogers et al 1995) were used to build and
commission MC models for each energy (6 and 15 MV) of a Varian 2300 iX linear accelerator
(Varian Medical Systems, Palo Alto, CA, USA). A phase space file (PHSP) was scored just
below the flattening filter for each of the energies. The PHSPs were scored by simulation
of 2.5 × 106 histories with cut-off energies of 521 keV (including rest mass) and 10 keV for
electrons and photons, respectively. The beam modifiers and patient geometry were simulated
in MCSIM (Jin et al 2007, Ma et al 2002) using the EGSnrc-generated PHSP as the source.
A set of in-house MATLAB scripts were used to generate input files for MCSIM from the
DICOM RP files. Thus, all parameters of the treatment plans were recreated in the simulations.
The number of simulated histories were chosen so that the estimated statistical uncertainty4
4 MCSIM estimates the relative statistical uncertainty of the dose in a voxel is estimated by
σD
D
=
√√√√n∑ e2i −
(∑
ei
)2
(n − 1) (∑ ei)2 , (3)
where ei is the energy deposited in the voxel in the ith energy deposition event and n is the total number of energy
deposition events in the voxel.
R O Ottosson and C F Behrens N269
Figure 2. Transversal slice of the head and neck case showing media assignment for the
constrainedair outside phantom (left), HU-map (center) and media assignment for the unconstrained
phantom (right). The colors correspond to air (dark blue), lung (green), soft tissue (cyan),
connective tissue (yellow) and bone (red). (Note that all media corresponding to bone appear
in red.)
was ≈0.5% for the voxels in the high-dose regions. The selected number of histories resulted
in estimated statistical uncertainties below 2%, 8% and 15% for voxels receiving 50%, 20%
and 10% of the maximum dose, respectively. All doses are reported as dose to medium.
3D-dose distributions were converted to DICOM RD files using CERR (Deasy et al 2003)
and subsequently imported to the TPS (Varian Eclipse 10.0) to generate DVHs.
3. Results
The unconstrained phantoms were assigned HUrange2 (corresponding to lung) in 9.9% and
12.2% of voxels inside the external outline (excluding voxels belonging to lung structures)
for the head and neck and the pelvic case, respectively. Moreover, 15.1% of the larynx in the
head and neck case was assigned lung in the unconstrained phantom. No voxel outside of the
lung structures was assigned lung for the constrained phantoms (figure 2). The unconstrained
phantoms also were assigned lung to voxels outside of the external outline. This was avoided
for the constrained phantoms (figure 2).
Local differences in dose, for the clinically used treatment plans, were computed
between constrained and unconstrained phantoms (the unconstrained phantoms were used
as references). Histograms of the local differences for voxels inside the external outline and
with statistical uncertainty on dose 6 2% were produced (figures 3(a) and (b)). Gaussian-
like distributions, with mean value close to zero, are noted when comparing constrained and
unconstrained phantoms globally. For the head and neck case, the comparison between the
constrainedair outside and the unconstrained phantom deviates from this behavior. Figure 3(b)
shows two things in particular for the constrainedair outside phantom: (i) a low dose tail and (ii)
a shift toward higher doses for the remaining distribution.
The user can make restrictions on which media CTC-ask is allowed to assign to voxels
within a given structure. In order to investigate the influence of this on the dose distribution
in detail, the dose of voxels assigned specific media as well as voxels differing in terms of
air and lung between the constrained and unconstrained phantoms were studied (figures 3(c)
and (d)). When comparing dose in voxels assigned to lung in the unconstrained phantom
while a different media in the constrained phantoms for the head and neck case, two peaks are
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Figure 3. Histograms over local dose differences (calculated as (doseconstrained–
doseunconstrained)/doseunconstrained × 100) between constrained and unconstrained phantoms (solid)
as well as constrainedair outside and unconstrained phantoms (dashed) for the head and neck case.
The histogram was plotted with a binwidth of 0.4% and normalized to the integral. Voxels outside
the external outline or with uncertainty larger than 2% were ignored. (a) Pelvic case. (b) Head and
neck case. (c) Voxels in the head and neck case assigned HUrange2 (lung) in the unconstrained
phantom and non-HUrange2 in the constrained phantoms. Two frequency peaks are noted for
the comparison with the constrained phantom (solid): around 0% and around −11%. The 0%
peak corresponds to voxels assigned HUrange3 (soft tissue), while the −11% peak (also shown
in the inset figure) corresponds to voxels assigned HUrange1 (air) in the constrained phantoms,
respectively. (d) Voxels in the head and neck case assigned Cranium in the constrained phantoms
(the corresponding voxels were assigned HUrange13 in the unconstrained phantom).
observed (figure 3(c)). The peaks are less distinct, but still existing, for the constrainedair outside
phantom. The dose for voxels assigned Cranium (figure 3(d)) in the constrained phantoms
was lowered by ≈2% on average.
The Gaussian-like distribution around 0% for the pelvic case indicates that dose
distributions generally agree. This is confirmed by the virtually indistinguishable DVHs of the
external outline (figure 4(a)). For other structures, the differences are more noticeable. A large
underdosage is noted for the unconstrained PTV and almost the entire PTV volume receives
5 Gy less dose. On the other hand, the bone and prostheses structures receive higher doses in
the unconstrained phantom. This is caused by the misassignment of media and density due to
the metal artifacts. Differences in DVHs of the constrained and constrainedair outside phantoms
for the head and neck case are not as dramatic as the 5 Gy shift for the PTV of the pelvic case.
Nevertheless, it is evident that a larger volume receives high doses for the constrainedair outside
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Figure 4. (a) Cumulative dose volume histograms for the pelvic case using the constrained (solid)
and unconstrained (dashed) phantoms. DVHs are plotted for the external outline (green), bones
(blue), prostheses (cyan), PTV (brown) and the PTV excluding the rectum (black). (b) Cumulative
dose volume histograms for the head and neck case using the constrainedair outside (solid) and
constrained (dashed) phantoms. DVHs are plotted for the external outline (brown), PTV (blue),
left parotid gland (red), right parotid gland (green), spinal cord (cyan), brainstem (black), larynx
(magenta) and the lungs (yellow).
(figure 4(b)). The effect is particularly noticeable for deep-seated structures (e.g. PTV, larynx
and spinal cord).
4. Discussion
The accuracy of MC dose calculation is strongly influenced by the conversion of CT number
to density and media. The most crucial contributor is arguably the density conversion. When
assigning media to voxels, the most critical task is to differentiate between media with distinct
mass attenuation properties. It was demonstrated that misassignment between air and lung
can introduce a local error in dose in the order of 10% (figure 3(c)), which agrees with the
findings of e.g. Verhaegen and Devic (2005).
CTC-ask is run interactively and allows for manual manipulation at any point. This is
useful in the case of CT scans obtained with contrast enhancing agents and/or metal artifacts.
For those cases, the CT number will not represent the actual density if not corrected for
manually and dose calculation will be performed using the inaccurate densities and/or media.
This can be solved by delineating the area containing the affected voxels and applying a filter
that compensates for the shift in density (or CT-number) on those voxels. This was done for
the constrained pelvic phantom, where voxels in slices containing metal artifacts were set to
ICRUTISSUE with a density of 1.00 g cm−3 unless the voxels belonged to the delineated
prostheses or bone structures. This heavily influenced the dose distribution of most structures
(figure 4(a)). An alternative method of correcting for metal artifacts was presented by Bazalova
et al (2007) where the general idea is to apply a metal filter and then by interpolating missing
projections of the filtered sinograms. CTC-ask may be used in combination with the method
suggested by Bazalova et al (2007).
The inclusion of an ‘outside’ structure, the inverse of the external outline, gives rise to the
possibility of specifying which media are allowed to be assigned outside of the patient. This
is a unique feature of CTC-ask. Other existing tools allow any voxel to be assigned any of the
media regardless of whether it is located within the body or not. Moreover, CTC-ask allows
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post-conversion manipulation of the density and/or media assignment for any structure. Hence,
it is possible to set objects (couch, clothes, support structures, etc) to air with zero density
and thereby removing their influence on the dose calculation. This may influence the entire
dose distribution. When setting all voxels outside of the external outline to air for the head
and neck case, the build-up region is effectively shifted deeper into the patient. This is what
causes the low-dose tail (compared to the unconstrained phantom) for the constrainedair outside
phantom (figure 3(b)). Shifting the build-up region deeper also means that the beam will
be less attenuated at a given distance beyond dmax and thus will give rise to a higher dose.
This is the explanation for the shift toward higher doses for the constrainedair outside phantom
(figures 3(b) and 4(b)). This effect will be somewhat compensated for distal voxels when
using opposing beams while it will be further enhanced for central voxels. Assigning all of
the voxels outside the external contour to air might not be accurate from a dosimetric point of
view since the patient might be covered by a mask, be placed in a fixation and the treatment
couch might be in the beam. In CTC-ask, delineated support structures may, like any other
delineated structure, be assigned the actual density and media composition should it be known.
Vandersraeten et al (2007) stress the importance of differentiating between air and lung
(i.e. HUrange1 and HUrange2 in this study) and media with different Ca content. Their
suggested solution is to tune the CT-number boundary between air and lung depending on the
tumor site and to include a number of media, with increasing Ca content, representing bone of
various densities. The CT numbers of air and lung are however not likely to differ depending
on tumor site. Another way to address the issue would be to exclude air and/or lung from areas
where they are not likely to exist. This is what is done in CTC-ask. Moreover, it is possible
to tune the HUrange corresponding to a given media individually for each structure. Thus, a
voxel with a HU of −940 might be assigned air, lung or gas depending on which structure it
belongs to. In addition to the possibility of using a range of interpolated media representing
tissues of various densities, CTC-ask allows for inclusion of tissue-specific media (and non-
tissue media), and for confinement of the eligibility of those media to structures where they
are likely to exist.
Media with distinct composition will likely differ in important dosimetrical properties
(such as stopping power and mass energy absorption coefficients). This is illustrated by
figure 3(d), where the voxels assigned Cranium are shifted to a lower dose for the constrained
phantoms due to lower mass stopping power of the composition corresponding to Cranium
media than that of HUrange13, which was the media assigned to the corresponding voxels in
the unconstrained phantom.
Compton effect is the dominating effect for radiotherapy beams and the probability for
Compton interaction is proportional to the electron density. Hydrogen has a higher electron
density than elements with higher Z; therefore, the attenuation properties of media will depend
heavily on the hydrogen content. This is most outspoken when comparing air and lung as lung
contains 10.3% hydrogen, whereas dry air does not contain any (Vandersraeten et al 2007).
This is illustrated by figure 3(c) where two peaks are evident for the constrained phantom
(solid line). The voxels constituting the largest peak, around 0%, were assigned HUrange3
(soft tissue), whereas the voxels in the peak around −11% (see the inset in figure 3(c)) were
assigned HUrange1 (air). The difference in hydrogen content is small (0.9%) when moving
from HUrange2 to HUrange3 and thus no large effect on dose is expected for those voxels.
The peaks are not as distinct for the constrainedair outside phantom since the build-up region is
shifted deeper into the patient in the constrainedair outside phantom and a large fraction of the
voxels are situated at shallow depths.
Erroneous assignment of media might lead to a local error in dose (figures 3(c) and (d)),
which may or may not be partially compensated for, due to the differences in mass stopping
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power, if converting to dose to water (Dw). The mass attenuation of the improper media will
however also perturb the beam, leading to an error in dose downstream and/or laterally. In
addition, an increased backscatter (or lack thereof, depending on if moving from media with
high H or Ca content to media with low, or vice versa) is noted at the boundary. Moreover,
the local dose may be affected by media misassignment of neighboring voxels. None of those
effects are compensated for when converting to Dw.
As CTC-ask utilizes delineated structures in the DICOM data, it is integral to ensure that
the structures of consideration were properly delineated.
5. Conclusions
CTC-ask utilizes delineated structures in the DICOM data to set local conversion constraints for
each structure and thus greatly reduces the probability of voxels being assigned anatomically
irrational media. Furthermore, CTC-ask uses the CT number to density relationship without
any linear interpolation within the range of a given media. Thus, the density matrix generated
by CTC-ask will be independent of the number of media considered.
CTC-ask is run interactively and density and media matrices can be manually modified at
any point. This gives rise to the possibility of applying filters to specific regions affected by
contrast enhancing agents, metal artifacts, etc during the CT scan.
As CTC-ask relies on delineated structures in the DICOM set, it is integral to ensure
that all structures are properly delineated as irrational media assignment otherwise may be
introduced.
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Appendix C is a paper published in Physics in Medicine and Biology in
2011. A dosimetry system based on fiber–coupled organic scintillators
is presented. It has the potential to conduct point measurements
of absorbed dose in radiotherapy beams involving high spatial and
temporal dose gradients. The system is tested against Monte Carlo
simulations for Percentage Depth Dose curve and Relative Output
Factor for square fields down to 0.6×0.6 cm2 size.
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Abstract
A fast-readout dosimetry system based on fibre-coupled organic scintillators
has been developed for the purpose of conducting point measurements of
absorbed dose in radiotherapy beams involving high spatial and temporal
dose gradients. The system measures the dose for each linac radiation pulse
with millimetre spatial resolution. To demonstrate the applicability of the
system in complex radiotherapy fields, output factors and per cent depth dose
measurements were performed in solid water for a 6 MV photon beam and
compared with Monte Carlo simulated doses for square fields down to 0.6 cm ×
0.6 cm size. No significant differences between measurements and simulations
were observed. The temporal resolution of the system was demonstrated by
measuring dose per pulse, beam start-up transients and the quality factor for
6 MV. The precision of dose per pulse measurements was within 2.7% (1 SD)
for a 10 cm × 10 cm field at 10 cm depth. The dose per pulse behaviour
compared well with linac target current measurements and accumulated dose
measurements, and the system was able to resolve transient dose delivery
differences between two Varian linac builds. The system therefore shows
promise for reference dosimetry and quality assurance of complex radiotherapy
treatments.
(Some figures in this article are in colour only in the electronic version)
1. Introduction
The use of organic scintillators for dosimetry in complex radiotherapy fields, such as the ones
used in stereotactic radiotherapy or intensity-modulated radiotherapy (IMRT), has been studied
3 Author to whom correspondence should be addressed.
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extensively (Le´tourneau et al 1999, Beddar et al 2001, Lambert et al 2010, Klein et al 2010).
However, no experimental studies have so far verified the use of organic scintillators by direct
comparison with Monte Carlo (MC) simulations of beam output in small fields, nor taken
advantage of the fast response of commercial organic scintillators to measure doses delivered
in radiotherapy beams on the actual timescale of the pulsed linac output. Dose measurements
in small fields put high demands on the dosimeters used, and present a rapidly evolving field
of research (IPEM 2010). Because of the lack of reference data for small fields, the best way
to verify dose measurements seems to be a comparison between different dosimetry methods
and MC simulations, as demonstrated in e.g. Das et al (2008), Cheng et al (2007) and Scott
et al (2008).
As for the temporal structure of dose delivery, detailed knowledge of the dose deposition
with time is of potential relevance for quality assurance (QA) purposes—especially for
dynamic treatments like IMRT, where small dose segments on the order of a cGy are not
uncommon. In general, the instantaneous dose rate within the μs duration linac radiation
pulses is very high, easily reaching 50 Gy s−1 for normal beam delivery and well over
100 Gy s−1 for flattening-filter-free delivery (Vassiliev et al 2006). Therefore, pulse-resolved
dose measurements will arguably provide physical insight into modern radiotherapy beam
delivery. Also, some microdosimetric and spectroscopic information about the irradiation
process might be uncovered, as suggested by Illemann et al (2009). An array of organic
scintillators using charge-coupled device (CCD) and electron multiplying charge-coupled
device (EMCCD) cameras has recently been developed for radiotherapy QA (Lacroix et al
2008), in vivo dosimetry (Archambault et al 2010), and small field dosimetry (Klein et al 2010).
To accumulate a satisfactory signal-to-noise ratio, dose measurements have been performed
with an integration time of approximately 5 s (for the CCD) or 150 ms (for the EMCCD).
However, such data acquisition times cannot resolve the μs duration pulsed dose delivery of
a medical linac, which typically has a frequency of 300–400 Hz. Studies of the theoretical
precision limits of these CCD-based systems (Lacroix et al 2010) reveal that integration times
as low as 0.1 ms can be achieved while maintaining a precision within 2%.
This study presents further development on the fast-readout dosimetry system introduced
by Beierholm et al (2010). The system is based on two fibre-coupled organic scintillators
coupled to photomultiplier tubes (PMTs). Our approach was to focus on the basic
dosimetric challenges presented by small fields and non-continuous dose delivery by making
measurements with a small number of point dosimeters. Our claim is that a thorough study
of the basic mechanisms of spatial and temporal dose delivery will further the knowledge
of the dosimetric challenges associated with modern radiotherapy. The purpose of the work
was to support that the method provides detailed and highly accurate dose measurements in
modern radiotherapy applications involving small fields and dynamic dose delivery. This was
achieved in a twofold process: first, we critically examined the accuracy that can be obtained
with organic scintillators in small field dosimetry by comparing dose measurements with MC
simulations in small static fields. Secondly, we demonstrated that new dosimetric information
can be uncovered with pulse resolution. We also provided experimental determination of the
uncertainties associated with pulse-resolved dose measurements.
2. Materials and methods
2.1. Organic scintillator probes
The organic scintillators employed in this study were 1 mm diameter, polystyrene-based
scintillating fibres (BCF-60, Saint-Gobain Ceramics & Plastics Inc., France). This type of a
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plastic scintillator is well characterized and has been used for similar purposes in the studies
by Fontbonne et al (2002) and Frelin et al (2005). The scintillating fibres were cut to a desired
length and coupled to PMMA-based optical fibres (ESKA GH-4001P, Mitsubishi-Rayon Co.,
Japan) of 1 mm core diameter, 2.2 mm outer jacket diameter and approximately 10 m length,
terminated by an SMA connector. Before coupling, the exposed ends of the scintillator
and the optical fibre were polished using aluminium oxide polishing paper of 5, 3, 1 and
0.3 μm grain size (Thorlabs Sweden AB) and cleaned using water and pressurized air. The two
components were aligned using a mechanical fixation mount and a stereo microscope, before
making the coupling permanent using UV-curing, refractive index-matching glue (NOA68,
Norland Products Inc., USA). Finally, a jacket of black epoxy cement (EPOTEK 320, Epoxy
Technology Inc., USA) was moulded around the exposed junction to light-tighten the probe.
The scintillators used for probes in this study were between 1 mm and 10 mm in length.
2.2. ME04 detector system
The ME04 dosimetry system (Risø DTU, Denmark) is designed as a hardware basis for the
fibre-coupled organic scintillators. The ME04 hardware handles the input of two dosimeter
probes. The optical fibres are long enough for the detection equipment to be placed outside
the main treatment room. This prevents interference from stray radiation on the detector
electronics. Parasitic fibre luminescence and Cerenkov radiation (the so-called stem signal)
was suppressed using the chromatic removal method originally introduced by Fontbonne et al
(2002). For each probe, light of wavelengths corresponding to mostly stem signal (designated
A) and scintillation (designated B) is chromatically separated using yellow and magenta 45◦
dichroic mirrors (Edmund Optics Ltd, UK) and subsequently detected using two Hamamatsu
H5784 PMT modules (Hamamatsu GmbH, Germany) operated in current mode at 0.3 V gain.
Calibration links the absorbed dose, D, to the stem signal contribution, A, and the scintillator
signal contribution, B. The data acquisition is synchronized with the pulsed synchronization
output of the linac. The ME04 system makes use of a ‘sample-hold’ setup using Burr–Brown
ACF2101 switched integrator circuits (Mountford et al 2008). The charge built up in the
100 pF capacitor is held, integrated, and read out before it is reset at the onset of the next
synchronization pulse. The system handles five input channels, with four of these being
used by the PMTs. The fifth is used for measuring the linac target current, which is the
current required to keep the linac gun target electrically neutral when the target is hit by the
accelerated electron bunches during irradiation. The temperature inside the hardware casing
is measured by a thermistor to correct for the temperature-dependent sensitivity of the PMTs
(approximately 0.1% per ◦C). The voltage signals are acquired using a NI 6218 DAQ card and
a data acquisition software interface in-house developed in LabVIEW (National Instruments
Inc., USA).
2.3. Setup for irradiation and dose measurement
A flow chart of the measurement setup is shown in figure 1. Dose measurements were made
using 6 MV x-rays delivered by a Varian 2300 iX medical linac at Copenhagen University
Hospital, Herlev. The linac was calibrated to deliver a dose to water of 1 cGy per monitor unit
(MU) for a 10 cm × 10 cm field at 100 cm source to surface distance (SSD), at the depth of
maximum dose delivery (dmax) which is approximately 1.5 cm at this energy. The details of
linac calibration can be found in Sjo¨stro¨m et al (2009). The ME04 system was connected to
the SYNC and I_TARGET BNC output of the linac to enable synchronized pulse counting of
the synchronization signal and target current. In this way, the synchronization pulses as well
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Figure 1. Flow chart of light detection and linac-synchronized data acquisition. For each linac
SYNC pulse, the light from fibres and scintillators is chromatically discriminated and converted
into voltage readings using Burr–Brown switched integrator circuits.
as the target current pulses of the linac were recorded. The time structure of the Varian 2300 iX
linac was determined using an oscilloscope as well as the ME04 system in non-synchronized
(continuous) sampling mode. Using the oscilloscope, the duration of the linac gun pulse
was measured to be 4 μs long and starting approximately 12.5 μs after the synchronization
signal leading edge. As expected, the pulse period was seen to change with dose rate, with
the pulse width being constant. Based on this, a sampling time of 80 μs was chosen. The
charge integration started 6 μs after the synchronization pulse leading edge and terminated
after 86 μs.
As emphasized in the studies by Chow et al (2005) and Klein et al (2010), the dosimetric
characteristics of a small field depends on the beam-shaping geometry. In this study, the linac
was operated in service mode with the multi-leaf collimators parked, and the square field size
varied between 0.6 cm × 0.6 cm and 10 cm × 10 cm using the secondary collimator jaws. All
irradiations were performed at 100 cm SSD with the linac gantry and collimators at 0◦ and 90◦
rotation, respectively. The probes were irradiated in a 30 cm × 30 cm × 21 cm solid water
phantom (CTG-457, Gammex Ltd, UK). 2.5 mm × 2.5 mm × 300 mm grooves were drilled
along the centre of some of the slabs for a tight housing of the dosimeter probes.
A critical point of small field measurements is to ensure correct alignment of the dosimeter
with the beam isocentre. In the case of scanning water tanks, this can be achieved by scanning
the dosimeter through the tank until the signal is at a maximum in the lateral and longitudinal
directions. This cannot be done in a solid water phantom, where the position of the dosimeter
is fixed. In the present case, we used a lead piece of the same dimensions as the scintillator.
The lead piece was aligned with the apparent beam isocentre using the positioning lasers and
alignment light field. A portal image was then obtained using the linac on-board imaging
device, confirming the actual position of the beam isocentre. In case of an offset, the solid
water phantom was carefully repositioned to correct for the offset and another portal image
was obtained to verify correct positioning of the dosimeter probe. For most irradiations,
25 MU were delivered at a dose rate of 300 MU min−1. The only exceptions were irradiations
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performed at different dose rates, made to investigate the dose per pulse dependence on
dose rate. Dosimeter calibration was carried out for each scintillator probe using the same
10 cm × 10 cm field size, but for two distinct measurement configurations: (i) an irradiation
with the scintillator positioned in the field isocentre; (ii) an irradiation with the fibre going
straight through the beam and the scintillator positioned approximately 20 cm outside the beam
and phantom. The shift in fibre position is minimized to ensure that the optical spectra of the
two channels are not changed significantly, since the chromatic removal method depends on a
constant stem signal spectrum (Frelin et al 2005, Beierholm et al 2008). The dosimeter probes
were calibrated at 10 cm depth, to follow the standards of the TRS-398 protocol (IAEA 2000).
A water-to-solid water depth correction factor of 1.011 was applied to account for differences
in electron density (Seuntjens et al 2005). Three consecutive measurements were used for
each of the two calibration configurations.
To demonstrate the spatial resolution of our dosimeter probes in the context of small
radiation fields, we used a probe of 1 mm scintillator length to measure output factors (OFs)
for collimator settings from 10 cm × 10 cm down to 0.6 cm × 0.6 cm, as well as per cent
depth dose (PDD) for the largest and smallest field. The OF for a given field is a measure of
the dose absorbed at the field isocentre per delivered MU, relative to a reference field which
is typically 10 cm × 10 cm. The OFs are normally defined at dmax, but to avoid electron
contamination, it is common practice to perform the measurements at a larger depth, and then
extrapolate to dmax using PDD reference measurements (Dutreix et al 1997). However, this
cannot be done for small fields, as reference measurements are normally not available for fields
smaller than 3 cm × 3 cm. In this study, the hospital reference depth was 10 cm, and therefore
we conducted our OF measurements at that depth. PDD measurements were performed by
moving the dosimeter slab down the stack for each measurement depth. A portal image was
taken at each depth using the lead piece to improve the dosimeter–isocentre alignment. The
normalization depth was 1.5 cm (dmax). An additional 9 cm solid water stack was added to the
phantom to ensure satisfactory backscatter conditions for measurements at 20 cm depth. To
assess the degree of dose underestimation due to volume averaging, dose was measured for
the 0.6 cm × 0.6 cm field at dmax as a function of scintillator size, for scintillators of 1 mm to
10 mm length.
2.4. Additional dosimetry methods
Independent dose measurements using LiF thermoluminescence dosimeters (TLDs) were made
for the out-of-field calibration configuration, to measure the out-of-field dose to the scintillator.
The TLDs were subsequently read out using a Dosacus TLD-reader (Alnor Oy, Finland) at the
Radiation Research Division, Risø DTU. Reference OF measurements, performed in a water
tank using a waterproof standard ionization chamber (IC) of the Farmer 30006/30013 type
(PTW Freiburg GmbH, Germany) were included in the OF study for verification of the MC
model. These reference measurements were originally presented by Sjo¨stro¨m et al (2009).
Because of large cavity volume (0.6 cm3), the IC was however not used for fields smaller
than 3 cm × 3 cm. For the volume averaging experiment, lateral profiles of the 0.6 cm ×
0.6 cm field were measured at dmax using GAFchromic EBT2 film (Radiation Products Design
Inc., USA), which was calibrated in the 1–5 Gy dose range and read out using a Canon LiDE
90 scanner and RisøScan (Helt-Hansen and Miller 2004).
2.5. Monte Carlo simulations
The OF measurements were compared with MC simulations of (i) a 1.0 mm × 1.0 mm ×
1.0 mm polystyrene scintillator in a 30 cm × 30 cm × 21 cm solid water volume and
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(ii) a 1.0 mm × 1.0 mm × 1.0 mm water voxel in a homogenous 30 cm × 30 cm ×
21 cm water volume. For the volume averaging experiment, dose was calculated for 1–10 mm
long scintillators in a 0.6 cm × 0.6 cm field at dmax. For MC calculations of PDD, an
additional 9 cm of solid water was included to allow for sufficient backscatter conditions. The
linac was modelled (Ottosson et al 2010) using the BEAMnrc user code (Rogers et al 1995
and 2009), and the MC model was commissioned for field sizes between 3 cm × 3 cm and
30 cm × 30 cm. Dose to scintillator/water was scored using DOSXYZnrc (Walters et al 2009)
with a precision of approximately 0.5% for 10 cm × 10 cm at 10 cm depth. Collimator jaw
positioning uncertainty was not evaluated, and the cladding and jacket of the scintillator probe
were not included in the MC simulations. The MC data included corrections for collimator
backscatter in the linac monitor chambers, in accordance with the method described by
Lam et al (1998).
3. Results and discussion
3.1. Measurement precision
Because the number of scintillation photons detected by the ME04 system is linearly related
to the dose absorbed in the scintillator, measurement precision depends on the accumulated
dose. The precision of pulse-resolved dose measurements was defined as the relative standard
deviation of the dose per pulse (DPP). Although a 25 MU irradiation typically consists
of approximately 900 radiation pulses, we used a subset consisting of the last 500 pulses
to establish a plateau value where accelerator dose rate fluctuations were minimized. In
this way, the precision of individual DPP measurements was found to be 2.7% (1 SD) at
10 cm depth (approximately 0.182 mGy per pulse), using the smallest scintillator (1 mm
length). The reproducibility obtained from consecutive irradiations was found to be within
0.4% (1 SD) for a 16.6 cGy accumulated dose. It should be emphasized that linac-
inherent DPP fluctuations always contribute to the uncertainty of dose estimates. Measuring
the target current within the 500 pulse interval revealed fluctuations of approximately
1.5% (1 SD).
The feasibility of dose-per-pulse measurements in medical dosimetry requires sufficient
signal per pulse to provide high sensitivity and dosimetric precision. The DPP precision
depends on the overall system throughput and therefore on the size of both detected signal
contributions (A and B). Parameters such as the PMT cathode luminous sensitivity, the
attenuation through the optical fibre, the scintillator size and the fibre–scintillator coupling
efficiency all affect the system throughput and must all be optimized to enhance the system
sensitivity and DPP precision. Depending on the scintillator length, fibre length, coupling
efficiency, field size and irradiation depth, the uncertainty of DPP measurements presented
in this study varied between 0.9% and 4.1% (1 SD). A clear correlation between the
magnitude of the detected signal and the relative standard deviation was evident from
measurements for arbitrary depths, field sizes and probes of different scintillator sizes,
emphasizing the importance of optimizing the light collection efficiency through the entire
dosimetry system. While the first version of the ME04 system sampled the decay of
an RC circuit at 50 kHz sampling rate with several samples per pulse (Beierholm et al
2010), the new switched-integrator method has reduced timing errors and intrinsic voltage
fluctuations of the hardware. This development has improved the measurement precision
of the system by approximately a factor 2. In addition, since each synchronization pulse is
only sampled once, the amount of data is reduced while maintaining the same pulse-inherent
information.
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Figure 2. Measured dose versus depth for a maximal stem signal configuration of a 25 MU
irradiation. Assessment of the success of stem signal removal. Only the fibre is in the beam;
for an ideal dosimeter, the dose measured would be equal to the out-of-field dose at the point of
measurement. Error bars (1 SD) correspond to the accumulated dose uncertainty.
3.2. Stem signal removal accuracy and calibration stability
When using fibre-coupled organic scintillators, the largest source of systematic measurement
errors is the parasitic stem signal originating from the optical fibre itself. Therefore, the
accuracy of such a dosimetry system is critically dependent on the ability to suppress the
stem signal. If correctly calibrated, the signal contribution from the optical fibre should be
completely suppressed and the dose measurements should be independent of the orientation
of the optical fibre, the length of irradiated fibre, or the irradiation depth. Lambert et al
(2009) suggested a dependence of the stem signal spectrum on the incident energy spectrum
in a water phantom, and recommended that any stem signal removal procedure that relied
on the constancy of the stem signal spectrum be tested as a function of depth. This test was
performed and the results are shown in figure 2, where estimated dose to the scintillator is
plotted against depth. The scintillator was in this case outside the main radiation field with the
fibre going straight through the field. Therefore, the dose absorbed in the scintillator should
be independent of the position of the fibre in the phantom. No significant deviation from the
mean value was seen with depth, and the standard deviation of 0.8 mGy was comparable to
the overall 0.6 mGy measurement reproducibility.
The dose to the TLDs out-of-field was measured to be 1.3 ± 0.4 mGy for a 10 cm ×
10 cm field. The uncertainty on the out-of-field dose during calibration hereby induces a
0.4 mGy systematic uncertainty on dose estimates. This is not significant compared with
measurement reproducibility, although measurements of doses out-of-field would be more
severely affected than in-field measurements. This error is circumvented if applying the
calibration configuration described in Lacroix et al 2008 and Beierholm et al 2010, which
however requires irradiations at known doses at small and large field sizes.
Measurement reproducibility, calibration uncertainty and PMT temperature correction
uncertainty all contribute to the overall measurement uncertainty of the ME04 system. An
uncertainty budget, giving approximate values of the combined uncertainties of pulse-resolved
as well as accumulated dose measurements, is presented in table 1 for a 1 mm length scintillator
in a 10 cm × 10 cm field, at 1.5 and 10 cm depths.
3.3. Small static field measurements
OF measurements for 10 cm × 10 cm down to 0.6 cm × 0.6 cm fields at 10 cm depth are
presented in figure 3, where they are compared with MC simulations of a scintillator in solid
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Figure 3. OF measurements for field sizes of 10 cm × 10 cm down to 0.6 cm × 0.6 cm at 10 cm
depth. Filled circles: organic scintillator probes in solid water. Solid line: MC calculated dose
to the scintillator in solid water. Hollow circles: reference IC measurements in water. Solid lines
in residual plot represent uncertainties on MC simulations. Error bars (1 SD) correspond to the
accumulated dose uncertainty.
Table 1. Uncertainty budget for pulse-resolved and accumulated dose measurements. All
uncertainties are given as 1 SD.
Delivered Total Total
Depth dose Reproducibility Calibration PMT uncertainty uncertainty
(cm) Measurement (mGy) (%) (%) (%) (%) (mGy)
1.5 Per pulse 0.277 2.13 0.17 0.10 2.14 0.006
1.5 Accumulated 250.0 0.28 0.17 0.10 0.34 0.850
10.0 Per pulse 0.182 2.72 0.26 0.10 2.73 0.005
10.0 Accumulated 166.0 0.40 0.26 0.10 0.49 0.807
water as well as to IC measurements in water. The scintillator measurements agreed with
MC calculations with a maximum deviation of 1.5%. Considering the IC measurements, the
scintillator measurements agreed to within 0.7%, while the MC simulations differed from
the IC measurements by maximum 1.3%. An agreement within 1.4% was observed between
measurements and MC calculated dose to water (plot not shown). It should be noted that the
scintillator OF measurements also compared well with the ones recently presented by Klein
et al (2010).
PDD measurements for the 10 cm × 10 cm and 0.6 cm × 0.6 cm fields are presented
in figure 4, for depths of 1 cm down to 20 cm. For both field sizes, measured dose to the
scintillator is compared with MC calculated dose. For the 10 cm × 10 cm field, measurements
agreed with MC simulations to within 0.9%. For the 0.6 cm × 0.6 cm field, most measurements
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Figure 4. PDD measurements for an organic scintillator probe in solid water for 10 cm × 10 cm
field size (left), and for 0.6 cm × 0.6 cm field size (right). Solid line: MC simulated dose to the
scintillator in solid water. Solid lines in residual plot represent uncertainties on MC simulations.
Error bars (1 SD) correspond to the accumulated dose uncertainty.
were within 0.9% agreement with MC while the measurement at 20 cm depth displayed a
3.2% lower PDD value compared with MC. Similarly, the measurements agreed within 1.8%
with MC-simulated PDD for water, except for the measurement at 20 cm depth which was
5.0% too low compared with MC (plot not shown). The discrepancy at 20 cm depth was likely
caused by erroneous probe–isocentre alignment, as a probe in solid water is hard to align with
the field isocentre compared with a probe in a water tank for small fields, especially at large
depths. Measurements using radiochromic film as well as MC simulations suggested that a
misalignment between the scintillator and the beam isocentre of 1 mm in either direction leads
to a dose underestimation of approximately 6%.
The volume averaging effect was examined by using scintillators of 1–10 mm lengths to
measure isocentre dose as a function of dosimeter size in a 0.6 cm × 0.6 cm field at dmax. The
measurements were compared with MC calculations and radiochromic film measurements,
and are shown in figure 5. The insert of figure 5 shows the lateral dose profile of the field,
measured with radiochromic film. For a 1 mm long scintillator, the dose estimate is averaged
over a 1 mm interval around the central axis of the field profile; for a longer scintillator, the
dose is averaged over a larger area and the peak dose is underestimated accordingly. The use
of scintillators longer than 2 mm was found to induce a dose underestimation of 2% or higher.
The use of dosimeters this large is therefore strongly discouraged in small field dosimetry,
since the enhancement in signal magnitude and precision comes at the expense of systematic
measurement errors due to volume averaging. Large discrepancies between the scintillator,
MC and film are evident when the dosimeter is comparable to or much larger than the size of
the field. For lengths shorter than 5 mm, the OF estimates obtained with the scintillator, film
and MC agree within 2.1%.
3.4. Pulse-resolved measurements
Figures 6(a) and (b) show an example of DPP measurements for the first 20 gun pulses of
beam delivery, performed using two probes at 10 cm and 20 cm depth. Part (a) shows the
response of the probe at 10 cm depth for the first 20 gun pulses of beam delivery. For each
synchronization pulse, the response of the scintillator is compared with the measured target
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Figure 5. Estimated isocentre dose in a 0.6 cm × 0.6 cm field at dmax as a function of dosimeter
size. Data are normalized to values corresponding to 1 mm length. Solid circles: dose measured
with organic scintillator probes in solid water. The x and y error bars are the uncertainty estimates of
the scintillator length and probe–isocentre alignment, respectively. Hollow circles: MC calculated
dose for a scintillator in solid water. Error bars are smaller than the symbols. Solid line:
dose measured with radiochromic film. The dashed lines indicate the ±2% deviation from the
normalization point. Insert: lateral dose profile of the 0.6 cm × 0.6 cm field, measured with
radiochromic film subjected to a 500 MU irradiation at dmax.
current, which has been normalized to the same scale as the measured mean DPP. Every
second measurement yields zero DPP because the pulse repetition frequency (dose rate) is half
of the maximum value, meaning that there is no gun pulse for every second synchronization
pulse. The transient behaviour is evident and comparable for both the scintillator and target
current measurements. Part (b) shows the measured quality factor of the radiation beam,
represented by the TPR20,10 value, obtained from the DPP simultaneously measured using the
probe at 10 cm depth and the one at 20 cm depth. The TPR20,10 value is seen to fluctuate with
a 5.8% standard deviation around a constant value of 0.667 for the first 20 pulses. For the
total number of pulses a mean value of 0.666 ± 0.001 was obtained, being comparable to the
expected value of 0.669 measured using a Farmer chamber (Sjo¨stro¨m et al 2009). This shows
that the radiation quality of the beam can be considered constant on the per-pulse level, for the
whole irradiation as well as in the transient. The transient behaviour is characteristic to the
individual Varian 2300 iX linac used in this study, and is distinctively different from previous
experiments performed on an older linac model (Varian 21 EX), as depicted in figure 6,
part (c).
The figure shows the start-up transient (normalized DPP) for five irradiations using the
2300 iX compared with an irradiation using the 21 EX, all at 300 MU min−1 dose rate. The
data for the 21 EX were part of the study presented in Beierholm et al (2010). While the 21 EX
apparently reaches stable dose per pulse after 20–30 pulses, the 2300 iX reaches a stable level
after merely 5–10 pulses. These measurements show a clear dosimetric difference between
the linacs concerning dose rate stability, potentially influencing the accuracy of linac dose
delivery for small dose segments (on the order of 1 cGy). According to Konnoff et al (2011),
there appears to be general consensus in the literature on the under-delivering of dose for
small dose segments, regardless of linac build. However, figure 6 indicates that the degree of
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Figure 6. Transient behaviour for dose delivery at 300 MU min−1 dose rate. (a) DPP measured at
10 cm depth (hollow circles), with the linac target current (filled circles and lines) normalized to
the mean DPP of the irradiation. (b) Measured TPR20,10 per pulse, obtained using two scintillator
probes positioned at 10 and 20 cm depth. Error bars (1 SD) correspond to the uncertainty on DPP
and TPR20,10 per pulse, respectively. (c) Transient behaviour for the Varian 2300 iX (thin lines)
and a Varian 21 EX (thick line).
Table 2. Transient behaviour, number of pulses, DPP precision (1 SD), and the difference between
measured and excepted DPP for irradiations at different field sizes, depths and dose rates.
Field Dose Total Total Transient DPP Meas. Exp. DPP
side Depth rate dose no of no of precision DPP DPP diff.
(cm) (cm) (MU min−1) (Gy) pulses pulses (%) (mGy) (mGy) (%)
10.0 1.5 100 0.250 896 16 2.2 0.2792 0.2790 0.1
10.0 1.5 200 0.250 899 18 2.3 0.2784 0.2781 0.1
10.0 1.5 300 0.250 900 15 2.1 0.2773 0.2778 −0.2
10.0 1.5 400 0.250 903 17 2.2 0.2769 0.2769 0.0
10.0 1.5 500 0.250 903 15 2.3 0.2757 0.2769 −0.4
10.0 1.5 600 0.250 905 20 2.2 0.2760 0.2762 −0.1
10.0 10.0 300 0.166 903 14 2.7 0.1826 0.1823 −0.6
10.0 20.0 300 0.095 902 15 3.6 0.1052 0.1039 −0.3
0.6 1.5 300 0.175 903 11 2.3 0.1937 0.1942 −0.2
0.6 10.0 300 0.099 902 10 3.1 0.1091 0.1096 −0.4
0.6 20.0 300 0.051 903 14 4.1 0.0551 0.0577 −3.4
under-dosing is linac specific. An interesting application of the new dosimetry system would
be to compare the precision of dose delivery on a pulse scale for a representative assortment of
linac builds used in hospitals, not only for static beam delivery but also for small IMRT plan
segments. Table 2 shows examples of beam characteristics for various dose-per-pulse values
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(i.e. field sizes and depths) and pulse repetition frequencies (i.e. dose rates). The transient
pulses at the start of irradiation were defined as the pulses exhibiting a dose value being lower
than the mean plateau value by more than two standard deviations. For each irradiation, the
expected DPP was calculated from the MC simulations of the scintillator in solid water and
the total number of pulses. A small change in the total number of pulses was seen with
dose rate. The DPP values for different field sizes and depths were comparable to the PDD
values presented in section 3.3, confirming the correlation between pulse-resolved dose and
accumulated dose.
4. Conclusion
We present a dosimetry system based on fibre-coupled organic scintillators to be used for
dose measurements in dynamic and stereotactic radiotherapy. Due to 0.1 ms readout time,
the system can measure the dose delivered for each individual linac radiation pulse, enabling
detailed time-resolved QA of small dynamic radiotherapy dose increments. The presented
system configuration measures the absorbed dose with an uncertainty within 2.7% per pulse
and within 0.5% for the accumulated dose (1 SD) at 10 cm × 10 cm field size and 10 cm depth.
No significant discrepancies were found between measurements and MC simulations for field
sizes down to 0.6 cm × 0.6 cm. The significance of the pulse-resolution capability of the
system can be further explored by comparing the fluctuations in dose rate during irradiations
for different linacs and beam energies, and ultimately by performing pulse-resolved QA of
gated 4D radiotherapy and IMRT segments. This study therefore shows that the system
presents a suitable and promising choice for reference dosimetry and quality assurance in
advanced radiotherapy.
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Abstract
The EPR signal of an alanine dosimeter is typically converted to dose by
using a reference spectrum. Spectral differences might necessitate correction
factors. In this study, the need for energy and perturbation correction factors
in small field dosimetry of MV photon beams were investigated by means of
Monte Carlo simulations. The intrinsic dependencies of the detector material
alone rather than that of the entire dosimetry system was studied.
DOSRZnrc was employed to score the dose to an alanine voxel (Dalan)
in an otherwise homogeneous water phantom with an outer radius of 20 cm.
The ratio of volume averaged doses, f ≡ Dalan/DH2O, was studied for three
situations: as a function of the field diameter (i), as a function of the detector
size (ii) and as a function of depth for a large field (iii).
A correction factor of f ≈ 0.98 was found for most situations. However,
as the field diameter approached the detector diameter the correction factor
increased. The same effect was found for very shallow depths (< 1 cm) for a
10 cm diameter field.
The results of this study illustrates that f is constant for a large range
of field sizes, detector sizes and depths. However, as the field size becomes
of the order of the detector size or the field size becomes very small (e.g. a
diameter of 0.5 cm) this breaks down.
The range of siutations exhibiting a constant f is likely to be sufficient
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for most applications in radiation therapy. Thus, only in extreme cases are f
of concern in dosimetry for radiotherapy and in those cases can f potentially
be determined by Monte Carlo simulations.
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1. Introduction
Alanine/EPR has been suggested as a suitable system for radiotherapy
dosimetry ((Anton, 2005, 2006)), in particular, for non–reference situations,
such as for small field sizes and composite beam delivery (e.g. IMRT and
VMAT). The appealing features of alanine are close–to–water equivalent in-
teraction properties, dose linearity up to the kGy range, small energy and
dose rate dependence, limited influence of environmental factors, non destruc-
tive read out, and small size. The EPR signal from the detector irradiated
with an unknown dose is related to dose to water through a calibration curve
obtained by measuring the EPR signal from detectors irradiated to known
doses in a large 60Co field under conditions of CPE. Sanches-Doblado et al.
(2003) demonstrated that the beam energy spectrum are significantly differ-
ent for small field sizes compared to a 10×10 cm2 field size situation. For
small field sizes, lateral CPE does not even exist along the CAX and Li et al.
(1995) found that it requires a field diameter of at least 2.6 cm to have lat-
eral CPE along the CAX in a 6 MV photon beam. The photon spectrum
emitted by the linac will also differ between small and large field sizes due to
differences in scatter contribution (Sanches-Doblado et al., 2003). Moreover,
the perturbation on the field by the detector itself becomes increasingly im-
portant with decreasing field size (Das et al., 2008). The energy dependence
of alanine in the MV photon range has been studied previously (Waldeland
and Malinen (2011); Anton et al. (2008); Bergstrand et al. (2003); Zeng et al.
(2004)), but the studies have been limited to situations under which reference
conditions apply (i.e. large fields, high dose, low gradient, CPE), which may
not be the case in IMRT and small fields.
In small–field MV photon beam dosimetry (e.g. output factor measure-
ments), the general aim is to determine the absorbed dose, D, at a single
mathematical point. Alanine detectors, however, have a finite size and they
therefore provide an average dose over the detector volume, D (Aspardakis
et al., 2010). For large, homogeneous irradiation fields, D and D are iden-
tical, but for small fields, correction factors are needed to estimate D from
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D. The volume averaging effect can be eliminated if the detector is made
sufficiently small or if the EPR–spectrometer only reads parts of the detector
signal (Anton et al., 2011).
The purpose of this study was to use Monte Carlo (MC) simulations in
order to investigate the effect of the perturbation and the energy response of
alanine for dosimetry in small 6 MV photon beams as function of detector
and field size and depth. The prime quantity of interest is the ratio of the
volume–averaged dose to the alanine detector versus the volume–average dose
over a voxel of water of the same size as the detector (f ≡ Dalan/DH2O).
2. Material and Methods
2.1. Alanine Probes
Harwell alanine probes (batch AM 576C) were considered as these are
used by the authors for dose measurements. The nominal composition of
Harwell alanine probes (90.9% L–α–alanine and 9.1% parrafin binder) were
processed through EGSnrc (Kawrakow (2000a), Kawrakow (2000b)) to com-
pute interaction cross sections. The density was determined by weighing and
measuring 15 probes from the same batch and found to be ρ=1.24 gcm−3.
2.2. Monte Carlo Simulation
DOSRZnrc was employed to score the dose to an alanine voxel (Dalan)
in an otherwise homogeneous water phantom with an outer radius of 20
cm. Each simulation geometry was reproduced for a homogeneous water
phantom, using the same dimensions, and thereby obtaining the dose to
water, DH2O. Thus, the doses scored are averaged over the same volume. The
center of the alanine/H2O voxel, where the dose was recorded, was located at
a depth of 10 cm on the central axis. The 6 MV photon spectrum previously
published by Mohan et al. (1985) was used as the input for the simulation
throughout the study. The advantage of using this spectrum is that it is well
documented and public available as it is distributed with EGSnrc. Moreover
it is computationally efficient to use a spectrum file, rather than a phase
space file and/or a beam treatment head simulation, as input to DOSRZnrc.
The spectrum in question corresponds to the bremsstrahlung spectrum for a
10×10 cm2 field emitted by a Varian Clinac (in 6MV mode). The spectrum
file was used in combination with DOSRZnrc source 0 (i.e. parallel beam
incident from the front). The number of histories were chosen so that the
statistical uncertainty was no larger than 0.4% in the voxel of interest. The
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only variance reduction turned on was photon forcing (for the first generation
particles only) and cut off energies were 521 keV (including rest mass) and
10 keV for electrons and photons, respectively.
3. Results
The ratio of volume averaged doses f ≡ Dalan/DH2O was studied as func-
tion of the field diameter for two different detector sizes i.e. with detector
diameter (ø) and height (h): (ø,h)=(5,2.5) mm and (ø,h)=(1,2.5) mm, re-
spectively (figure 1). A correction factor of f ≈ 0.98 is needed to correct
Dalan to DH2O for fields with a diameter of ≈ 1 cm and above for both de-
tector sizes. However, f increases more rapidly for the larger detector as the
field diameter decrease below 1 cm, e.g. f ≈ 1.03 and f ≈ 1.00 for a field
diameter of 0.5 cm for the larger and smaller detector, respectively.
In order to further study the dependency of f on field– and detector size,
f was evaluated for a range of detector sizes for three field diameters: 0.5,
1.0, 4.0 cm (figure 2). For the two largest fields f ≈ 0.98 for all detector
sizes except, possibly, for the smallest detector (ø=1 mm). However, for the
smallest field size (0.5 cm) f increases with the detector diameter, illustrating
that the detector needs to be very small for such a small field size.
In order to evaluate whether f is depth dependent, f was evaluated
as a function of depth for a 10 cm diameter field and a detector size of
(ø,h)=(5,2.5) mm (figure 3). f is fairly constant for depths ≥1 cm, but
deviates for shallower depths. A correction factor of 0.9779(±0.0067)1 was
found for depths ≥1 cm. A ratio of volume averaged doses of 0.9779 is on
the order of what to be expected when looking at alanine/water restricted
mass stopping power ratios and mass energy absorbtion coefficient ratios.
A depth independent detector is a much desired feature as measurements
may be conducted at any depth without additional considerations. Depth
invariance is to be expected as alanine is rather water equivalent. For the
shallowest depth, however, f was ≈ 1.01. This might be due to the substan-
tially different energy spectrum at such a shallow depth. The result may not
be accurate as contaminating electrons, which contribute to the dose at shal-
low depths, were omitted in the simulation. The impact of contaminating
electrons on f for shallow depths was not further studied.
1The reported uncertainty is the standard deviation of the average value for depths ≥1
cm.
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Figure 1: The ratio of volume averaged doses, f , as function of field diameter for two
detector sizes. f ≈ 0.98 for fields with a diameter of ≈ 1 cm and above. Error bars are
the combined statistical uncertainty of the MC simulations.
4. Discussion
If alanine is to be used as a detector for radiotherapy the correction factor
f needs to be constant or its variation known. Obviously, in the ideal case
f is constant and thus calibrated out of the equation and one does not need
to think further thereof. Second best, is that its variation as function of e.g.
field size and detector size is known. The results of this study illustrates
that f is constant for a large range of field sizes, detector sizes and depths.
However, as the field size becomes of the order of the detector size or the field
size becomes very small (e.g. a diameter of 0.5 cm) this breaks down. The
detector cannot be made infinitely small. One practical obstacle is that the
handling of the detector becomes cumbersome if it is too small and further
the signal to noise ratio gets lower as the detector becomes smaller. However,
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Figure 2: The ratio of volume averaged doses, f , as function of detector diameter (ø) for
three field sizes. f is fairly constant over the range of detector sizes for the larger two
field sizes whereas this does not hold true for the smallest field size. Error bars are the
combined statistical uncertainty of the MC simulations.
a detector size of (ø,h)=(5,2.5) mm is easily handled and as illustrated f is
constant down to field sizes of the order of ø=1 cm for such a detector size.
This will most likely be sufficient for most applications within radiotherapy.
Even for field sizes of this order, and certainly for smaller field sizes, other
problems arise anyhow such as position inaccuracies of the detector in the
beam. For instance, Beierholm et al. (2011) states that a 1 mm misalignment
between the isocenter and a 1 mm wide scintillator probe for a 0.6×0.6 mm2
square field leads to a dose measurement error (at 20 cm’s depth) in the order
of 6%.
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Figure 3: The ratio of volume averaged doses, f , as function of depth (d) for a field with a
diameter of 10 cm and detector size (ø,h)=(5,2.5) mm. The ratio of volume averaged doses,
f , was fairly constant at depths ≥1 cm, with an average of ≈ 0.98. For the shallowest
depth (0.5 cm), a value of ≈ 1.01 was needed in order to correct Dalan to DH2O. Error
bars are the combined statistical uncertainty of the MC simulations. The average f for
1 ≤ d ≤ 15 cm is included in the figure (dashed line).
5. Conclusions
This work demonstrates that f is constant for a large range of depths,
detector– and field sizes. This range is sufficient for most applications in
radiation therapy. Thus, only in extreme cases are f of concern in dosimetry
for radiotherapy and in those cases can f potentially be determined by Monte
Carlo simulations.
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E
P R E PA R AT O RY S T U D Y C O M PA R I N G M C T P T O
C L I N I C A L D O S E C A L C U L AT I O N A L G O R I T H M S
A preparatory study using the workflow, as described in Chapter 6,
was conducted for ten palliative lung cancer patients, in which MC
computed dose distribution was compared to that generated by clini-
cally available dose calculation algorithms. However, the MC model
used was not identical to that described in Chapter 3. The error in-
troduced by using a non–optimal MC model is not accounted for.
Phantoms were created using the HU–to–density–relationship given
in Kawrakow et al. [1996], rather than one obtained for the CT scanner
used. Moreover, no specific considerations were made to the voxels
outside of the patient external outline, as is done by the TPS. Errors
due to improper patient modeling are also not considered.
e.1 introduction
PB dose calculation is frequently used for lung cancer treatment plan-
ning. If PB based treatment plans generated with high and low energy
(e.g. 15 MV or 18 MV and 4 MV or 6 MV, respectively) are compared,
the ones based on the higher energies will in many cases appear more
favorable. However, it is well known that the inaccuracies introduced
by the PB dose calculation generally are larger for higher energies and
depend on several parameters such as field size and geometry (e.g.
[Behrens, 2006], [Klein et al., 1993], [Tsiakalos et al., 2006], [Vander-
straeten et al., 2006], [Krieger and Sauer, 2005]). Therefore, usually low
energy is chosen as default for lung treatments. This begs the question
whether this always is the best choice. For some cases, treatment plans
based on higher energies may be more favorable. In order to address
this question, more accurate dose calculation methods (e.g. MC) must
be employed. PB and a more sophisticated superposition/convolu-
tion algorithm, AAA, were compared to MC–based dose calculations
clinical IMRT and AP–PA lung treatments.
e.2 material and methods
All patients previously treated with AP–PA 6 MV irradiation based
on PB dose calculation at the Copenhagen University Hospital, Herlev.
All patients were planned to a total of 25 Gy to the normalization
point delivered in five fractions. For each patient a treatment plan for
15 MV was generated based on the 6 MV treatment plan. All treatment
plan geometries were kept the same including field sizes, MLC and
217
218 preparatory study comparing mctp to clinical dose calculation algorithms
collimator rotations. Only the beam energy were changed to 15 MV
and the plan recalculated with the PB algorithm giving the same dose
to the prescription point as for the 6 MV plan (i.e. 5 Gy×5). Both
the 6 and 15 MV treatment plans were recalculated with the AAA
using identical MLC settings and monitor units. Dose calculation was
conducted using Varian Eclipse build 8.2.24.10720 (Varian Medical
Systems, Inc. Palo Alto, CA, USA) modeling a Varian 2300 iX (Varian
Medical Systems, Inc., Palo Alto, CA, USA). Except for special cases
only the patient outline is delineated for palliative lung treatments
at our institution. Therefore a GTV, the esophagus, the lungs, and
the spinal cord were delineated retrospectively for this study by a
radiation oncologist with specialized knowledge in lung radiation
therapy.
When it comes to target coverage, generally, a PTV generated by
adding a symmetric or asymmetric margin to the GTV or CTV is the
most interesting volume to study for curative patients. However, for
palliative patients this may not be the case. For the patients in this
study the delineated GTV is the volume of primary interest. There is
no CTV as microscopic spread is not of primary concern. Obviously,
in order to cover the GTV some margin must be added to adequately
take systematic and random positional errors, beam penumbra and
organ motion into account (e.g. Ottosson, Baker, Hedman, Behrens
and Sjöström [2010]). Such a margin is added in the sense that the
field size is always made 1-2 cm larger (in all directions) than what is
considered the visual target on the CT.
All algorithms (PB, AAA and MC) used identical setups for each
treatment plan and all differences in the resulting dose distributions
were solely due to discrepancies between the dose calculation algo-
rithms. Throughout this study MC is considered the golden standard
or “ground truth”. Unless explicitly stated all references to dose distri-
butions or dose differences are based on the MC calculations.
e.3 results and discussion
In general, the GTV coverage was better for the 15 MV plans and the
dose was more homogeneous i.e. for the 6 MV plans the minimum
dose to the GTV was lower and the maximum dose to the GTV was
higher. These trends were also reflected in the PB and AAA calcu-
lations (Figure 84). However, the calculated dose to the prescription
point (Table 19) varied between the algorithms and resulted in shifts
of the DVHs to higher and lower dose levels. Compared to PB a higher
dose to the prescription point was calculated by MC in eight and six
(out of the ten) treatment plans for 15 MV and 6 MV, respectively.
On average there was close agreement between the algorithms in the
prescription point dose with a maximum deviation of 3.2% (Table 19).
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Figure 84: DVH (GTV, esophagus, and total lung volume) for patients 01
and 05 to the left and right, respectively. MC was used as ground
truth. The dose to the GTV was more homogeneous for 15 MV (as
compared to 6 MV). For the esophagus more dose was delivered
utilizing 15 MV. These trends were also reflected in the PB and
AAA calculations. The dose to the lungs were lower for 15 MV.
This was reflected in the AAA calculations but not in general
predicted by PB.
In the border regions between tissues of different density there will
be build up and –down effects. For instance, if a beam passes though
the series of tissues: lung – tumor – lung, there will be a build up
effect in the more dense tumor tissue at the proximal (entrance) side
and a much smaller build down in the tumor at the distal (exit) side
of the tumor. These effects are more pronounced for higher energies.
Thus, it might be anticipated that a small part of the GTV would be
underdosed by the higher energy as compared to the lower energy.
However, as seen above this was not the case. In order to investigate
the reasons for this the AP–PA profiles through the normalization
point (Norm. point) for patient 01 were examined (Figure 85). Based
on both PB, AAA and MC it was clear that the dose to the lung was
lower for 15 MV than for 6 MV along this profile. For the PB and AAA
calculations the dose to the GTV was very similar for 6 MV and 15
MV, though sightly more homogeneous for 15 MV. However, the MC
calculations clearly showed a better and slightly more homogeneous
GTV coverage for 15 MV (Figure 85A).
The build up effect on the anterior part of the GTV for the AP
beam for 15 MV was larger than for 6 MV. However, this was counter
balanced by a higher dose in the same volume from the PA beam
for 15 MV as compared to 6 MV (close to X, Figure 85B). Similar,
for the posterior part of the GTV the build up effect of the 15 MV
PA beam was counter balanced by the higher dose of the AP beam
as compared to 6 MV. At the same time the build down effect was
negligible. Therefore, for 15 MV there was not a small part of the GTV
that received less dose as compared to 6 MV. For patient 01 there was
a small volume containing both lung tissue and more dense soft tissue
close the anterior border of the GTV (between V and X, Figure 85).
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Table 19: AAA and MC calculated dose to the prescription point as percent-
age of the prescribed dose (all PB calculations resulted in 100% to
the precription point).
Dose [%] 6MV 15MV
Patient AAA MC AAA MC
01 97.8 100.2 97.9 102.6
02 99.2 101.3 99.1 100.9
03 99.2 101.2 99.4 100.3
04 100.3 101.8 99.7 101.5
05 97.7 100.5 98.1 99.7
06 100.3 97.8 100.4 100.7
07 96.8 99.9 97.4 100.9
08 99.0 102.1 98.2 100.9
09 101.9 99.9 100.5 101.4
10 98.5 98.6 97.4 98.7
Interval [96.8;101.9] [97.8;102.1] [97.4;100.5] [98.7;102.6]
Average 99.1 100.3 98.8 100.8
This may enhance the dose in the anterior part of the GTV slightly.
Considering this volume as part of the GTV corresponds to a “very
bad scenario” for utilizing 15 MV. However, even in this case, the
dose for 15 MV was higher than for 6 MV along the studied profile
(Figure 85A assuming the GTV to be between V and Y).
For patients 02, 09 and 10 the dose to the esophagus is irrelevant
since the esophagus is not within the irradiated volume. For all other
patients similar trends are seen as for the GTV i.e. more dose was
delivered to the esophagus for the 15 MV plans. This trend was
reflected in the PB and AAA calculations. However, as for the GTV,
there was a shift in the calculated dose level between the algorithms
(Figure 84).
In general a lower dose was delivered to the total lung volume for
the 15 MV plans. This trend was reflected for AAA but not in general
for PB (figure Figure 84). However, for patient 05 and 07 this trend
was even reflected in the PB calculations. For the other eight patients
in the study PB predicts a higher lung dose delivered by the 15 MV
plans. This defect of the PB calculations is well known and expected
(e.g. Ottosson, Karlsson and Behrens [2010]).
In summery the differences between the three calculation algorithms
are of limited concern when it comes to the palliative patients included
in this study. The AAA calculations reflect the trends in the relative
differences between 15 and 6 MV plans e.g. more homogeneous dose
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Figure 85: Profiles in the AP direction through the normalization point
(Norm. point) for patient 01. In A profiles for all calculation al-
gorithms and energies are shown. In B the profiles for the MC
calculations are shown separately for each of the two beams i.e.
the sum of the profiles for a given energy in B is equal to the
profile for the corresponding MC profile in A. The vertical dashed
lines (U, V, X, Y and Z) in A and B indicate borders between dif-
ferent tissue types e.g. lung, soft tissue. The corresponding points
are indicated in C where also the line along which the profile is
plotted is indicated. Further the Norm. point is indicated in both
A, B and C. The yellow lines in C indicate the field borders and
the structure drawn in read is the GTV. The little bump (higher
dose) in the MC profiles at ≈ 18 cm depth is caused by a few
voxels of bone.
to the GTV for the 15 MV plans. The same is true for PB except in
the lung. The absolute dose levels are shifted and the trend is that
the PB calculations actually is closer to MC than AAA except for the
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lungs. However, the largest differences between the three calculation
algorithms found in the ten patients were for patient 01 where the
differences still is within clinical acceptable levels for the palliative
patients in this study (Figure 84).
e.4 conclusions
The 15 MV AP–PA treatment plans for the palliative lung tumor
patients included in this study consistently resulted in more homoge-
neous target (GTV) coverage regardless of dose calculation method.
This came at the expense of a higher dose to the esophagus for the
patients where the esophagus was within the irradiated volume. The
lung dose was also lower for 15 MV compared to 6 MV, based on AAA
and MC dose calculations, but not for PB.
Based on the findings of this study, there is no reason to abandon
15 MV for AP–PA lung irradiations of the type studied. The choice
whether to use 6 or 15 MV can be based on AAA or PB calculations.
However, it is still advisable to use low energies as default for tumor
sites involving large inhomogeneities unless a precise dose calculation
algorithm is available.
The large disagreement between the analytical algorithms (PB and
AAA) and MC (see Figure 85) is most likely attributed to improper
calibration of the MC model and erroneous patient modeling rather
than the particle transport itself. The magnitude of the error introduced
was not further investigated.
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